<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cas="urn:cas:" xmlns:date="http://mulgara.org/mulgara/tool/DateExtractor#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:document="http://mulgara.org/mulgara/Document#" xmlns:feature="http://mulgara.org/mulgara/tool/FeatureExtractor#" xmlns:med="urn:medline:" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941725">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Methylmercury accumulation in tissues and its effects on growth and appetite in captive great egrets.</document:title>
<document:abstractSection>To test the hypothesis that fledging wading birds would be more at risk from mercury toxicosis than younger nestlings, captive great egret nestlings were maintained as controls or were dosed from 1- to 14-wk-old with 0.5 or 5 mg methylmercury chloride/kg wet weight in fish. Birds dosed with 5 mg/kg suffered from subacute toxicosis at wk 10-12. Growing feather concentrations were the most closely correlated with cumulative mercury consumed per weight. Blood concentrations of mercury increased more rapidly after 9 wk in all groups when feathers stopped growing. Total mercury accumulated in tissues in concentrations in the following order: growing scapular feathers &gt; powderdown &gt; mature scapular feathers &gt; liver &gt; kidney &gt; blood &gt; muscle &gt; pancreas &gt; brain &gt; bile &gt; fat &gt; eye. The proportion of total mercury that was methylated depended upon tissue type and dose group. Selenium accumulated in liver in direct proportion to liver mercury concentrations. After wk 9, appetite and weight index (weight/bill length) declined significantly in both dosed groups. At current exposure levels in the Everglades (Florida, USA) mercury deposited in rapidly growing feathers may protect nestlings from adverse effects on growth until feathers cease growing.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M G Spalding</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P C Frederick</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H C McGill</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S N Bouton</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L R McDowell</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville 32611, USA. rosie@nersp.nerdc.ufl.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Methylmercury Compounds</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:115-09-3">
<cas:registryNumber>115-09-3</cas:registryNumber>
<cas:name>methylmercuric chloride</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7439-97-6">
<cas:registryNumber>7439-97-6</cas:registryNumber>
<cas:name>Mercury</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7782-49-2">
<cas:registryNumber>7782-49-2</cas:registryNumber>
<cas:name>Selenium</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Age Factors</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animal Feed</document:subject>
<document:subject>Appetite</document:subject>
<document:subject>Bird Diseases</document:subject>
<document:subject>Birds</document:subject>
<document:subject>Body Weight</document:subject>
<document:subject>Feathers</document:subject>
<document:subject>Feces</document:subject>
<document:subject>Female</document:subject>
<document:subject>Fishes</document:subject>
<document:subject>Kidney</document:subject>
<document:subject>Liver</document:subject>
<document:subject>Male</document:subject>
<document:subject>Mercury</document:subject>
<document:subject>Mercury Poisoning</document:subject>
<document:subject>Methylmercury Compounds</document:subject>
<document:subject>Selenium</document:subject>
<document:subject>Sex Factors</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Tissue Distribution</document:subject>
<document:subject>Appetite; drug effects</document:subject>
<document:subject>Bird Diseases; chemically induced</document:subject>
<document:subject>Bird Diseases; physiopathology</document:subject>
<document:subject>Birds; growth &amp; development</document:subject>
<document:subject>Birds; metabolism</document:subject>
<document:subject>Birds; physiology</document:subject>
<document:subject>Body Weight; drug effects</document:subject>
<document:subject>Feathers; metabolism</document:subject>
<document:subject>Feces; chemistry</document:subject>
<document:subject>Kidney; metabolism</document:subject>
<document:subject>Liver; metabolism</document:subject>
<document:subject>Mercury; analysis</document:subject>
<document:subject>Mercury; blood</document:subject>
<document:subject>Mercury Poisoning; physiopathology</document:subject>
<document:subject>Mercury Poisoning; veterinary</document:subject>
<document:subject>Methylmercury Compounds; administration &amp; dosage</document:subject>
<document:subject>Methylmercury Compounds; pharmacokinetics</document:subject>
<document:subject>Methylmercury Compounds; toxicity</document:subject>
<document:subject>Selenium; administration &amp; dosage</document:subject>
<document:subject>Selenium; pharmacokinetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941726">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Histologic, neurologic, and immunologic effects of methylmercury in captive great egrets.</document:title>
<document:abstractSection>Captive great egret (Ardea albus) nestlings were maintained as controls or were dosed with methylmercury chloride at low (0.5), and high doses (5 mg/kg, wet weight) in fish. Low dosed birds were given methylmercury at concentrations comparable to current exposure of wild birds in the Everglades (Florida, USA). When compared with controls, low dosed birds had lower packed cell volumes, dingy feathers, increased lymphocytic cuffing in a skin test, increased bone marrow cellularity, decreased bursal wall thickness, decreased thymic lobule size, fewer lymphoid aggregates in lung, increased perivascular edema in lung, and decreased phagocytized carbon in lung. High dosed birds became severely ataxic and had severe hematologic, neurologic, and histologic changes. The most severe lesions were in immune and nervous system tissues. By comparing responses in captive and wild birds, we found that sublethal effects of mercury were detected at lower levels in captive than in wild birds, probably due to the reduced sources of variation characteristic of the highly controlled laboratory study. Conversely, thresholds for more severe changes (death, disease) occurred at lower concentrations in wild birds than in captive birds, probably because wild birds were exposed to multiple stressors. Thus caution should be used in applying lowest observed effect levels between captive and wild studies.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M G Spalding</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P C Frederick</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H C McGill</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S N Bouton</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L J Richey</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I M Schumacher</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C G Blackmore</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Harrison</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Pathobiology, College of Veterinary Medicine, University of Florida, Gainesville 32611, USA. rosie@nersp.nerdc.ufl.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Blood Proteins</document:subject>
<document:subject>Capsules</document:subject>
<document:subject>Methylmercury Compounds</document:subject>
<document:subject>Serum Albumin, Bovine</document:subject>
<document:subject>Viral Vaccines</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:115-09-3">
<cas:registryNumber>115-09-3</cas:registryNumber>
<cas:name>methylmercuric chloride</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Analysis of Variance</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Bird Diseases</document:subject>
<document:subject>Birds</document:subject>
<document:subject>Blood Cell Count</document:subject>
<document:subject>Blood Proteins</document:subject>
<document:subject>Bone Marrow</document:subject>
<document:subject>Capsules</document:subject>
<document:subject>Encephalitis Virus, Eastern Equine</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hematocrit</document:subject>
<document:subject>Immune System</document:subject>
<document:subject>Lung</document:subject>
<document:subject>Male</document:subject>
<document:subject>Mercury Poisoning</document:subject>
<document:subject>Methylmercury Compounds</document:subject>
<document:subject>Nervous System</document:subject>
<document:subject>Neurologic Examination</document:subject>
<document:subject>Serum Albumin, Bovine</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Support, U.S. Gov't, P.H.S.</document:subject>
<document:subject>Viral Vaccines</document:subject>
<document:subject>Bird Diseases; chemically induced</document:subject>
<document:subject>Bird Diseases; immunology</document:subject>
<document:subject>Bird Diseases; pathology</document:subject>
<document:subject>Bird Diseases; physiopathology</document:subject>
<document:subject>Blood Cell Count; veterinary</document:subject>
<document:subject>Blood Proteins; drug effects</document:subject>
<document:subject>Bone Marrow; pathology</document:subject>
<document:subject>Encephalitis Virus, Eastern Equine; immunology</document:subject>
<document:subject>Hematocrit; veterinary</document:subject>
<document:subject>Immune System; pathology</document:subject>
<document:subject>Lung; pathology</document:subject>
<document:subject>Mercury Poisoning; immunology</document:subject>
<document:subject>Mercury Poisoning; pathology</document:subject>
<document:subject>Mercury Poisoning; physiopathology</document:subject>
<document:subject>Mercury Poisoning; veterinary</document:subject>
<document:subject>Methylmercury Compounds; administration &amp; dosage</document:subject>
<document:subject>Methylmercury Compounds; toxicity</document:subject>
<document:subject>Nervous System; pathology</document:subject>
<document:subject>Neurologic Examination; veterinary</document:subject>
<document:subject>Serum Albumin, Bovine; immunology</document:subject>
<document:subject>Viral Vaccines; immunology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941727">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>The effect of dietary aflatoxin on wild turkey poults.</document:title>
<document:abstractSection>Aflatoxins, toxic metabolites of Aspergillus flavus or Aspergillus parasiticus, cause poor feed utilization, decreased weight gains, depressed immune function, liver dysfunction, coagulation abnormalities, and death in a wide variety of species including humans. Conservationists have become concerned that increasingly popular wildlife feeding or baiting practices could expose wildlife to toxic amounts of aflatoxin-contaminated grains. In particular, the effects of aflatoxins on the wild turkey (Meleagris gallopova silvestris) are of concern because the conspecific domestic turkey is highly susceptible to aflatoxins. To evaluate the effect of dietary aflatoxin on wild turkeys, four groups of 4-mo-old wild turkeys were fed diets containing either 0, 100, 200, or 400 micrograms aflatoxin/kg feed for 2 wk in September and October 1996. Aflatoxin-fed poults had decreased feed consumption and weight gains as compared with control poults. Decreased liver-to-body weight ratios, liver enzyme alterations, slightly altered blood coagulation patterns, and mild histologic changes indicated low-level liver damage. Compromise of cell-mediated immunity was indicated by decreased lymphoblast transformation. The effects were apparent in all treatment groups to variable levels, but significant differences most often were found at 400 micrograms aflatoxin/kg feed. This study shows that short-term aflatoxin ingestion by wild turkeys can induce undesirable physiologic changes; therefore, exposure of wild turkeys to feeds containing aflatoxin levels of 100 micrograms aflatoxin/kg feed or more should be avoided.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C F Quist</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D I Bounous</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J V Kilburn</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V F Nettles</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R D Wyatt</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Poultry Science, University of Georgia, Athens 30602, USA. cquist@cvm.vet.uga.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Aflatoxins</document:subject>
<document:subject>Carotenoids</document:subject>
<document:subject>Aflatoxins</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animal Feed</document:subject>
<document:subject>Blood Cell Count</document:subject>
<document:subject>Blood Chemical Analysis</document:subject>
<document:subject>Blood Coagulation</document:subject>
<document:subject>CD4-CD8 Ratio</document:subject>
<document:subject>Carotenoids</document:subject>
<document:subject>Eating</document:subject>
<document:subject>Immunophenotyping</document:subject>
<document:subject>Liver</document:subject>
<document:subject>Lymphocyte Transformation</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Turkeys</document:subject>
<document:subject>Weight Gain</document:subject>
<document:subject>Aflatoxins; administration &amp; dosage</document:subject>
<document:subject>Aflatoxins; toxicity</document:subject>
<document:subject>Animal Feed; toxicity</document:subject>
<document:subject>Blood Cell Count; veterinary</document:subject>
<document:subject>Blood Chemical Analysis; veterinary</document:subject>
<document:subject>Blood Coagulation; drug effects</document:subject>
<document:subject>CD4-CD8 Ratio; veterinary</document:subject>
<document:subject>Carotenoids; blood</document:subject>
<document:subject>Eating; drug effects</document:subject>
<document:subject>Immunophenotyping; veterinary</document:subject>
<document:subject>Liver; drug effects</document:subject>
<document:subject>Lymphocyte Transformation; drug effects</document:subject>
<document:subject>Turkeys; blood</document:subject>
<document:subject>Turkeys; immunology</document:subject>
<document:subject>Turkeys; physiology</document:subject>
<document:subject>Weight Gain; drug effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941728">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Hematologic and serum chemistry values of the captive European wildcat.</document:title>
<document:abstractSection>Hematologic and serum chemistry values were determined for 20 adult captive European wildcats (Felis silvestris) in Lleida (Catalonia, Spain). Seven wildcats (4 females and 3 males) were captured in the wild and 13 (4 females and 9 males) were born and raised in captivity. Samples were collected between September and December from 1993 to 1998. Blood was obtained by jugular venipuncture after administration of either ketamine and xylazine or ketamine and medetomidine. Females had significantly higher mean eosinophil counts, albumin concentration, (and A/G ratio) and lower mature neutrophil counts, although these differences were not clinically relevant. Results for many of the blood parameters fall within the reference range for domestic cats. Mean values for alanine aminotransferase, aspartate aminotransferase, creatine phosphokinase, and lactate dehydrogenase activities as well as blood urea nitrogen, glucose, and sodium concentrations were higher than the upper limit of the reference range for domestic cats.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>I Marco</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Martinez</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Pastor</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Lavin</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Servicio de Ecopatolog√≠a de Fauna Salvaje, Facultad de Veterinaria, Universidad Autonoma de Barcelona, Bellaterra, Spain. Ignasi.Marco@uab.es</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Animals, Zoo</document:subject>
<document:subject>Blood Chemical Analysis</document:subject>
<document:subject>Carnivora</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hematologic Tests</document:subject>
<document:subject>Male</document:subject>
<document:subject>Reference Values</document:subject>
<document:subject>Sex Characteristics</document:subject>
<document:subject>Animals, Zoo; blood</document:subject>
<document:subject>Blood Chemical Analysis; veterinary</document:subject>
<document:subject>Carnivora; blood</document:subject>
<document:subject>Hematologic Tests; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941729">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Evaluation of zuclopenthixol acetate to decrease handling stress in wapiti.</document:title>
<document:abstractSection>Handling stress and capture myopathy are important consequences of intensively managing wildlife species. Over the last 15 yr, the use of long-acting neuroleptic (LAN) drugs in wildlife has increased, and these drugs have become a valuable tool for decreasing capture and handling stress in many species. At this time, reports on the use of these drugs in North American species are limited. The major objective of this study was to evaluate the use of the LAN, zuclopenthixol acetate (Clopixol-Acuphase), to decrease both quantifiable and subjective measurements of stress and activity in wild wapiti (Cervus elaphus, North American elk). This blinded, randomized study took place in February 1999 in Manitoba (Canada) and involved 11 animals receiving the drug and 12 animals acting as controls. At 24 hr after drug administration, there were measurable and significant decreases in the stress and activity of treated animals versus controls during handling. Treated animals had significantly lower mean body temperatures (39.0 versus 40.6 C), less hemoconcentration (mean packed cell volume 0.42 versus 0.49, mean hemoglobin 159.09 versus 181.75 g/L, mean total protein 65.0 versus 70.25 g/L), lower mean serum cortisol (97.91 versus 139.50 mmol/L), lower mean blood lactate (3.39 versus 5.98 mmol/L), and were less metabolically acidotic (mean pHv 7.45 versus 7.34, mean bicarbonate 29.36 versus 24.25 mmol/L, mean base excess 5.64 versus -0.83 mmol/L). Only control animals had evidence of muscle damage based on serum biochemistry (creatine phosphate values of two animals of 42,080 and 25,887 U/L). No animals developed clinical capture myopathy, and no animals died. Measurable effects of this drug were still apparent at 72 hr post-administration. The results of this study support the use of Clopixol-Acuphase in wapiti as a means to decrease handling stress and activity.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M Read</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N Caulkett</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M McCallister</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Veterinary Anesthesiology, Radiology and Surgery, Western College of Veterinary Medicine, Saskatoon, Saskatchewon, Canada. matt.read@usask.ca</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antipsychotic Agents</document:subject>
<document:subject>Delayed-Action Preparations</document:subject>
<document:subject>Hemoglobins</document:subject>
<document:subject>Lactates</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:50-23-7">
<cas:registryNumber>50-23-7</cas:registryNumber>
<cas:name>Hydrocortisone</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:67-07-2">
<cas:registryNumber>67-07-2</cas:registryNumber>
<cas:name>Phosphocreatine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7440-23-5">
<cas:registryNumber>7440-23-5</cas:registryNumber>
<cas:name>Sodium</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:85721-05-7">
<cas:registryNumber>85721-05-7</cas:registryNumber>
<cas:name>clopenthixol acetate ester</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:982-24-1">
<cas:registryNumber>982-24-1</cas:registryNumber>
<cas:name>Clopenthixol</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:EC%202.6.1.1">
<cas:registryNumber>EC 2.6.1.1</cas:registryNumber>
<cas:name>Aspartate Transaminase</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antipsychotic Agents</document:subject>
<document:subject>Aspartate Transaminase</document:subject>
<document:subject>Body Temperature</document:subject>
<document:subject>Clopenthixol</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Delayed-Action Preparations</document:subject>
<document:subject>Handling (Psychology)</document:subject>
<document:subject>Hematocrit</document:subject>
<document:subject>Hemoglobins</document:subject>
<document:subject>Hydrocortisone</document:subject>
<document:subject>Injections, Intramuscular</document:subject>
<document:subject>Lactates</document:subject>
<document:subject>Male</document:subject>
<document:subject>Motor Activity</document:subject>
<document:subject>Phosphocreatine</document:subject>
<document:subject>Random Allocation</document:subject>
<document:subject>Single-Blind Method</document:subject>
<document:subject>Sodium</document:subject>
<document:subject>Stress</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Antipsychotic Agents; administration &amp; dosage</document:subject>
<document:subject>Antipsychotic Agents; therapeutic use</document:subject>
<document:subject>Aspartate Transaminase; blood</document:subject>
<document:subject>Body Temperature; drug effects</document:subject>
<document:subject>Clopenthixol; administration &amp; dosage</document:subject>
<document:subject>Clopenthixol; analogs &amp; derivatives</document:subject>
<document:subject>Clopenthixol; therapeutic use</document:subject>
<document:subject>Hematocrit; veterinary</document:subject>
<document:subject>Hemoglobins; drug effects</document:subject>
<document:subject>Hydrocortisone; blood</document:subject>
<document:subject>Injections, Intramuscular; veterinary</document:subject>
<document:subject>Lactates; blood</document:subject>
<document:subject>Motor Activity; drug effects</document:subject>
<document:subject>Phosphocreatine; blood</document:subject>
<document:subject>Sodium; blood</document:subject>
<document:subject>Stress; prevention &amp; control</document:subject>
<document:subject>Stress; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941730">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Microbes in tree swallow semen.</document:title>
<document:abstractSection>A frequently hypothesized but poorly studied cost of multiple mating in birds is that exposure to pathogenic sexually transmitted microbes (STM's) can lower reproductive success. Conversely, female birds may benefit from high frequencies of copulation and multiple copulation partners if they receive cloacal inoculations of beneficial STM's that can either protect them against future encounters with pathogens and/or serve as therapy against present infection. We examined the semen of 30 male tree swallows (Tachycineta bicolor) in 1998 to determine the presence and prevalence of potential pathogenic and beneficial STM's. Semen was collected directly from males after applying gentle pressure to the cloaca and we used standard microbiological techniques to identify microbes. We found that 19 of 30 samples contained one or more types of microbes. In these 19 positive samples, we isolated both pathogenic and beneficial microbes from 11, only pathogenic microbes from seven, and only beneficial microbes from one. This variation among males suggests that females would benefit from considering a particular male's potential as a donor of either pathogenic or beneficial STM's as a criterion for mate choice. There were few significant differences between males with pathogen-infected semen and those without pathogens in their semen in measures of size, morphology, and ectoparasite score and feather damage. Likewise, there were few significant differences between males with beneficial Lactobacilli spp. in their semen and those without Lactobacilli spp. in their semen in measures of size, morphology, and ectoparasite score and feather damage. We were unable to determine if there was a relationship between microbe presence and prevalence on reproductive performance.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M P Lombardo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P A Thorpe</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Biology, Grand Valley State University, Allendale, Michigan 49401-9403, USA. lombardm@gvsu.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Bird Diseases</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Ectoparasitic Infestations</document:subject>
<document:subject>Escherichia coli</document:subject>
<document:subject>Feathers</document:subject>
<document:subject>Female</document:subject>
<document:subject>Lactobacillus</document:subject>
<document:subject>Male</document:subject>
<document:subject>Oviposition</document:subject>
<document:subject>Salmonella</document:subject>
<document:subject>Semen</document:subject>
<document:subject>Shigella</document:subject>
<document:subject>Songbirds</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Yersinia</document:subject>
<document:subject>Bird Diseases; epidemiology</document:subject>
<document:subject>Colony Count, Microbial; veterinary</document:subject>
<document:subject>Ectoparasitic Infestations; epidemiology</document:subject>
<document:subject>Ectoparasitic Infestations; veterinary</document:subject>
<document:subject>Escherichia coli; growth &amp; development</document:subject>
<document:subject>Escherichia coli; isolation &amp; purification</document:subject>
<document:subject>Feathers; pathology</document:subject>
<document:subject>Lactobacillus; growth &amp; development</document:subject>
<document:subject>Lactobacillus; isolation &amp; purification</document:subject>
<document:subject>Salmonella; growth &amp; development</document:subject>
<document:subject>Salmonella; isolation &amp; purification</document:subject>
<document:subject>Semen; microbiology</document:subject>
<document:subject>Shigella; growth &amp; development</document:subject>
<document:subject>Shigella; isolation &amp; purification</document:subject>
<document:subject>Songbirds; anatomy &amp; histology</document:subject>
<document:subject>Songbirds; microbiology</document:subject>
<document:subject>Songbirds; parasitology</document:subject>
<document:subject>Yersinia; growth &amp; development</document:subject>
<document:subject>Yersinia; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941731">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Validation of the fluorescence polarization assay and comparison to other serological assays for the detection of serum antibodies to Brucella abortus in bison.</document:title>
<document:abstractSection>A number of serological tests were compared for the detection of antibodies to Brucella abortus in bison (Bison bison). The performance of the fluorescence polarization assay (FPA) in both the preliminary evaluation and a subsequent blind validation indicated that this test was the most suitable for serological diagnosis of brucellosis in bison. The sensitivity and specificity in the preliminary evaluation were 92.1% and 99.4%, respectively. The sensitivity and specificity in a subsequent blind study were 96.3% and 97.6%, respectively. In a double blind study conducted on bison vaccinated with B. abortus strain 19, the data suggests that the FPA can differentiate bison infected with B. abortus from bison vaccinated with B. abortus strain 19. Both the indirect immunoassay (IELISA) and the competitive immunoassay (CELISA) performed nearly as well as the FPA. The buffered antigen plate agglutination test (BPAT) and the complement fixation test (CFT) did not perform as well as the FPA, CELISA or the IELISA in both studies. The FPA is a homogeneous assay eliminating the washing steps and reducing incubation to minutes rather than hours saving on time, equipment, materials, reagents and cost. These attributes, together, with its excellent sensitivity and specificity make the FPA an attractive test for the detection of serum antibodies to Brucella abortus in bison.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D Gall</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K Nielsen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Forbes</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Davis</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Elzer</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Olsen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Balsevicius</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Kelly</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Smith</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Tan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Joly</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Canadian Food Inspection Agency, Animal Diseases Research Institute, Nepean, Ontario, Canada. gall@em.agr.ca</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Brucella Vaccine</document:subject>
<document:subject>Agglutination Tests</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Area Under Curve</document:subject>
<document:subject>Bison</document:subject>
<document:subject>Brucella Vaccine</document:subject>
<document:subject>Brucella abortus</document:subject>
<document:subject>Brucellosis</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Complement Fixation Tests</document:subject>
<document:subject>Cross Reactions</document:subject>
<document:subject>Double-Blind Method</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay</document:subject>
<document:subject>Fluorescence Polarization Immunoassay</document:subject>
<document:subject>ROC Curve</document:subject>
<document:subject>Sensitivity and Specificity</document:subject>
<document:subject>Vaccination</document:subject>
<document:subject>Agglutination Tests; veterinary</document:subject>
<document:subject>Antibodies, Bacterial; blood</document:subject>
<document:subject>Brucella Vaccine; immunology</document:subject>
<document:subject>Brucella abortus; immunology</document:subject>
<document:subject>Brucellosis; diagnosis</document:subject>
<document:subject>Brucellosis; immunology</document:subject>
<document:subject>Brucellosis; veterinary</document:subject>
<document:subject>Complement Fixation Tests; veterinary</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay; veterinary</document:subject>
<document:subject>Fluorescence Polarization Immunoassay; standards</document:subject>
<document:subject>Fluorescence Polarization Immunoassay; veterinary</document:subject>
<document:subject>Vaccination; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941732">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk.</document:title>
<document:abstractSection>Brucella abortus strain RB51 is a laboratory-derived rough mutant of virulent B. abortus strain 2308 used as a vaccine because it induces antibodies that do not react on standard brucellosis serologic tests. Strain RB51 vaccine was evaluated in pregnant captive elk (Cervus elaphus) to determine (1) if it induced abortion and (2) if it protected against abortion following subsequent challenge. The time period of this study (February-June, 1998) was similar to field conditions where elk are vaccinated and possibly exposed to B. abortus. Fourteen elk were randomly and equally divided into vaccinated and control groups. The vaccinated group was vaccinated intramuscularly with 1.03 x 10(10) colony-forming units (CFU) of strain RB51 and seroconverted postvaccination. Antibodies to strain RB51 were detected by a modification of an existing dot-blot assay. Both groups were challenged 40 days postvaccination with 9.8 x 10(6) CFU of B. abortus strain 2308 administered intraconjunctivally. The first abortion occurred 38 days postchallenge. Abortion occurred in all control elk and in five of seven vaccinated elk 5 to 12 wk postchallenge (P = 0.23). Mixed strain RB51 and 2308 infections were present in fetuses and vaginas from the vaccinated group whereas only strain 2308 was cultured from control group fetuses and vaginal swabs. Further evaluation of strain RB51 will be necessary to determine if it will be safe and efficacious in free-ranging pregnant elk.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>T J Kreeger</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M W Miller</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M A Wild</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P H Elzer</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S C Olsen</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Wyoming Game and Fish Department, Wheatland 82201, USA. tekreege@wyoming.com</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Brucella Vaccine</document:subject>
<document:subject>Abortion, Veterinary</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Brucella Vaccine</document:subject>
<document:subject>Brucella abortus</document:subject>
<document:subject>Brucellosis</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Female</document:subject>
<document:subject>Immunoblotting</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Pregnancy Complications, Infectious</document:subject>
<document:subject>Random Allocation</document:subject>
<document:subject>Safety</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Abortion, Veterinary; prevention &amp; control</document:subject>
<document:subject>Antibodies, Bacterial; blood</document:subject>
<document:subject>Brucella Vaccine; standards</document:subject>
<document:subject>Brucella abortus; immunology</document:subject>
<document:subject>Brucellosis; prevention &amp; control</document:subject>
<document:subject>Brucellosis; veterinary</document:subject>
<document:subject>Immunoblotting; veterinary</document:subject>
<document:subject>Pregnancy Complications, Infectious; prevention &amp; control</document:subject>
<document:subject>Pregnancy Complications, Infectious; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941733">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Safety of Brucella abortus strain RB51 in bull elk.</document:title>
<document:abstractSection>Some of the elk (Cervus elaphus nelsoni) of the Greater Yellowstone Area (Wyoming, Idaho, Montana; USA) are infected with Brucella abortus, the bacterium that causes bovine brucellosis. Brucella abortus strain RB51 vaccine is being considered as a means to control B. abortus induced abortions in cow elk. However, the most probable vaccination strategies for use in free-ranging elk might also result in some bull elk being inoculated, thus, it is important to insure that the vaccine is safe in these animals. In the winter of 1995, 10 free-ranging bull elk calves were captured, tested for B. abortus antibodies, and intramuscularly inoculated with 1.0 x 10(9) colony forming units (CFU) of B. abortus strain RB51. Blood was collected for hemoculture and serology every 2 wk after inoculation for 14 wk. Beginning 4 mo postinoculation and continuing until 10 mo postinoculation elk were serially euthanized, necropsied, and tissues collected for culture and histopathology. These elk cleared the organism from the blood within 6 wk and from all tissues within 10 mo. No lesions attributable to B. abortus were found grossly and only minimal to mild lymphoplasmacytic epididymitis was found in a few elk on histologic examination. In a separate study, six adult bull elk from Wind Cave National Park (South Dakota, USA) were taken to a ranch near Carrington (North Dakota, USA). Three were orally inoculated with approximately 1.0 x 10(10) CFU of RB51 and three were inoculated with corn syrup and saline. Ninety days post-inoculation semen was examined and cultured from these bulls. Strain RB51 was not cultured from their semen at that time. There were no palpable abnormalities in the genital tract and all elk produced viable sperm. Although they contain small sample sizes, these studies suggest that B. abortus strain RB51 is safe in bull elk.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>W E Cook</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E S Williams</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E T Thorne</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T J Kreeger</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G W Stout</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G Schurig</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L A Colby</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Enright</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P H Elzer</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Veterinary Science, University of Wyoming, Laramie 82070, USA. wcookl@missc.state.wy.us</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Brucella Vaccine</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Brucella Vaccine</document:subject>
<document:subject>Brucella abortus</document:subject>
<document:subject>Brucellosis</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay</document:subject>
<document:subject>Male</document:subject>
<document:subject>Safety</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Antibodies, Bacterial; blood</document:subject>
<document:subject>Brucella Vaccine; standards</document:subject>
<document:subject>Brucella abortus; immunology</document:subject>
<document:subject>Brucella abortus; isolation &amp; purification</document:subject>
<document:subject>Brucellosis; prevention &amp; control</document:subject>
<document:subject>Brucellosis; veterinary</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941734">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Efficacy of a type C botulism vaccine in green-winged teal.</document:title>
<document:abstractSection>We tested the efficacy of a single dose of Botumink toxoid for protecting wild green-winged teal (Anas crecca) during botulism epizootics caused by Clostridium botulinum type C. We challenged control and immunized ducks with four different doses of type C botulinum toxin to determine the LD50 for this species and to evaluate vaccine protection. Fewer immunized ducks were affected with botulism than control ducks, indicating that a single dose of Botumink toxoid could increase the survival of ducks during epizootics. However, the frequency of immunized ducks with signs of botulism increased with the challenge dose of botulinum toxin. Even at doses of botulinum toxin approximately 2 to 4 green-winged teal LD50, about 50% of the immunized ducks were affected. We believe an improved vaccine or a better delivery system is required to justify immunization of wild birds for experimental survival studies.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>T E Rocke</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M D Samuel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P K Swift</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G S Yarris</feature:name>
</feature:Person>
</document:author>
<dc:contributor>U.S. Geological Survey, National Wildlife Health Center, Madison, Wisconsin 53711, USA. tonie_rocke@usgs.gov</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Bacterial Vaccines</document:subject>
<document:subject>Botulinum Toxins</document:subject>
<document:subject>botulinum toxin type C</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animals, Wild</document:subject>
<document:subject>Bacterial Vaccines</document:subject>
<document:subject>Bird Diseases</document:subject>
<document:subject>Botulinum Toxins</document:subject>
<document:subject>Botulism</document:subject>
<document:subject>Clostridium botulinum</document:subject>
<document:subject>Ducks</document:subject>
<document:subject>Female</document:subject>
<document:subject>Male</document:subject>
<document:subject>Random Allocation</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Bacterial Vaccines; standards</document:subject>
<document:subject>Bird Diseases; prevention &amp; control</document:subject>
<document:subject>Botulism; prevention &amp; control</document:subject>
<document:subject>Botulism; veterinary</document:subject>
<document:subject>Clostridium botulinum; immunology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941735">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Serologic and molecular evidence of Ehrlichia spp. in coyotes in California.</document:title>
<document:abstractSection>In order to determine the role of coyotes in the epidemiology of granulocytic and monocytic ehrlichial agents in California (USA), we tested 149 serum samples for antibodies against Ehrlichia equi, E. risticii, and E. canis, using an indirect immunofluorescent antibody test. Polymerase chain reaction (PCR) assay was used to survey for the presence of members of the E. phagocytophila genogroup, E. risticii and E. canis in blood samples of 95 coyotes. Sixty-eight (46%) samples were seropositive for E. equi, two (1%) for E. risticii and none of the samples had antibodies reactive to E. canis. Two and one coyote were positive for E. risticii and members of the E. phagocytophila genogroup by PCR assay, respectively. In contrast, the 95 samples were negative for E. canis by PCR. Ninety-five percent of the 68 E. equi seropositive coyotes and the one coyote PCR positive for members of the E. phagocytophila genogroup originated from a coastal area. However, the two E. risticii seropositive coyotes and the two coyotes PCR positive for E. risticii were from northern California. Sequence analysis of the three amplified PCR products revealed the agent to be similar in two coyotes to the sequences of E. risticii from horses originating from northern California and identical in one coyote to the agent of human granulocytic ehrlichiosis and E. equi from California. Thus, coyotes are exposed to granulocytic ehrlichiae and E. risticii and may play a role in the epidemiology of these ehrlichial agents in California.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>N Pusterla</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C C Chang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B B Chomel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J S Chae</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J E Foley</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E DeRock</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V L Kramer</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H Lutz</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J E Madigan</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis 95616, USA. npusterla@ucdavis.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>RNA, Ribosomal, 16S</document:subject>
<document:subject>Age Factors</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Bacterial</document:subject>
<document:subject>Base Sequence</document:subject>
<document:subject>California</document:subject>
<document:subject>Carnivora</document:subject>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Ehrlichia</document:subject>
<document:subject>Ehrlichiosis</document:subject>
<document:subject>Female</document:subject>
<document:subject>Fluorescent Antibody Technique, Indirect</document:subject>
<document:subject>Male</document:subject>
<document:subject>Molecular Sequence Data</document:subject>
<document:subject>Polymerase Chain Reaction</document:subject>
<document:subject>RNA, Ribosomal, 16S</document:subject>
<document:subject>Seroepidemiologic Studies</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Antibodies, Bacterial; blood</document:subject>
<document:subject>California; epidemiology</document:subject>
<document:subject>DNA, Bacterial; blood</document:subject>
<document:subject>DNA, Bacterial; chemistry</document:subject>
<document:subject>Ehrlichia; genetics</document:subject>
<document:subject>Ehrlichia; immunology</document:subject>
<document:subject>Ehrlichiosis; epidemiology</document:subject>
<document:subject>Ehrlichiosis; veterinary</document:subject>
<document:subject>Fluorescent Antibody Technique, Indirect; veterinary</document:subject>
<document:subject>Polymerase Chain Reaction; veterinary</document:subject>
<document:subject>RNA, Ribosomal, 16S; chemistry</document:subject>
<document:subject>RNA, Ribosomal, 16S; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941736">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Epizootic vesicular disease in captive California sea lions.</document:title>
<document:abstractSection>An epizootic of vesicular disease occurred in a group of semi-domesticated California sea lions (Zalophus californianus) during the months of April and May 1997. Ten castrated mature male sea lions, ages 12 to 19 yr, were housed in three adjacent open-ocean net enclosures in San Diego Bay (California, USA). Four animals (40%) developed oral and extremity vesicles, anorexia, and were reluctant to perform learned behaviors. One animal developed vesicles but maintained a normal appetite and behavior. The remaining animals showed no clinical signs of infection. Virus (designated FADDL 7005) was isolated from four of the five animals that developed vesicles. Serum antibody titers to FADDL 7005, a previously untyped calicivirus, were demonstrated in animals that showed any combination of clinical signs and in two animals that did not show any clinical signs. No virus was isolated from five fecal samples collected from four of the group animals. Clinical signs lasted 4 to 20 days in affected animals. All affected animals recovered from infection. An experimental swine was inoculated with FADDL 7005 and developed vesicular disease, which was transmitted to another experimental swine upon contact. It is proposed that FADDL 7005 is a new San Miguel sea lion virus.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>W Van Bonn</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E D Jensen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C House</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J A House</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T Burrage</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D A Gregg</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Upstream Associates, San Diego, California 92166, USA. vanbonn@spawar.navy.mil</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Animals, Zoo</document:subject>
<document:subject>Caliciviridae Infections</document:subject>
<document:subject>Calicivirus</document:subject>
<document:subject>California</document:subject>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Male</document:subject>
<document:subject>Microscopy, Electron</document:subject>
<document:subject>Mouth Diseases</document:subject>
<document:subject>Seals</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Vesicular Exanthema of Swine</document:subject>
<document:subject>Caliciviridae Infections; epidemiology</document:subject>
<document:subject>Caliciviridae Infections; veterinary</document:subject>
<document:subject>Caliciviridae Infections; virology</document:subject>
<document:subject>Calicivirus; classification</document:subject>
<document:subject>Calicivirus; immunology</document:subject>
<document:subject>Calicivirus; isolation &amp; purification</document:subject>
<document:subject>California; epidemiology</document:subject>
<document:subject>Disease Outbreaks; veterinary</document:subject>
<document:subject>Microscopy, Electron; veterinary</document:subject>
<document:subject>Mouth Diseases; epidemiology</document:subject>
<document:subject>Mouth Diseases; veterinary</document:subject>
<document:subject>Mouth Diseases; virology</document:subject>
<document:subject>Vesicular Exanthema of Swine; virology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941737">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>A morbillivirus antibody survey of Atlantic walrus, narwhal and beluga in Canada.</document:title>
<document:abstractSection>A longitudinal serologic survey was conducted for morbillivirus antibodies in Atlantic walruses (Odobenus rosmarus rosmarus), narwhal (Monodon monoceros), and beluga (Delphinapterus leucas) from the Northwest Territories, Nunavut and the St. Lawrence estuary (Canada). Sixty-five of 131 (50%) walruses sampled between 1984 and 1993 had detectable morbillivirus neutralizing antibodies. Positive walrus were identified from four of five Arctic sampling sites, to as far back as 1984. Prevalence of morbillivirus neutralizing antibodies in walruses from Foxe Basin ranged from a high of 76% (n = 21) in 1993 to a low of 22% (n = 28) in 1984. Limitations in sample acquisition may have produced underestimates for the 1984 data. There are no reports of clinical morbillivirus infection in walruses. Our results are consistent with the hypothesis that a morbillivirus similar or identical to phocine distemper virus (PDV) has circulated among walrus populations of the eastern Canadian Arctic, at least since the early 1980s. No narwhal (n = 79) or beluga (n = 445) from Arctic waters were identified as having antibodies to dolphin morbilivirus (DMV) above the threshold serum dilution of log2 4. Also, none of the beach-cast cetacean carcasses (n = 28) from the Gulf of St. Lawrence and the St. Lawrence estuary were positive for antibodies to DMV. This indicates that Gulf of St. Lawrence, St. Lawrence estuary, and Arctic cetaceans either have not been exposed to DMV or an antigenically related morbillivirus, or are not susceptible to infection.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>O Nielsen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R E Stewart</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Measures</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Duignan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C House</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Fisheries and Oceans, Maurice Lamontagne Institute, Quebec, Canada. NielsenO@DFO-MPO.GC.CA</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Arctic Regions</document:subject>
<document:subject>Canada</document:subject>
<document:subject>Female</document:subject>
<document:subject>Longitudinal Studies</document:subject>
<document:subject>Male</document:subject>
<document:subject>Morbillivirus</document:subject>
<document:subject>Morbillivirus Infections</document:subject>
<document:subject>Neutralization Tests</document:subject>
<document:subject>Seroepidemiologic Studies</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Walrus</document:subject>
<document:subject>Whales</document:subject>
<document:subject>Antibodies, Viral; blood</document:subject>
<document:subject>Arctic Regions; epidemiology</document:subject>
<document:subject>Canada; epidemiology</document:subject>
<document:subject>Morbillivirus; immunology</document:subject>
<document:subject>Morbillivirus Infections; epidemiology</document:subject>
<document:subject>Morbillivirus Infections; veterinary</document:subject>
<document:subject>Neutralization Tests; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941738">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Antigenic, phenotypic and molecular characterization confirms Babesia odocoilei isolated from three cervids.</document:title>
<document:abstractSection>Babesia isolates from an elk (Cervus elaphus canadensis) and a caribou (Rangifer tarandus caribou) with fatal infections were compared to Babesia odocoilei (Engeling isolate) from white-tailed deer (Odocoileus virginianus) by experimental infection, serologic, and small subunit ribosomal RNA (SSU rRNA) gene sequence analysis studies. Both the indirect fluorescent antibody test and immunoprecipitation assays demonstrated antigenic variation among the isolates. Experimental infection studies showed no clinical differences among the isolates. Nucleotide sequence analysis showed that the elk and caribou Babesia sp. isolates possessed SSU rRNA genes with identical sequences to that of B. odocoilei. A phylogenetic tree constructed from SSU rRNA gene sequences shows that B. odocoilei is most closely related to Babesia divergens, both of which branch together in the true babesia clade.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>P J Holman</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Madeley</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T M Craig</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B A Allsopp</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M T Allsopp</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K R Petrini</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S D Waghela</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G G Wagner</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Veterinary Pathobiology, Texas Veterinary Medical Center, Texas A&amp;M University, College Station 77843-4467, USA. pholman@cvm.tamu.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Protozoan</document:subject>
<document:subject>Antigens, Protozoan</document:subject>
<document:subject>DNA, Protozoan</document:subject>
<document:subject>DNA, Ribosomal</document:subject>
<document:subject>RNA, Ribosomal</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Protozoan</document:subject>
<document:subject>Antigenic Variation</document:subject>
<document:subject>Antigens, Protozoan</document:subject>
<document:subject>Babesia</document:subject>
<document:subject>Babesiosis</document:subject>
<document:subject>Base Sequence</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>DNA, Protozoan</document:subject>
<document:subject>DNA, Ribosomal</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Disease Reservoirs</document:subject>
<document:subject>Female</document:subject>
<document:subject>Fluorescent Antibody Technique, Indirect</document:subject>
<document:subject>Male</document:subject>
<document:subject>Molecular Sequence Data</document:subject>
<document:subject>Phenotype</document:subject>
<document:subject>Phylogeny</document:subject>
<document:subject>Precipitin Tests</document:subject>
<document:subject>RNA, Ribosomal</document:subject>
<document:subject>Reindeer</document:subject>
<document:subject>Sequence Alignment</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Antibodies, Protozoan; blood</document:subject>
<document:subject>Antigens, Protozoan; immunology</document:subject>
<document:subject>Babesia; classification</document:subject>
<document:subject>Babesia; genetics</document:subject>
<document:subject>Babesia; immunology</document:subject>
<document:subject>Babesiosis; parasitology</document:subject>
<document:subject>Babesiosis; veterinary</document:subject>
<document:subject>DNA, Protozoan; chemistry</document:subject>
<document:subject>DNA, Ribosomal; chemistry</document:subject>
<document:subject>Deer; parasitology</document:subject>
<document:subject>Disease Reservoirs; veterinary</document:subject>
<document:subject>Fluorescent Antibody Technique, Indirect; veterinary</document:subject>
<document:subject>Precipitin Tests; veterinary</document:subject>
<document:subject>RNA, Ribosomal; chemistry</document:subject>
<document:subject>RNA, Ribosomal; genetics</document:subject>
<document:subject>Reindeer; parasitology</document:subject>
<document:subject>Sequence Alignment; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941739">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Sylvatic trichinellosis in southwestern Spain.</document:title>
<document:abstractSection>The epidemiology of Trichinella spp. in their main sylvatic hosts, wild boar (Sus scrofa ferus and red fox (Vulpes vulpes), in Extremadura (southwestern Spain) was studied. We examined 88 Trichinella spp.-positive wild boar muscle-tissue samples from a total of 29,333 killed animals, referred to the Veterinary Parasitology Department (University of Extremadura, Spain) by the Extremadura Veterinary Service. Additionally, 227 red foxes killed during the hunting season and thus not subject to veterinary controls were examined for trichinellosis. Trichinella spp. larvae were found in six (3%) of the red foxes. All samples were examined using direct diagnostic techniques, including trichinoscopy and artificial digestion. The mean intensity of infection was 74.8 larvae/g (LPG) of muscle tissue in wild boars, compared to 30.6 LPG in foxes. Trichinella spiralis (sensu stricto) predominated over T. britovi in wild boars. Random amplified polymorphic DNA (RAPD) and alloenzyme typing showed that 74% of infected wild boars had only T. spiralis, 21% had only T. britovi, and 5% showed mixed infections. In contrast, 33% of infected foxes were infected only with T. spiralis, while 67% had T. britovi, suggesting a clear predominance of the latter in foxes. We suspect the existence of a paranthropic or sylvatic cycle in large areas of this region; given the ease of transfer between sylvatic and domestic or semi-domestic animals, this implies a high epidemiological risk.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J E P√©rez-Mart√≠n</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F J Serrano</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Reina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J A Mora</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I Navarrete</feature:name>
</feature:Person>
</document:author>
<dc:contributor>jeperez@unex.es</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Animals, Wild</document:subject>
<document:subject>Foxes</document:subject>
<document:subject>Larva</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Spain</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Trichinella</document:subject>
<document:subject>Trichinella spiralis</document:subject>
<document:subject>Trichinosis</document:subject>
<document:subject>Foxes; parasitology</document:subject>
<document:subject>Larva; classification</document:subject>
<document:subject>Spain; epidemiology</document:subject>
<document:subject>Trichinella; classification</document:subject>
<document:subject>Trichinella; isolation &amp; purification</document:subject>
<document:subject>Trichinella spiralis; classification</document:subject>
<document:subject>Trichinella spiralis; isolation &amp; purification</document:subject>
<document:subject>Trichinosis; epidemiology</document:subject>
<document:subject>Trichinosis; parasitology</document:subject>
<document:subject>Trichinosis; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941740">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Use of a two-step Percoll gradient for separation of loggerhead sea turtle peripheral blood mononuclear cells.</document:title>
<document:abstractSection>In order to determine a suitable procedure for isolating peripheral blood mononuclear cells (PBMCs) from loggerhead sea turtles (Caretta caretta), blood was collected using three different anticoagulants (sodium heparin, sodium citrate or potassium EDTA) and separated using a single step commercially-prepared arabinogalactan gradient of 1.077 g/ml density or multiple step Percoll gradients between 1.053 and 1.076 g/ml density (40-60% stock isotonic Percoll suspension). Heparinized blood centrifuged over a two-step 45/55% (1.059/1.070 g/ml) Percoll gradient yielded 99 to 100% mononuclear cells at the 45/55% interface. Mononuclear cell viability ranged from 85 to 97% with cell yields up to 9.2 x 10(6) cells/mL. An unexpected finding was a population of low density granulocytes migrating to 40% (1.053 g/ml) and 45% Percoll layers in the multiple step gradients. These granulocytes could be eliminated from the PBMC preparation by use of the two-step 45/55% Percoll gradient. Isolated PBMCs can be used for cellular immunology and toxicology studies on these threatened marine organisms for which other tissues can usually be obtained only sporadically from post-mortem specimens.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C A Harms</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J M Keller</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Kennedy-Stoskopf</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh 27606, USA. craig_harms@ncsu.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anticoagulants</document:subject>
<document:subject>Citrates</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:18996-35-5">
<cas:registryNumber>18996-35-5</cas:registryNumber>
<cas:name>sodium citrate</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:60-00-4">
<cas:registryNumber>60-00-4</cas:registryNumber>
<cas:name>Edetic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9005-49-6">
<cas:registryNumber>9005-49-6</cas:registryNumber>
<cas:name>Heparin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Anticoagulants</document:subject>
<document:subject>Cell Separation</document:subject>
<document:subject>Cell Survival</document:subject>
<document:subject>Centrifugation, Density Gradient</document:subject>
<document:subject>Citrates</document:subject>
<document:subject>Edetic Acid</document:subject>
<document:subject>Heparin</document:subject>
<document:subject>Leukocyte Count</document:subject>
<document:subject>Leukocytes, Mononuclear</document:subject>
<document:subject>Osmolar Concentration</document:subject>
<document:subject>Reference Values</document:subject>
<document:subject>Specimen Handling</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Turtles</document:subject>
<document:subject>Cell Separation; veterinary</document:subject>
<document:subject>Centrifugation, Density Gradient; methods</document:subject>
<document:subject>Centrifugation, Density Gradient; veterinary</document:subject>
<document:subject>Leukocyte Count; veterinary</document:subject>
<document:subject>Leukocytes, Mononuclear; cytology</document:subject>
<document:subject>Specimen Handling; veterinary</document:subject>
<document:subject>Turtles; blood</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941741">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Blood plasma chemistries from wild mourning doves held in captivity.</document:title>
<document:abstractSection>Despite the extensive amount of research conducted on mourning doves (Zenaida macroura), no biochemical reference values exist for this species. Our objective, therefore, was to establish base line clinical chemistry reference values for mourning doves to assist with establishing clinical diagnoses. Wild mourning doves were captured 19 March 1996 to 8 August 1996, and 6 February 1998 to 12 May 1998; blood samples were collected from 382 mourning doves. Plasma biochemical values were established for glucose, sodium, potassium, chloride, enzymatic CO2, albumin, total protein, globulin, calcium, phosphorus, cholesterol, magnesium, aspartate aminotransferase (AST), gamma glutamyl transferase (GGT), lactate dehydrogenase (LDH), and uric acid. These reference values are invaluable for determining diagnosis of diseases of the gastrointestinal, hepatic, renal, cardiovascular, musculoskeletal, and endocrine systems.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J H Schulz</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A J Bermudez</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J L Tomlinson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J D Firman</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Z He</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Missouri Department of Conservation, Conservation Research Center, Columbia 65201, USA. schulj@mail.conservation.state.mo.us</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Blood Chemical Analysis</document:subject>
<document:subject>Female</document:subject>
<document:subject>Male</document:subject>
<document:subject>Pigeons</document:subject>
<document:subject>Reference Values</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Blood Chemical Analysis; veterinary</document:subject>
<document:subject>Pigeons; blood</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941742">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Immobilization of wild ocelots with tiletamine and zolazepam in southern Texas.</document:title>
<document:abstractSection>Telazol was used to immobilize nine wild ocelots (Leopardus pardalis) captured in box-traps in southern Texas (USA) between May 1997 and April 1998. Mean (+/- SD) intramuscular dosage rate of 5.05 (+/- 0.76) mg/kg produced an induction time of 3.7 +/- 1.8 min. Duration of cataleptic anesthesia was 67.4 +/- 19.8 min and ocelots stood 50.0 +/- 30.7 min after emergence from cataleptic anesthesia. Ocelots recovered to their preinjection condition 129.7 +/- 28.8 min after first standing and 250.8 +/- 55.1 min after initial injection. We observed no adverse reactions to Telazol aside from minor loss of thermoregulatory control. Telazol administered at 5 mg/kg was an effective and safe immobilizing agent for wild ocelots.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D B Shindle</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M E Tewes</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Caesar Kleberg Wildlife Research Institute, Texas A&amp;M University-Kingsville 78363, USA. shindld@gfc.state.fl.us</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anesthetics, Dissociative</document:subject>
<document:subject>Anti-Anxiety Agents, Benzodiazepine</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:14176-49-9">
<cas:registryNumber>14176-49-9</cas:registryNumber>
<cas:name>Tiletamine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:31352-82-6">
<cas:registryNumber>31352-82-6</cas:registryNumber>
<cas:name>Zolazepam</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Anesthetics, Dissociative</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Anti-Anxiety Agents, Benzodiazepine</document:subject>
<document:subject>Carnivora</document:subject>
<document:subject>Female</document:subject>
<document:subject>Immobilization</document:subject>
<document:subject>Male</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Tiletamine</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Zolazepam</document:subject>
<document:subject>Carnivora; physiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941743">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Survival of Trichomonas gallinae in white-winged dove carcasses.</document:title>
<document:abstractSection>Survival of Trichomonas gallinae was examined in white-winged dove (Zenaida asiatica) carcasses to assess whether birds that have been dead up to 8 hr can be sampled reliably for this protozoan. Carcasses of 100 T. gallinae-positive white-winged doves were separated into four groups of 25 birds, representing 2, 4, 6, and 8 hr post mortem sampling intervals and placed into an environmental chamber maintained at 27 C and 75% relative humidity. Live T. gallinae were isolated in 96, 100, 100, and 92% of the carcasses at each of the respective post mortem intervals. The experiment was repeated with another 100 carcasses of T. gallinae-positive white-winged doves placed in the environmental chamber, this time maintained at 27 C and 40% relative humidity. Live T. gallinae occurred in 96, 100, 96, and 100% of the carcasses at each of the respective post mortem intervals. Across both trials, the overall ability to detect positive birds from sampling carcasses up to 8 hrs post mortem was 97%. An a posteriori experiment was conducted in which 23 and 18 carcasses from the second trial were maintained in the environmental chamber at 27 C and 40% relative humidity and resampled at 24 and 48 hr post mortem, respectively. Live trichomonads were isolated from 91 and 44% of the carcasses at 24 and 48 hr, respectively. Results suggest live T. gallinae can be obtained from dove carcasses reliably up to 8 hr and possibly up to 24 hr after host death. The ability for T. gallinae to survive within this time interval can aid wildlife personnel in monitoring this protozoan at hunter check stations or obtaining samples from recently killed birds.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>K G Erwin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Kloss</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Lyles</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Felderhoff</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A M Fedynich</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S E Henke</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J A Roberson</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Caesar Kleberg Wildlife Research Institute, Texas A&amp;M University-Kingsville 78363-8202, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Bird Diseases</document:subject>
<document:subject>Cadaver</document:subject>
<document:subject>Pigeons</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Trichomonas</document:subject>
<document:subject>Trichomonas Infections</document:subject>
<document:subject>Bird Diseases; diagnosis</document:subject>
<document:subject>Bird Diseases; parasitology</document:subject>
<document:subject>Pigeons; parasitology</document:subject>
<document:subject>Trichomonas; isolation &amp; purification</document:subject>
<document:subject>Trichomonas; physiology</document:subject>
<document:subject>Trichomonas Infections; diagnosis</document:subject>
<document:subject>Trichomonas Infections; parasitology</document:subject>
<document:subject>Trichomonas Infections; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941744">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Evaluation of host preferences by helminths and ectoparasites among black-tailed jackrabbits in northern California.</document:title>
<document:abstractSection>Fifty-four black-tailed jackrabbits (Lepus californicus) (five juvenile males, 22 adult males, five juvenile females, and 22 adult females) from Humboldt County, California (USA) were evaluated for sex and age-specific differences in parasite prevalences and intensities, 26 February through 30 October 1996. Nematodes found included Biogastranema leporis in 42 hares (78% prevalence), Rauschia triangularis in 26 hares (48%), Trichostrongylus calcaratus in 14 hares (26%), and Trichuris sylvilagi in two hares (4%). Cestodes found included Taenia sp. cysticerci in five hares (9%) and Taenia sp. coenurus found in one hare (2%). Ectoparasites found included the ticks Dermacentor variabilis on 10 hares (19%) and Ixodes spinipalpis (= Ixodes neotomae) on nine hares (17%), as well as the anoplurid louse Haemodipsus setoni on 12 hares (22%). No significant differences in the parasite prevalences or intensities were found between male and female jackrabbits; this was for all males and females collectively, juvenile males and females only, as well as adult males and females only. Combining male and female hosts, adult jackrabbits had a significantly higher prevalence of B. leporis and R. triangularis compared to juveniles. This is the first known report of Trichostrongylus calcaratus, Rauschia triangularis, Trichuris sylvilagi, and Dermacentor variabilis among black-tailed jackrabbits and the first known report of T. calcaratus and T. sylvilagi in the western USA. This is the first published report of I. spinipalpis, the vector for Lyme disease in California, on black-tailed jackrabbits.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C Clemons</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L G Rickard</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J E Keirans</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R G Botzler</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Wildlife, Humboldt State University, Arcata, California 95521, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Age Distribution</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Arachnid Vectors</document:subject>
<document:subject>California</document:subject>
<document:subject>Ectoparasitic Infestations</document:subject>
<document:subject>Female</document:subject>
<document:subject>Helminthiasis, Animal</document:subject>
<document:subject>Ixodes</document:subject>
<document:subject>Lagomorpha</document:subject>
<document:subject>Male</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Sex Distribution</document:subject>
<document:subject>Arachnid Vectors; growth &amp; development</document:subject>
<document:subject>California; epidemiology</document:subject>
<document:subject>Ectoparasitic Infestations; epidemiology</document:subject>
<document:subject>Ectoparasitic Infestations; parasitology</document:subject>
<document:subject>Ectoparasitic Infestations; veterinary</document:subject>
<document:subject>Helminthiasis, Animal; epidemiology</document:subject>
<document:subject>Helminthiasis, Animal; parasitology</document:subject>
<document:subject>Ixodes; growth &amp; development</document:subject>
<document:subject>Lagomorpha; parasitology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941745">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Strigea falconispalumbi in Eurasian buzzards from Germany.</document:title>
<document:abstractSection>Eighty-three free-living Eurasian buzzards (Buteo buteo) from three different areas in Germany were examined for adult stages and the metacercaria of the trematode Strigea falconispalumbi. Prevalences of adult parasites in the small intestine was 36% (Berlin/Brandenburg), 28% (Lower Saxony) and 3% (Baden-W√ºrttemberg). Metacercaria in the connective tissue of the neck were found in 58%, 55%, and 10% of birds from the respective areas. Significant differences in the prevalence of S. falconispalumbi adults and metacercaria between the areas were attributed to the different abundance of freshwater which is the key habitat for two intermediate hosts.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>O Krone</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>W J Streich</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institute for Zoo Biology and Wildlife Research, Berlin, Germany. krone@izw-berlin.de</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Bird Diseases</document:subject>
<document:subject>Connective Tissue</document:subject>
<document:subject>Female</document:subject>
<document:subject>Germany</document:subject>
<document:subject>Intestine, Small</document:subject>
<document:subject>Male</document:subject>
<document:subject>Neck</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Raptors</document:subject>
<document:subject>Trematoda</document:subject>
<document:subject>Trematode Infections</document:subject>
<document:subject>Bird Diseases; epidemiology</document:subject>
<document:subject>Bird Diseases; parasitology</document:subject>
<document:subject>Connective Tissue; parasitology</document:subject>
<document:subject>Germany; epidemiology</document:subject>
<document:subject>Intestine, Small; parasitology</document:subject>
<document:subject>Raptors; parasitology</document:subject>
<document:subject>Trematoda; isolation &amp; purification</document:subject>
<document:subject>Trematode Infections; epidemiology</document:subject>
<document:subject>Trematode Infections; parasitology</document:subject>
<document:subject>Trematode Infections; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941746">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Parelaphostrongyliasis in white-tailed deer in Missouri.</document:title>
<document:abstractSection>The heads of 137 white-tailed deer (Odocoileus virginianus) were collected on the opening day of the 1996 Missouri (USA) fire-arms deer season and surveyed for the presence of meningeal worm (Parelaphostrongylus tenuis). Eighteen percent of the deer examined were infected. Mean intensity of infection was 2.0 (range 1-7). There were no significant differences of infection or mean intensity when deer were classified and compared according to sex or age class.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S M Banks</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D C Ashley</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Biology, Missouri Western State College, St. Joseph 64507, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Age Distribution</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Female</document:subject>
<document:subject>Head</document:subject>
<document:subject>Male</document:subject>
<document:subject>Metastrongyloidea</document:subject>
<document:subject>Missouri</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Sex Distribution</document:subject>
<document:subject>Strongylida Infections</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Deer; parasitology</document:subject>
<document:subject>Head; parasitology</document:subject>
<document:subject>Metastrongyloidea; isolation &amp; purification</document:subject>
<document:subject>Missouri; epidemiology</document:subject>
<document:subject>Strongylida Infections; epidemiology</document:subject>
<document:subject>Strongylida Infections; parasitology</document:subject>
<document:subject>Strongylida Infections; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941747">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Gastric intramural hematoma and hemoperitoneum in a captive northern fur seal.</document:title>
<document:abstractSection>A 16-yr-old adult male northern fur seal (Callorhinus ursinus) was found dead in its outdoor pool in November 1995. The animal was maintained at Mystic Aquarium (Mystic, Connecticut, USA) from March 1980 to November 1995. Gross necropsy findings included hemoperitoneum and locally extensive gastric intramural hemorrhage that involved the posterior fundic, antral, and pyloric regions and extended into the duodenum. The gastric mural thickening grossly resembled hemangioma, and the gastric serosa was ruptured at the site of maximal mural expansion. In histologic sections of the stomach, a cribiform network of fibrin, which encompassed numerous variably-sized aggregates of closely packed erythrocytes, markedly expanded the submucosa. No vascular endothelium was identified in serial histologic sections of the expanded gastric submucosa stained with hematoxylin and eosin or immunohistochemically with antibodies to vimentin and Factor VIII-related antigen, establishing an absence of hemangioma. Carstairs' and Weigert's histochemical stains confirmed that the framework expanding the submucosa was fibrin. Although the appearance of the gastric wall resembled hemangioma, a population of neoplastic endothelial cells was not identified within the submucosal expansion of hemorrhage and fibrin, and microscopic evidence was most consistent with the diagnosis of gastric intramural hematoma. This lesion is a rare pathologic event that has not been reported in marine mammals, but one that should be included in diagnostic considerations of hemoperitoneum and gastric mural expansion.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S Frasca Jr</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H J Van Kruiningen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J L Dunn</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D J St Aubin</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Pathobiology, University of Connecticut, Storrs 06269-3089, USA. sfrasca@canr.uconn.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9001-31-4">
<cas:registryNumber>9001-31-4</cas:registryNumber>
<cas:name>Fibrin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Case Report</document:subject>
<document:subject>Fatal Outcome</document:subject>
<document:subject>Fibrin</document:subject>
<document:subject>Gastric Mucosa</document:subject>
<document:subject>Gastrointestinal Hemorrhage</document:subject>
<document:subject>Hematoma</document:subject>
<document:subject>Hemoperitoneum</document:subject>
<document:subject>Immunohistochemistry</document:subject>
<document:subject>Male</document:subject>
<document:subject>Seals</document:subject>
<document:subject>Stomach</document:subject>
<document:subject>Stomach Diseases</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Fibrin; analysis</document:subject>
<document:subject>Gastric Mucosa; chemistry</document:subject>
<document:subject>Gastric Mucosa; pathology</document:subject>
<document:subject>Gastrointestinal Hemorrhage; pathology</document:subject>
<document:subject>Gastrointestinal Hemorrhage; veterinary</document:subject>
<document:subject>Hematoma; pathology</document:subject>
<document:subject>Hematoma; veterinary</document:subject>
<document:subject>Hemoperitoneum; pathology</document:subject>
<document:subject>Hemoperitoneum; veterinary</document:subject>
<document:subject>Immunohistochemistry; veterinary</document:subject>
<document:subject>Stomach; pathology</document:subject>
<document:subject>Stomach Diseases; pathology</document:subject>
<document:subject>Stomach Diseases; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941748">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Sarcoma of possible nerve sheath origin in a captive muskrat.</document:title>
<document:abstractSection>A captive adult female muskrat (Ondatra zibethicus) was found dead without previous signs of disease. At necropsy, abdominal organs were infiltrated with a poorly demarcated, soft, tan tissue. Microscopically this tissue was composed of neoplastic cells assuming two distinct growth characteristics consistent with Antoni A and B patterns. Ultrastructurally, the neoplastic cells were pleomorphic, lacked junctional devices, had abundant mitochondria and ergastoplasm, and frequently were closely associated with extracellular collagen. Immunocytochemical examination of tumor cells demonstrated sporadic expression of neuron specific enolase. Microscopic tumor metastases to the myocardium, ascending aorta, lungs and visceral pleura were present. This is the first report of a sarcoma compatible with a malignant peripheral nerve sheath tumor in a muskrat.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J D Borucinska</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Trettel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Knibbs</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Biology, University of Hartford, West Hartford, Connecticut, USA. borucinsk@mail.hartford.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Abdominal Neoplasms</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Case Report</document:subject>
<document:subject>Female</document:subject>
<document:subject>Immunohistochemistry</document:subject>
<document:subject>Microtinae</document:subject>
<document:subject>Nerve Sheath Tumors</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Abdominal Neoplasms; pathology</document:subject>
<document:subject>Abdominal Neoplasms; ultrastructure</document:subject>
<document:subject>Abdominal Neoplasms; veterinary</document:subject>
<document:subject>Immunohistochemistry; veterinary</document:subject>
<document:subject>Nerve Sheath Tumors; pathology</document:subject>
<document:subject>Nerve Sheath Tumors; secondary</document:subject>
<document:subject>Nerve Sheath Tumors; ultrastructure</document:subject>
<document:subject>Nerve Sheath Tumors; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941749">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Absence of antibodies against canine distemper virus in free-ranging populations of the Eurasian badger in Great Britain.</document:title>
<document:abstractSection>Canine distemper virus (CDV) is a serious disease of wild carnivores throughout the world. In Europe, infection has been detected in several carnivores including the Eurasian badger (Meles meles). In the present study 182 badger blood samples were collected from an intensively studied population of wild badgers in southwestern England (January-July, 1997), and a further 286 from throughout southern Britain (June 1996-November 1998). A neutralizing peroxidase-linked antibody test was used for the detection of antibodies against CDV. All the samples were negative for CDV antibodies, suggesting that in contrast to mainland Europe, the disease may be either absent or maintained at low levels in British badgers.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R Delahay</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K Fr√∂lich</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Central Science Laboratory, Sand Hutton, York, United Kingdom. r.delahay@csl.gov.uk</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animals, Wild</document:subject>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Carnivora</document:subject>
<document:subject>Distemper</document:subject>
<document:subject>Distemper Virus, Canine</document:subject>
<document:subject>England</document:subject>
<document:subject>Female</document:subject>
<document:subject>Immunoenzyme Techniques</document:subject>
<document:subject>Male</document:subject>
<document:subject>Neutralization Tests</document:subject>
<document:subject>Wales</document:subject>
<document:subject>Antibodies, Viral; blood</document:subject>
<document:subject>Distemper; epidemiology</document:subject>
<document:subject>Distemper Virus, Canine; immunology</document:subject>
<document:subject>England; epidemiology</document:subject>
<document:subject>Immunoenzyme Techniques; veterinary</document:subject>
<document:subject>Neutralization Tests; veterinary</document:subject>
<document:subject>Wales; epidemiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941750">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>First report of myxomatosis in Mexico.</document:title>
<document:abstractSection>An outbreak of myxomatosis occurred between September and October 1993 on a rabbit farm in Punta Colnett (Ensenada, Baja California in northwestern Mexico, Transpeninsular Highway, km 128) and was confirmed by the Mexico-USA Commission for Prevention of Foreign Diseases of Animals (CPA). This represents the first officially confirmed case of the disease in Mexico. Like the cases in California (USA), the brush rabbit (Sylvilagus bachmani) seems to be the carrier of the virus, since serum samples from wild rabbits from different areas of the peninsula of Baja California were found to contain antibodies against the myxoma virus.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R M Lic√≥n Luna</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Facultad de Ciencias, Universidad Aut√≥noma de Baja California, Baja California, M√©xico. Rosy.Licon@anu.edu.au</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Animals, Domestic</document:subject>
<document:subject>Animals, Wild</document:subject>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Disease Reservoirs</document:subject>
<document:subject>Insect Vectors</document:subject>
<document:subject>Lagomorpha</document:subject>
<document:subject>Mexico</document:subject>
<document:subject>Myxoma Virus</document:subject>
<document:subject>Myxomatosis, Infectious</document:subject>
<document:subject>Rabbits</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Tumor Virus Infections</document:subject>
<document:subject>Disease Outbreaks; veterinary</document:subject>
<document:subject>Disease Reservoirs; veterinary</document:subject>
<document:subject>Insect Vectors; classification</document:subject>
<document:subject>Mexico; epidemiology</document:subject>
<document:subject>Myxoma Virus; isolation &amp; purification</document:subject>
<document:subject>Myxomatosis, Infectious; epidemiology</document:subject>
<document:subject>Tumor Virus Infections; epidemiology</document:subject>
<document:subject>Tumor Virus Infections; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941751">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Bovine virus diarrhea virus in free-living deer from Denmark.</document:title>
<document:abstractSection>Free-living deer are suggested as a possible source of infection of cattle with bovine virus diarrhea (BVD) virus. To examine this hypothesis blood samples from 476 free-living deer were collected during two different periods and tested for BVD virus and antibody in Denmark. In 1995-96, 207 animals were tested. These included 149 roe deer (Capreolus capreolus), 29 fallow deer (Dama dama), 20 red deer (Cervus elaphus) and one sika deer (Cervus sika). For the remaining eight animals no species information was available. In 1998-99, 269 animals were tested including 212 roe deer and 57 red deer. The animals were selected from areas with a relatively high prevalence of cattle herds with a BVD persistent infection status in 1997 and 1998. All 207 samples from 1995-96 were found antibody-negative except two samples from red deer. Only 158 of the 207 samples were tested for virus and were all found negative. Of the 269 samples from 1998-99 all but one were antibody negative. The positive sample was from a red deer. All samples were virus-negative. It appears that BVD infection does not occur in roe deer in Denmark. The presence of antibody in a few red deer from various districts in Jutland probably results from cattle to deer transmission, rather than spread among deer. Hence, the possibility of free-living deer as a source of infection for cattle in Denmark seems to be remote.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S S Nielsen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Roensholt</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V Bitsch</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Cattle Health Laboratory, Br√∏rup, Denmark. ssn@kvl.dk</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animals, Wild</document:subject>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Bovine Virus Diarrhea-Mucosal Disease</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Denmark</document:subject>
<document:subject>Diarrhea Virus, Bovine Viral</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay</document:subject>
<document:subject>Female</document:subject>
<document:subject>Seroepidemiologic Studies</document:subject>
<document:subject>Antibodies, Viral; blood</document:subject>
<document:subject>Bovine Virus Diarrhea-Mucosal Disease; epidemiology</document:subject>
<document:subject>Denmark; epidemiology</document:subject>
<document:subject>Diarrhea Virus, Bovine Viral; immunology</document:subject>
<document:subject>Diarrhea Virus, Bovine Viral; isolation &amp; purification</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941752">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>An epizootic of hemorrhagic disease in white-tailed deer in Missouri.</document:title>
<document:abstractSection>As part of a white-tailed deer (Odocoileus virginianus) survival study in Missouri (USA) we were actively monitoring 97 radio-collared deer when 8 (8%) died. This mortality, which occurred from 20 August to 23 September 1996, consisted of five adult females, two yearling females and one yearling male. Based on the seasonality of this mortality and the isolation of epizootic hemorrhagic disease virus (EHDV) serotype 2 from one of these animals, we believe that these losses resulted from an epizootic of hemorrhagic disease. The remains of five unmarked deer that may have died from HD also were found on the study area during this same period. During the fall following this mortality, we tested serum from 96 deer taken by hunters in the immediate area. Fifteen (16%) were positive for EHDV or bluetongue virus (BTV) antibodies as determined by agar gel immunodiffusion tests. Serum neutralization test results indicated that previous infections were caused by EHDV virus serotype 2. Based on these data, and assuming that there was no prior exposure to EHDV serotype 2 in this population, the exposure rate for this epizootic was 24% of which 8% died. We noted hoof interruptions in only two of the 96 deer sampled. During this mortality event, the Missouri Department of Conservation received no reports of dead deer, and without the radio-monitored animals the event would have been undetected.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J Beringer</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L P Hansen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D E Stallknecht</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Missouri Department of Conservation, Columbia 65201, USA. berinj@mail.conservation.state.mo.us</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibodies, Viral</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hemorrhagic Disease Virus, Epizootic</document:subject>
<document:subject>Immunodiffusion</document:subject>
<document:subject>Male</document:subject>
<document:subject>Missouri</document:subject>
<document:subject>Neutralization Tests</document:subject>
<document:subject>Reoviridae Infections</document:subject>
<document:subject>Seasons</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Antibodies, Viral; blood</document:subject>
<document:subject>Disease Outbreaks; veterinary</document:subject>
<document:subject>Hemorrhagic Disease Virus, Epizootic; immunology</document:subject>
<document:subject>Hemorrhagic Disease Virus, Epizootic; isolation &amp; purification</document:subject>
<document:subject>Immunodiffusion; veterinary</document:subject>
<document:subject>Missouri; epidemiology</document:subject>
<document:subject>Neutralization Tests; veterinary</document:subject>
<document:subject>Reoviridae Infections; epidemiology</document:subject>
<document:subject>Reoviridae Infections; mortality</document:subject>
<document:subject>Reoviridae Infections; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941753">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Attempted transmission of Ehrlichia chaffeensis among white-tailed deer by Amblyomma maculatum.</document:title>
<document:abstractSection>A deer was needle-exposed intravenously to Ehrlichia chaffeensis (Rickettsiales: Ehrlichieae) in canine macrophage (DH82) cells and 7 days later was infested with laboratory-reared Amblyomma maculatum (Koch) (Acari:Ixodidae) nymphs for acquisition feeding. After molting, the adult ticks were allowed to feed on a naive deer. The organism was reisolated from the needle-exposed deer by cell culture and E. chaffeensis DNA was detected in the deer's blood by PCR. Similar isolation/recovery techniques were used for the tick-exposed deer and no evidence of infection was found. Although these findings must be considered as preliminary owing to inadequate controls, the data suggest that A. maculatum is probably not a suitable vector for E. chaffeensis.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A A Kocan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S A Ewing</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Stallknecht</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G L Murphy</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Little</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L C Whitworth</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R W Barker</feature:name>
</feature:Person>
</document:author>
<dc:contributor>College of Veterinary Medicine, Oklahoma State University, Stillwater 74078-2006, USA. aak4453@vms.okstate.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Arachnid Vectors</document:subject>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Deer</document:subject>
<document:subject>Ehrlichia chaffeensis</document:subject>
<document:subject>Ehrlichiosis</document:subject>
<document:subject>Nymph</document:subject>
<document:subject>Polymerase Chain Reaction</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Ticks</document:subject>
<document:subject>Arachnid Vectors; microbiology</document:subject>
<document:subject>DNA, Bacterial; blood</document:subject>
<document:subject>Ehrlichia chaffeensis; genetics</document:subject>
<document:subject>Ehrlichia chaffeensis; isolation &amp; purification</document:subject>
<document:subject>Ehrlichia chaffeensis; physiology</document:subject>
<document:subject>Ehrlichiosis; transmission</document:subject>
<document:subject>Ehrlichiosis; veterinary</document:subject>
<document:subject>Nymph; microbiology</document:subject>
<document:subject>Polymerase Chain Reaction; veterinary</document:subject>
<document:subject>Ticks; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0244160">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Wildl Dis</dc:title>
<med:code>KEM</med:code>
<med:nlmUniqueID>0244160</med:nlmUniqueID>

<med:issn>0090-3558</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0244160:36:3">
<med:volume>36</med:volume>
<med:issue>3</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Jul</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:10941754">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>08</date:month>
<date:day>17</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Brucellosis in ringed seals and harp seals from Canada. lforbes@em.agr.ca.</document:title>
<document:abstractSection>A novel Brucella sp. was isolated from lymph nodes of four ringed seals (Phoca hispida) collected near Pangnirtung (Baffin Island, Canada) in January and February 1995 and in one harp seal (Phoca groenlandica) collected near the Magdalen Islands (Gulf of St. Lawrence, Canada) in March 1996. Bacteriological characteristics were the same for all five isolates. The colonies were typical of Brucella spp., but took 2 to 5 days longer than the traditional species to appear on primary isolation media. Biotyping results did not match any of the known biovars of Brucella, but were similar to isolates of the genus Brucella previously reported from marine mammals inhabiting other areas of the northern hemisphere. This is the first confirmed report of brucellosis in marine mammals from Canada, and the first report of this organism in ringed and harp seals.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>L B Forbes</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O Nielsen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Measures</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D R Ewalt</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Centre for Animal Parasitology, Canadian Food Inspection Agency, Saskatoon, Saskatchewan, Canada.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Arctic Regions</document:subject>
<document:subject>Brucella</document:subject>
<document:subject>Brucellosis</document:subject>
<document:subject>Canada</document:subject>
<document:subject>Lymph Nodes</document:subject>
<document:subject>Seals</document:subject>
<document:subject>Arctic Regions; epidemiology</document:subject>
<document:subject>Brucella; classification</document:subject>
<document:subject>Brucella; isolation &amp; purification</document:subject>
<document:subject>Brucellosis; epidemiology</document:subject>
<document:subject>Brucellosis; veterinary</document:subject>
<document:subject>Canada; epidemiology</document:subject>
<document:subject>Lymph Nodes; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079685">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>The effect of different grain diets on fecal shedding of Escherichia coli O157:H7 by steers.</document:title>
<document:abstractSection>Three groups of six yearling steers (three rumen fistulated plus three nonfistulated) fed one of three different grain diets (85% cracked corn, 15% whole cottonseed and 70% barley, or 85% barley) were inoculated with 10(10) CFU of Escherichia coli O157:H7 strain 3081, and the presence of the inoculated strain was followed in the rumen fluid and feces for a 10-week period. E. coli O157:H7 was rapidly eliminated from the rumen of the animals on all three diets but persisted in the feces of some animals up to 67 days after inoculation, suggesting that the bovine hindgut is the site of E. coli O157:H7 persistence. A significant difference existed in the levels of E. coli O157:H7 shed by the animals among diets on days 5, 7, 49, and 63 after inoculation (P &lt; 0.05). No significant difference was found between the levels shed among diets on days 9 through 42 and on day 67 (P &gt; 0.05). The number of animals that were culture positive for E. coli O157:H7 strain 3081 during the 10-week period was significantly higher for the barley fed group (72 of 114 samplings) as opposed to the corn fed group (44 of 114 samplings) (P &lt; 0.005) and the cottonseed and barley fed group (57 of 114 samplings) (P &lt; 0.05). The fecal pH of the animals fed the corn diet was significantly lower (P &lt; 0.05) than the fecal pH of the animals fed the cottonseed and barley and barley diets, likely resulting in a less suitable environment for E. coli O157:H7 in the hindgut of the corn fed animals. E. coli O157:H7 strain 3081 was present in 3 of 30 (corn, 1 of 10; cottonseed, 1 of 10; barley, 1 of 10) animal drinking water samples, 3 of 30 (corn, 1 of 10; cottonseed, 0 of 10; barley, 2 of 10) water trough biofilm swabs, 5 of 30 (corn, 0 of 10; cottonseed, 2 of 10; barley, 3 of 10) feed samples, and 30 of 30 manure samples taken from the pens during the entire experimental period. Mouth swabs of the steers were also culture positive for E. coli O157:H7 strain 3081 in 30 of 180 samples (corn, 7 of 60; cottonseed, 4 of 60; barley, 19 of 60) taken during the 10-week period. Minimizing environmental dissemination of E. coli O157:H7 in conjunction with diet modification may reduce numbers of E. coli O157:H7-positive cattle.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S J Buchko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R A Holley</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>W O Olson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V P Gannon</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D M Veira</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science, University of Manitoba, Winnipeg, Canada.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Cottonseed Oil</document:subject>
<document:subject>Fatty Acids, Volatile</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animal Feed</document:subject>
<document:subject>Barley</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Cereals</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Corn</document:subject>
<document:subject>Cottonseed Oil</document:subject>
<document:subject>Diet</document:subject>
<document:subject>Drinking</document:subject>
<document:subject>Escherichia coli O157</document:subject>
<document:subject>Fatty Acids, Volatile</document:subject>
<document:subject>Feces</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Male</document:subject>
<document:subject>Mouth</document:subject>
<document:subject>Rumen</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Water Microbiology</document:subject>
<document:subject>Animal Feed; microbiology</document:subject>
<document:subject>Cattle; microbiology</document:subject>
<document:subject>Cattle; physiology</document:subject>
<document:subject>Cereals; metabolism</document:subject>
<document:subject>Diet; veterinary</document:subject>
<document:subject>Escherichia coli O157; isolation &amp; purification</document:subject>
<document:subject>Escherichia coli O157; physiology</document:subject>
<document:subject>Fatty Acids, Volatile; analysis</document:subject>
<document:subject>Feces; chemistry</document:subject>
<document:subject>Feces; microbiology</document:subject>
<document:subject>Mouth; microbiology</document:subject>
<document:subject>Rumen; chemistry</document:subject>
<document:subject>Rumen; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079686">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Comparison of aqueous chemical treatments to eliminate Salmonella on alfalfa seeds.</document:title>
<document:abstractSection>Several outbreaks of salmonellosis associated with alfalfa sprouts have been documented in the United States since 1995. This study was undertaken to evaluate various chemical treatments for their effectiveness in killing Salmonella on alfalfa seeds. Immersing inoculated seeds in solutions containing 20,000 ppm free chlorine (Ca[OCl]2), 5% Na3PO4, 8% H2O2, 1% Ca(OH)2, 1% calcinated calcium, 5% lactic acid, or 5% citric acid for 10 min resulted in reductions of 2.0 to 3.2 log10 CFU/ g. Treatment with 1,060 ppm Tsunami or Vortex, 1,200 ppm acidified NaClO2, or 5% acetic acid were less effective in reducing Salmonella populations. With the exceptions of 8% H2O2, 1% Ca(OH)2, and 1% calcinated calcium that reduced populations by 3.2, 2.8, and 2.9 log10 CFU/g, respectively, none of treatments reduced the number of Salmonella by more than 2.2 log10 CFU/g without significantly reducing the seed germination percentage. Treatment with 5% acetic, lactic, or citric acids substantially reduced the ability of seeds to germinate. Treatment with 1% Ca(OH)2 in combination with 1% Tween 80, a surfactant, enhanced inactivation by 1.3 log10 CFU/g compared to treatment with 1% Ca(OH)2 alone. Presoaking seeds in water, 0.1% EDTA, 1% Tween 80, or 1% Tween 80 plus 0.1% EDTA for 30 min before treatment with water, 2,000 ppm NaOCl, or 2% lactic acid had a minimal effect on reducing populations of Salmonella. Results indicate that, although several chemical treatments cause reductions in Salmonella populations of up to 3.2 log10 CFU/g initially on alfalfa seeds when analyzed by direct plating, no treatment eliminated the pathogen, as evidenced by detection in enriched samples.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>W R Weissinger</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L R Beuchat</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science and Technology, University of Georgia, Griffin 30223-1797, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Calcium Compounds</document:subject>
<document:subject>Chlorine Compounds</document:subject>
<document:subject>Disinfectants</document:subject>
<document:subject>Solutions</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:50-21-5">
<cas:registryNumber>50-21-5</cas:registryNumber>
<cas:name>Lactic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:64-19-7">
<cas:registryNumber>64-19-7</cas:registryNumber>
<cas:name>Acetic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:77-92-9">
<cas:registryNumber>77-92-9</cas:registryNumber>
<cas:name>Citric Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7722-84-1">
<cas:registryNumber>7722-84-1</cas:registryNumber>
<cas:name>Hydrogen Peroxide</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Acetic Acid</document:subject>
<document:subject>Alfalfa</document:subject>
<document:subject>Calcium Compounds</document:subject>
<document:subject>Chlorine Compounds</document:subject>
<document:subject>Citric Acid</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Disinfectants</document:subject>
<document:subject>Disinfection</document:subject>
<document:subject>Germination</document:subject>
<document:subject>Human</document:subject>
<document:subject>Hydrogen Peroxide</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Lactic Acid</document:subject>
<document:subject>Salmonella</document:subject>
<document:subject>Salmonella Food Poisoning</document:subject>
<document:subject>Seeds</document:subject>
<document:subject>Solutions</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Acetic Acid; pharmacology</document:subject>
<document:subject>Alfalfa; microbiology</document:subject>
<document:subject>Calcium Compounds; pharmacology</document:subject>
<document:subject>Chlorine Compounds; pharmacology</document:subject>
<document:subject>Citric Acid; pharmacology</document:subject>
<document:subject>Disinfectants; pharmacology</document:subject>
<document:subject>Disinfection; methods</document:subject>
<document:subject>Germination; drug effects</document:subject>
<document:subject>Hydrogen Peroxide; pharmacology</document:subject>
<document:subject>Lactic Acid; pharmacology</document:subject>
<document:subject>Salmonella; drug effects</document:subject>
<document:subject>Salmonella; growth &amp; development</document:subject>
<document:subject>Salmonella Food Poisoning; prevention &amp; control</document:subject>
<document:subject>Seeds; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079687">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Enrichment procedures and plating media for isolation of Yersinia enterocolitica.</document:title>
<document:abstractSection>A shortened enrichment procedure (25 degrees C for 24 h) was compared with cold enrichment procedures (4 degrees C for 1 to 3 weeks) and direct plating for isolation of Yersinia enterocolitica from commercial ground meat samples. The combined data of all recovery procedures showed that this organism was isolated from 34% of the ground beef samples. The highest isolation rate was 32% for the 4 degrees C/3-week enrichment, followed by 28% for the 4 degrees C/2-week enrichment, 26% for the 25 degrees C/24-h enrichment, 22% for the 4 degrees C/1-week enrichment, and 10% for direct plating. No significant differences (P &gt; 0.05) in isolation rate occurred between the 4 degrees C/3-week, 4 degrees C/2-week, 25 degrees C/24-h, and 4 degrees C/1-week enrichments. The combined data of all recovery procedures showed that Y. enterocolitica was isolated from 64% of ground pork samples. The highest isolation rate was 48% for the 4 degrees C/3-week enrichment, followed by 40% for the 25 degrees C/24-h enrichment, 34% for the 4 degrees C/2-week enrichment, 24% for the 4 degrees C/1-week enrichment, and 24% for direct plating. No significant differences (P &gt; 0.05) in isolation rate occurred between the 4 degrees C/3-week, 25 degrees C/24-h, and 4 degrees C/2-week enrichments. During the plating phase of the experiment, the efficiency of a dye-containing, Yersinia-selective medium (KV202) was compared with that of a commercially available cefsulodin-irgasan-novobiocin medium. Recovery rates were similar for both media. However, KV202 agar differentiated Y. enterocolitica from such contaminating bacteria as Enterobacter, Serratia, and Salmonella by colony morphologic characteristics and color.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>G C Jiang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D H Kang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Y Fung</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506-1600, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Culture Media</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Bacteriological Techniques</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Culture Media</document:subject>
<document:subject>Meat</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Temperature</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Yersinia enterocolitica</document:subject>
<document:subject>Meat; microbiology</document:subject>
<document:subject>Yersinia enterocolitica; growth &amp; development</document:subject>
<document:subject>Yersinia enterocolitica; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079688">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Genotypes and enterotoxicity of Staphylococcus aureus isolated from the hands and nasal cavities of flight-catering employees.</document:title>
<document:abstractSection>Hand and nasal samples of flight-catering staff were collected from 1995 to 1997 to find employees carrying Staphylococcus aureus. Altogether 153 hand samples and 136 nose samples were taken. Nasal sampling showed a higher prevalence of S. aureus among food handlers (29%) than hand sampling (9%). A high proportion of the strains (46%) were enterotoxigenic, and a considerable amount of food handlers carried enterotoxigenic S. aureus, 6% and 12% according to hand and nasal sampling, respectively. Pulsed-field gel electrophoresis macrorestriction profiles revealed a total of 32 different types associated with the 35 employees carrying S. aureus. In most cases, the same type colonized both the hand and nose of a person. Despite the wide variety of types found, one strain colonized five persons and the second most common strain was associated with four food handlers. The predominant toxin produced was B, which was produced by the most common strain. The results showed that nasal sampling is a good way to detect S. aureus carriers, whereas hand sampling may fail to reveal carriers. The high proportion of enterotoxigenic strains show that a food handler harboring S. aureus must be considered a potential source of enterotoxigenic strains for airline meals.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M Hatakka</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K J Bj√∂rkroth</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K Asplund</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N M√§ki-Pet√§ys</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H J Korkeala</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food and Environmental Hygiene, Faculty of Veterinary Medicine, University of Helsinki, Finland. maija.hatakka@elintarvikevirasto.fi</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Enterotoxins</document:subject>
<document:subject>Carrier State</document:subject>
<document:subject>Electrophoresis, Gel, Pulsed-Field</document:subject>
<document:subject>Enterotoxins</document:subject>
<document:subject>Female</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Genotype</document:subject>
<document:subject>Hand</document:subject>
<document:subject>Human</document:subject>
<document:subject>Male</document:subject>
<document:subject>Nasal Cavity</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Staphylococcal Infections</document:subject>
<document:subject>Staphylococcus aureus</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Carrier State; epidemiology</document:subject>
<document:subject>Carrier State; microbiology</document:subject>
<document:subject>Enterotoxins; analysis</document:subject>
<document:subject>Hand; microbiology</document:subject>
<document:subject>Nasal Cavity; microbiology</document:subject>
<document:subject>Staphylococcal Infections; epidemiology</document:subject>
<document:subject>Staphylococcus aureus; classification</document:subject>
<document:subject>Staphylococcus aureus; genetics</document:subject>
<document:subject>Staphylococcus aureus; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079689">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Stimulation of starter culture for further reduction of foodborne pathogens during salami fermentation.</document:title>
<document:abstractSection>This study was conducted to determine if stimulated meat starter culture (MSC; Pediococcus acidilactici) would further control Escherichia coli O157:H7, Listeria monocytogenes, and Staphylococcus aureus during salami fermentation. Manganese ion (0.005% of MnSO4) was used as a stimulator for the growth and acid production of MSC. After 24-h salami fermentation, nonstimulated MSC and stimulated MSC reduced E. coli O157:H7 levels by 1.3 and 2.3 log10 units, respectively. Nonstimulated MSC reduced L. monocytogenes levels by 1.2 log10 units, whereas the stimulated MSC achieved a 2.2-log10 reduction after 24-h fermentation. In the case of S. aureus, nonstimulated MSC and stimulated MSC reduced S. aureus levels by 1.3 and 2.3 log10 units after 24-h fermentation, respectively. Stimulated MSC by MnSO4 reduced those foodborne pathogens more effectively compared with nonstimulated MSC (P &lt; 0.05).</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D H Kang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Y Fung</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Animal Sciences and Industry, Kansas State University, Manhattan 66501-1600, USA. kang@email.marc.usda.gov</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Culture Media</document:subject>
<document:subject>Manganese Compounds</document:subject>
<document:subject>Sulfates</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7785-87-7">
<cas:registryNumber>7785-87-7</cas:registryNumber>
<cas:name>manganese sulfate</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Antibiosis</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Culture Media</document:subject>
<document:subject>Escherichia coli O157</document:subject>
<document:subject>Fermentation</document:subject>
<document:subject>Listeria monocytogenes</document:subject>
<document:subject>Manganese Compounds</document:subject>
<document:subject>Meat Products</document:subject>
<document:subject>Pediococcus</document:subject>
<document:subject>Staphylococcus aureus</document:subject>
<document:subject>Sulfates</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Escherichia coli O157; drug effects</document:subject>
<document:subject>Escherichia coli O157; growth &amp; development</document:subject>
<document:subject>Listeria monocytogenes; drug effects</document:subject>
<document:subject>Listeria monocytogenes; growth &amp; development</document:subject>
<document:subject>Manganese Compounds; pharmacology</document:subject>
<document:subject>Meat Products; microbiology</document:subject>
<document:subject>Pediococcus; physiology</document:subject>
<document:subject>Staphylococcus aureus; drug effects</document:subject>
<document:subject>Staphylococcus aureus; growth &amp; development</document:subject>
<document:subject>Sulfates; pharmacology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079690">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Bacillus cereus group strains, their hemolysin BL activity, and their detection in foods using a 16S RNA and hemolysin BL gene-targeted multiplex polymerase chain reaction system.</document:title>
<document:abstractSection>Hemolysin BL (HBL) is a major virulence factor for Bacillus cereus group strains. It is also a target enterotoxin for the most commonly used B. cereus detection kit, i.e., the B. cereus enterotoxin (diarrheal type) reversed passive latex agglutination (BCET-RPLA) test kit. A survey of the HBL activities and the cytotoxicities to the Chinese hamster ovary (CHO) cells for the B. cereus group strains, however, showed that although only part of the B. cereus group strains are HBL active, all strains show cytotoxicity to the CHO cells. Thus, methods that allow the detection of not only the HBL but also of the B. cereus group strains are important. In this study, by comparison of the gene sequences of the 16S rRNA for B. cereus group and other bacteria strains, we designed primers B16S1 and B16S2 specific to all the B. cereus group strains. In addition, because HBL is a major enterotoxin, we also designed HBL gene-specific polymerase chain reaction (PCR) primers, i.e., Hm1 and Hm2, that generated the same results as those of the hemolysis and BCET-RPLA assays. Primers B16S1/B16S2 and Hm1/Hm2 could be combined into a multiplex PCR system for the simultaneous detection of B. cereus group cells and the possible presence of their HBL enterotoxins. Also, all these PCR systems allowed the detection of n x 10(0) CFU B. cereus cells per g of food sample if an 8-h enrichment step was performed prior to the PCR.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>H Y Tsen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M L Chen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Y M Hsieh</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S J Sheu</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Y L Chen</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science, National Chung-Hsing University, Taichung, Taiwan, ROC. hytsen@dragon.nchu.edu.tw</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Bacterial Proteins</document:subject>
<document:subject>DNA Primers</document:subject>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Enterotoxins</document:subject>
<document:subject>RNA, Ribosomal, 16S</document:subject>
<document:subject>hemolysin BL</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Bacillus cereus</document:subject>
<document:subject>Bacterial Proteins</document:subject>
<document:subject>CHO Cells</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>DNA Primers</document:subject>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Enterotoxins</document:subject>
<document:subject>Hamsters</document:subject>
<document:subject>Polymerase Chain Reaction</document:subject>
<document:subject>RNA, Ribosomal, 16S</document:subject>
<document:subject>Sensitivity and Specificity</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Bacillus cereus; classification</document:subject>
<document:subject>Bacillus cereus; genetics</document:subject>
<document:subject>Bacillus cereus; isolation &amp; purification</document:subject>
<document:subject>Bacterial Proteins; genetics</document:subject>
<document:subject>Bacterial Proteins; metabolism</document:subject>
<document:subject>DNA, Bacterial; analysis</document:subject>
<document:subject>Enterotoxins; genetics</document:subject>
<document:subject>Polymerase Chain Reaction; methods</document:subject>
<document:subject>RNA, Ribosomal, 16S; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079691">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Bacterial spore inhibition and inactivation in foods by pressure, chemical preservatives, and mild heat.</document:title>
<document:abstractSection>Sucrose laurates, sucrose palmitate, sucrose stearates, and monolaurin (Lauricidin) were evaluated for inhibitory effects against spores of Bacillus sp., Clostridium sporogenes PA3679, and Alicyclobacillus sp. in a model agar system. The combined treatment of sucrose laurate, high hydrostatic pressure, and mild heat was evaluated on spores of Bacillus and Alicyclobacillus in foods. The minimum inhibitory concentrations of the sucrose esters were higher than that of Lauricidin for all spores tested in the model agar system, but Lauricidin was not the most readily suspended in the test media. The sucrose laurates and sucrose palmitate were more effective and more readily suspended than the sucrose stearates. A combined treatment of sucrose laurate (&lt;1.0%), 392 megaPascals (MPa) at 45 degrees C for 10 to 15 min provided 3- to 5.5-log10 CFU/ml reductions from initial populations of 10(6) CFU/ml for Bacillus subtilis 168 in milk, Bacillus cereus 14579 in beef, Bacillus coagulans 7050 in tomato juice (pH 4.5), Alicyclobacillus sp. N1089 in tomato juice (pH 4.5), and Alicyclobacillus sp. N1098 in apple juice. The most notable change in the appearance of the products was temporary foaming during mixing of the sucrose laurate in the foods. The effect of sucrose laurate appeared to be inhibitory rather than lethal to the spores. The inhibitory effects observed on Bacillus and Alicyclobacillus spores by the combined treatment of pressure, mild heat, and sucrose laurate appear promising for food applications where alternatives to high heat processing are desired.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A E Shearer</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C P Dunne</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A Sikes</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D G Hoover</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Animal and Food Sciences, University of Delaware, Newark 19717, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Food Preservatives</document:subject>
<document:subject>Glycerides</document:subject>
<document:subject>Laurates</document:subject>
<document:subject>Surface-Active Agents</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:25339-99-5">
<cas:registryNumber>25339-99-5</cas:registryNumber>
<cas:name>sucrose monolaurate</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:27215-38-9">
<cas:registryNumber>27215-38-9</cas:registryNumber>
<cas:name>monolaurin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:57-50-1">
<cas:registryNumber>57-50-1</cas:registryNumber>
<cas:name>Sucrose</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Bacillus</document:subject>
<document:subject>Beverages</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Clostridium</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Preservatives</document:subject>
<document:subject>Glycerides</document:subject>
<document:subject>Heat</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Hydrostatic Pressure</document:subject>
<document:subject>Laurates</document:subject>
<document:subject>Milk</document:subject>
<document:subject>Spores, Bacterial</document:subject>
<document:subject>Sucrose</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Surface-Active Agents</document:subject>
<document:subject>Bacillus; drug effects</document:subject>
<document:subject>Bacillus; growth &amp; development</document:subject>
<document:subject>Beverages; microbiology</document:subject>
<document:subject>Clostridium; drug effects</document:subject>
<document:subject>Clostridium; growth &amp; development</document:subject>
<document:subject>Food Preservatives; pharmacology</document:subject>
<document:subject>Glycerides; pharmacology</document:subject>
<document:subject>Laurates; pharmacology</document:subject>
<document:subject>Milk; microbiology</document:subject>
<document:subject>Spores, Bacterial; drug effects</document:subject>
<document:subject>Spores, Bacterial; growth &amp; development</document:subject>
<document:subject>Sucrose; analogs &amp; derivatives</document:subject>
<document:subject>Sucrose; pharmacology</document:subject>
<document:subject>Surface-Active Agents; pharmacology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079692">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Nonproteolytic Clostridium botulinum toxigenesis in cooked turkey stored under modified atmospheres.</document:title>
<document:abstractSection>The ability of nonproteolytic Clostridium botulinum type B spores to grow and produce toxin in cooked, uncured turkey packaged under modified atmospheres was investigated at refrigeration and mild to moderate abuse temperatures. Cook-in-bag turkey breast was carved into small chunks, surface-inoculated with a mixture of nonproteolytic C. botulinum type B spores, packaged in O2-impermeable bags under two modified atmospheres (100% N2 and 30% CO2:70% N2), and stored at 4, 10, and 15 degrees C. Samples were analyzed for botulinal toxin and indigenous microorganisms, as well as subjected to sensory evaluation, on days 0, 7, 14, 28, 42, and 60. Given sufficient incubation time, nonproteolytic C. botulinum type B grew and produced toxin in all temperature and modified atmosphere treatment combinations. At moderate temperature abuse (15 degrees C), toxin was detected by day 7, independent of packaging atmosphere. At mild temperature abuse (10 degrees C), toxin was detected by day 14, also independent of packaging atmosphere. At refrigeration temperature (4 degrees C), toxin was detected by day 14 in product packaged under 100% N2 and by day 28 in product packaged under 30% CO2:70% N2. Reduced storage temperature significantly delayed toxin production and extended the period of sensory acceptability of cooked turkey, but even strict refrigeration did not prevent growth and toxigenesis by nonproteolytic C. botulinum. At all three storage temperatures, toxin detection preceded or coincided with development of sensory characteristics of spoilage, demonstrating the potential for consumption of toxic product when spoilage-signaling sensory cues are absent.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>K A Lawlor</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M D Pierson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C R Hackney</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J R Claus</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J E Marcy</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science and Technology, Virginia Polytechnic Institute and State University, Blacksburg 24061-0418, USA. kathy.lawlor@silliker.com</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Botulinum Toxins</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Botulinum Toxins</document:subject>
<document:subject>Clostridium botulinum</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Poultry</document:subject>
<document:subject>Spores, Bacterial</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Taste</document:subject>
<document:subject>Temperature</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Turkeys</document:subject>
<document:subject>Botulinum Toxins; biosynthesis</document:subject>
<document:subject>Clostridium botulinum; growth &amp; development</document:subject>
<document:subject>Clostridium botulinum; metabolism</document:subject>
<document:subject>Poultry; microbiology</document:subject>
<document:subject>Spores, Bacterial; growth &amp; development</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079693">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Detection of guaiacol produced by Alicyclobacillus acidoterrestris in apple juice by sensory and chromatographic analyses, and comparison with spore and vegetative cell populations.</document:title>
<document:abstractSection>Spoilage of fruit juice by Alicyclobacillus acidoterrestris is characterized by a distinct medicinal or antiseptic off odor attributed to guaiacol, a metabolic by product of the bacterium. Detection of low populations of A. acidoterrestris that would precede sensory detection of guaiacol would enable juice processors to select appropriate processing and storage conditions that would minimize or eliminate spoilage. The objective of this study was to determine the recognition threshold of guaiacol in apple juice by sensory analysis and the population of A. acidoterrestris and incubation time at 21 and 37 degrees C necessary for chemical detection of guaiacol. Commercially sterilized apple juice (pH 3.54 +/- 0.04, 11.3 +/- 0.3 degrees Brix) was inoculated with a five-strain mixture of A. acidoterrestris spores (2.98 log10 CFU/ml) and stored at 21 or 37 degrees C for up to 61 days. Using an experienced sensory panel and the forced-choice ascending concentration method of limits, the best estimate threshold (BET) for recognition of guaiacol added to uninoculated apple juice was 2.23 ppb. Numbers of A. acidoterrestris spores and cells in inoculated juice remained constant during the 61-day storage period; however, the panel detected (P &lt; or = 0.01) guaiacol in juice stored at 37 degrees C within 8 days. At three of four sampling times ranging from 13 to 61 days at which the sensory panel detected (P &lt; or = 0.001) guaiacol, concentrations of 8.1 to 11.4 ppb were detected by chromatographic analysis. The panel detected (P &lt; or = 0.1 to P &lt; or = 0.01) guaiacol in five samples stored at 21 to 37 degrees C for 8 to 61 days in which the compound was not detected by chromatographic analyses. It appears that guaiacol content in apple juice inoculated with A. acidoterrestris is not always correlated with numbers of cells, and the limit of sensitivity of chromatographic quantitation of the compound is higher than the BET.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R V Orr</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R L Shewfelt</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C J Huang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Tefera</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L R Beuchat</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science and Technology, University of Georgia, Griffin 30223-1797, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:90-05-1">
<cas:registryNumber>90-05-1</cas:registryNumber>
<cas:name>Guaiacol</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Bacillus</document:subject>
<document:subject>Beverages</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Guaiacol</document:subject>
<document:subject>Human</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Mass Fragmentography</document:subject>
<document:subject>Odors</document:subject>
<document:subject>Rosales</document:subject>
<document:subject>Spores, Bacterial</document:subject>
<document:subject>Taste</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Bacillus; growth &amp; development</document:subject>
<document:subject>Bacillus; isolation &amp; purification</document:subject>
<document:subject>Bacillus; metabolism</document:subject>
<document:subject>Beverages; microbiology</document:subject>
<document:subject>Guaiacol; analysis</document:subject>
<document:subject>Guaiacol; metabolism</document:subject>
<document:subject>Spores, Bacterial; growth &amp; development</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079694">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Aerobiology of a high-line speed cattle abattoir.</document:title>
<document:abstractSection>The operation of the high-line speed cattle abattoir studied follows a plant-created hazard analysis and critical control point (HACCP) plan that is recognized by the Canadian Food Inspection Agency. Measurement of bioaerosols is not a part of this plan. In this study CFUs in air of selected abattoir processes were enumerated after impinging air onto tryptic soy agar plates with a slit air sampler for 10 to 20 min. The total viable count (TVC) per liter of air was calculated for each sample following incubation at 30 degrees C for 24 h. Monthly samples were collected on the hide removal floor and the carcass dressing floor from March 1998 to April 1999. Mud tag, dirt, and wetness of incoming hides were scored subjectively on the hide removal floor. The other processes were sampled in 3 separate months. The TVC at two locations on the hide removal floor (center of hide removal floor [CHF] and top of hide puller [THP]) had a strong association to each other (r = 0.84; P &lt; 0.001). The mean TVC at the CHF and THP was 10.0 and 11.5, respectively, and the TVC for individual samples ranged from 2 to 42 at these locations. The TVC means for all the other processes ranged from 0.01 to 0.7. Tag and TVC on the hide removal floor had a different seasonal distribution with TVC being highest in the warm months (April to October 1998) and lowest for November to April 1999. No significant relations between TVC and the dirt and wetness variables were evident for the CHF and THP locations on the hide removal floor. It was concluded that the control of aerosols in the hide removal floor should be treated as a critical control point in the HACCP plan.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>K W Jericho</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Ho</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G C Kozub</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Health Canada, Population and Public Health Branch, Animal Diseases Research Institute, Lethbridge, Alberta. jerichok@em.agr.ca</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Abattoirs</document:subject>
<document:subject>Air Microbiology</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animal Husbandry</document:subject>
<document:subject>Bacteria, Aerobic</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Female</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Hygiene</document:subject>
<document:subject>Male</document:subject>
<document:subject>Seasons</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Bacteria, Aerobic; growth &amp; development</document:subject>
<document:subject>Bacteria, Aerobic; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079695">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>The synergistic effect of excimer and low-pressure mercury lamps on the disinfection of flowing water.</document:title>
<document:abstractSection>Microorganisms in flowing water were disinfected by UV radiation from two excimer (excited dimer) lamps (emitting at 172 and 222 nm) in combination with two low-pressure mercury lamps (emitting at 254 nm). Synergies were investigated among the three types of radiation in the treatment of water spiked in turn with Escherichia coli, Listeria innocua, Shewanella putrefaciens, and spores of Bacillus subtilis and Bacillus cereus. Synergy was demonstrated between radiations at 222 and 254 nm in the treatment of E. coli, L. innocua, and S. putrefaciens, but little or no synergy was observed in the treatment of B. subtilis and B. cereus. At maximum flow rates (60 liters/min), 5-log reductions in E. coli were achieved at 254 nm, although at 222 nm, less than 1-log reductions were observed. No bacterial kill was observed with 172-nm radiation alone, despite increasing exposure time by reducing flow rates to less than 3 liters/min.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>I A Ramsay</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J C Niedziela</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I D Ogden</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Laser Installations Limited, Arbirlot, by Arbroath, UK.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anti-Infective Agents, Local</document:subject>
<document:subject>Mercury Compounds</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7722-84-1">
<cas:registryNumber>7722-84-1</cas:registryNumber>
<cas:name>Hydrogen Peroxide</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Anti-Infective Agents, Local</document:subject>
<document:subject>Bacillus cereus</document:subject>
<document:subject>Bacillus subtilis</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Disinfection</document:subject>
<document:subject>Escherichia coli</document:subject>
<document:subject>Hydrogen Peroxide</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Listeria</document:subject>
<document:subject>Mercury Compounds</document:subject>
<document:subject>Shewanella putrefaciens</document:subject>
<document:subject>Spores, Bacterial</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Temperature</document:subject>
<document:subject>Ultraviolet Rays</document:subject>
<document:subject>Water Microbiology</document:subject>
<document:subject>Anti-Infective Agents, Local; chemistry</document:subject>
<document:subject>Anti-Infective Agents, Local; pharmacology</document:subject>
<document:subject>Bacillus cereus; radiation effects</document:subject>
<document:subject>Bacillus subtilis; radiation effects</document:subject>
<document:subject>Disinfection; methods</document:subject>
<document:subject>Escherichia coli; radiation effects</document:subject>
<document:subject>Hydrogen Peroxide; chemistry</document:subject>
<document:subject>Hydrogen Peroxide; pharmacology</document:subject>
<document:subject>Listeria; radiation effects</document:subject>
<document:subject>Shewanella putrefaciens; radiation effects</document:subject>
<document:subject>Spores, Bacterial; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079696">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Ultraviolet spectrophotometric characterization and bactericidal properties of electrolyzed oxidizing water as influenced by amperage and pH.</document:title>
<document:abstractSection>To identify the primary component responsible in electrolyzed oxidizing (EO) water for inactivation, this study determined the concentrations of hypochlorous acid (HOCl) and hypochlorite ions (OCl-) and related those concentrations to the microbicidal activity of the water. The ultraviolet absorption spectra were used to determine the concentrations of HOCl and OCl- in EO water and the chemical equilibrium of these species with change in pH and amperage. EO water generated at higher amperage contained a higher chlorine concentration. The maximum concentration of HOCl was observed around pH 4 where the maximum log reduction (2.3 log10 CFU/ml) of Bacillus cereus F4431/73 vegetative cells also occurred. The high correlation (r = 0.95) between HOCl concentrations and bactericidal effectiveness of EO water supports HOCl's role as the primary inactivation agent. Caution should be taken with standard titrimetric methods for measurement of chlorine as they cannot differentiate the levels of HOCl present in EO water of varying pHs.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S V Len</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Y C Hung</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Erickson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Kim</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science and Technology, College of Agricultural and Environmental Sciences, University of Georgia, Griffin 30223-1797, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7790-92-3">
<cas:registryNumber>7790-92-3</cas:registryNumber>
<cas:name>Hypochlorous Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Bacillus cereus</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Electrolysis</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Hypochlorous Acid</document:subject>
<document:subject>Oxidation-Reduction</document:subject>
<document:subject>Spectrophotometry, Ultraviolet</document:subject>
<document:subject>Water</document:subject>
<document:subject>Water Microbiology</document:subject>
<document:subject>Bacillus cereus; drug effects</document:subject>
<document:subject>Hypochlorous Acid; analysis</document:subject>
<document:subject>Hypochlorous Acid; pharmacology</document:subject>
<document:subject>Spectrophotometry, Ultraviolet; methods</document:subject>
<document:subject>Water; analysis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079697">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Prevalence of high-risk food consumption and food-handling practices among adults: a multistate survey, 1996 to 1997. The Foodnet Working Group.</document:title>
<document:abstractSection>Risk factors for foodborne diseases include consumption of high-risk foods and unsanitary food-handling practices; however, little is known about the prevalence of these risk factors in the general population. A survey was done in five FoodNet sites (California, Connecticut, Georgia, Minnesota, Oregon) to determine the prevalence of these risk factors in the population. A total of 7,493 adults were interviewed by telephone between 1 July 1996 and 30 June 1997. Results showed that 1.5% drank raw milk, 1.9% ate raw shellfish, 18% ate runny egg, 30% preferred pink hamburger, 93% said they almost always washed their cutting board after cutting raw chicken, and 93% said they almost always washed their hands after handling raw meat or poultry, during 5 days before interview. The results differed by state and demographic group. Consumption of raw shellfish (3.2%) and undercooked hamburger (43%) were more common in Connecticut than other states. Raw milk consumption was more common among people who lived on a farm (8.6%) compared with people who lived in a city or urban area (1.1%). Preference for undercooked hamburger was more common among men (35%), young adults (18 to 25 years, 33%), people with college education (38%), and among people with household income of more than $100,000/year (49%). African-Americans were less likely to prefer undercooked hamburger compared to other racial groups (10% versus 30%). Young adults compared to older adults were less likely to wash their hands after handling raw chicken (88% versus 95%), and men washed their hands less often than women (89% versus 97%). Although there were statistical differences between demographic groups, they are insufficient to warrant targeted educational programs.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>B Shiferaw</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Yang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Cieslak</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Vugia</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R Marcus</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Koehler</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V Deneen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Angulo</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Human Services, Oregon Health Division, Portland 97232, USA. beletshachew.shiferaw@state.or.us</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Animal</document:subject>
<document:subject>California</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Connecticut</document:subject>
<document:subject>Data Collection</document:subject>
<document:subject>Eggs</document:subject>
<document:subject>Feeding Behavior</document:subject>
<document:subject>Female</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Georgia</document:subject>
<document:subject>Handwashing</document:subject>
<document:subject>Human</document:subject>
<document:subject>Interviews</document:subject>
<document:subject>Knowledge, Attitudes, Practice</document:subject>
<document:subject>Male</document:subject>
<document:subject>Meat Products</document:subject>
<document:subject>Milk</document:subject>
<document:subject>Minnesota</document:subject>
<document:subject>Oregon</document:subject>
<document:subject>Risk Factors</document:subject>
<document:subject>Sex Factors</document:subject>
<document:subject>Shellfish</document:subject>
<document:subject>Socioeconomic Factors</document:subject>
<document:subject>California; epidemiology</document:subject>
<document:subject>Connecticut; epidemiology</document:subject>
<document:subject>Food Handling; statistics &amp; numerical data</document:subject>
<document:subject>Georgia; epidemiology</document:subject>
<document:subject>Minnesota; epidemiology</document:subject>
<document:subject>Oregon; epidemiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079698">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Influence of hygienic quality of raw materials on biogenic amine production during ripening and storage of dry fermented sausages.</document:title>
<document:abstractSection>The effect of the hygienic status of raw materials on biogenic amine production during ripening and storage (at 4 and 15 degrees C) of fermented sausages was studied. Two portions of fresh lean and back fat pork were stored for 5 days at -20 degrees C (treatment A) and at 4 degrees C (treatment B), respectively. Raw materials of treatment A maintained their hygienic quality high and low amine content. Raw materials of treatment B showed from 1 to 3 log (CFU/g) higher microbial counts and a biogenic amine index near 50 mg/kg, indicating poorer hygienic quality. The quality of raw materials influenced the composition and the concentration of biogenic amines produced during the ripening sausages. Sausages of treatment A (A-sausages) showed a large accumulation of tyramine (up to 100 mg/kg dm) followed by putrescine and cadaverine (&lt;15 mg/kg). In contrast, B-sausages resulted in earlier and much greater amine production, and cadaverine, tyramine, and putrescine levels were 50-, 2.6-, and 6.5-fold higher than those of A-sausages. Other biogenic amines, such as octopamine, tryptamine, phenylethylamine, and histamine were also produced in B-sausages. The higher proteolysis and the lower pH of B-sausages might have favored the decarboxylase activity of microorganisms. Biogenic amine contents of sausages during storage depended on the raw materials used and storage temperature. No significant modification on the amine contents was observed during the storage of A-sausages at either temperature. Greater changes occurred in B-sausages stored at 15 degrees C than in those stored at 4 degrees C. Higher temperatures favored proteolytic and decarboxylase reactions, resulting in increased amine concentrations after storage.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S Bover-Cid</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Izquierdo-Pulido</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M C Vidal-Carou</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Departament de Nutrici√≥ i Bromatologia, CeRTA, Facultat de Farm√†cia, Universitat de Barcelona, Spain.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Biogenic Amines</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Biogenic Amines</document:subject>
<document:subject>Chromatography, High Pressure Liquid</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Decarboxylation</document:subject>
<document:subject>Enterobacteriaceae</document:subject>
<document:subject>Fermentation</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Hygiene</document:subject>
<document:subject>Meat Products</document:subject>
<document:subject>Spain</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Temperature</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Biogenic Amines; biosynthesis</document:subject>
<document:subject>Enterobacteriaceae; growth &amp; development</document:subject>
<document:subject>Food Preservation; methods</document:subject>
<document:subject>Meat Products; analysis</document:subject>
<document:subject>Meat Products; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079699">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Formation of biogenic amines in raw milk Hisp√°nico cheese manufactured with proteinases and different levels of starter culture.</document:title>
<document:abstractSection>Two proteinases, a neutral proteinase from Bacillus subtilis and a cysteine proteinase from Micrococcus sp., were used to accelerate the ripening process of raw cow's milk Hisp√°nico cheese, a semihard variety. Two levels (0.1% and 1%) of a commercial starter culture containing Lactococcus lactis subsp. lactis and L. lactis subsp. cremoris were added for cheese manufacture. The influence of both factors, proteinase addition and level of starter culture, on the growth of amino acid-decarboxylating microorganisms and on the formation of biogenic amines during cheese ripening was investigated in duplicate experiments. The population of tyrosine decarboxylase-positive bacteria, which represented less than 1% of the total bacterial population in most cheese samples, and tyrosine decarboxylase-positive lactobacilli was not influenced by proteinase addition or level of starter culture. Tyramine was detected in all batches of cheese from day 30. Its concentration was significantly (P &lt; 0.05) influenced by proteinase addition but not by the level of starter culture and increased with cheese age. After 90 days of ripening, 103 to 191 mg/kg of tyramine was found in the different cheese batches. Histamine was not detected until day 60 in cheese with neutral proteinase and 1% starter culture and until day 90 in the rest of the cheeses. The concentration of this amine did not exceed 20 mg/kg in any of the batches investigated. Phenylethylamine and tryptamine were not found in any of the samples.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>E Fernandez-Garc√≠a</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Tomillo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Nu√±ez</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Departamento de Tecnolog√≠a de Alimentos, INIA, Madrid, Spain. fgarcia@inia.es</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Biogenic Amines</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:51-45-6">
<cas:registryNumber>51-45-6</cas:registryNumber>
<cas:name>Histamine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:51-67-2">
<cas:registryNumber>51-67-2</cas:registryNumber>
<cas:name>Tyramine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:EC%203.4.-">
<cas:registryNumber>EC 3.4.-</cas:registryNumber>
<cas:name>Endopeptidases</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:EC%204.1.1.25">
<cas:registryNumber>EC 4.1.1.25</cas:registryNumber>
<cas:name>Tyrosine Decarboxylase</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Bacillus subtilis</document:subject>
<document:subject>Biogenic Amines</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Cheese</document:subject>
<document:subject>Endopeptidases</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Histamine</document:subject>
<document:subject>Lactococcus</document:subject>
<document:subject>Micrococcus</document:subject>
<document:subject>Milk</document:subject>
<document:subject>Spain</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Tyramine</document:subject>
<document:subject>Tyrosine Decarboxylase</document:subject>
<document:subject>Bacillus subtilis; enzymology</document:subject>
<document:subject>Biogenic Amines; analysis</document:subject>
<document:subject>Biogenic Amines; biosynthesis</document:subject>
<document:subject>Cheese; analysis</document:subject>
<document:subject>Cheese; microbiology</document:subject>
<document:subject>Endopeptidases; metabolism</document:subject>
<document:subject>Histamine; analysis</document:subject>
<document:subject>Histamine; biosynthesis</document:subject>
<document:subject>Lactococcus; isolation &amp; purification</document:subject>
<document:subject>Micrococcus; enzymology</document:subject>
<document:subject>Tyramine; analysis</document:subject>
<document:subject>Tyramine; biosynthesis</document:subject>
<document:subject>Tyrosine Decarboxylase; adverse effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079700">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Mixed starter cultures to control biogenic amine production in dry fermented sausages.</document:title>
<document:abstractSection>Several combinations of an amine-negative Lactobacillus sakei strain, along with proteolytic Staphylococcus carnosus or Staphylococcus xylosus strains, were used to study the influence of mixed starter cultures on biogenic amine production during the manufacture of dry fermented sausages. Changes in pH, water content, proteolysis, microbial counts, and biogenic amine contents were simultaneously examined in a spontaneously fermented batch and in three mixed starter-mediated batches. A double-controlled microbial charge initially inoculated as mixed starter culture of L. sakei and Staphylococcus spp. (all amine-negative strains) drastically reduced tyramine, cadaverine, and putrescine accumulation. No production of other aromatic amines such as histamine, phenylethylamine, or tryptamine was observed in any batch. The polyamines, spermine and spermidine, were found in raw materials and their levels decreased slightly in the spontaneously fermented batch. No correlation between proteolysis and biogenic amine production was observed. The use of proper technological conditions favoring starter development and the use of the raw materials with good hygienic quality make it possible to produce fermented sausages nearly free of biogenic amines.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S Bover-Cid</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Izquierdo-Pulido</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M C Vidal-Carou</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Nutrition and Food Science-CeRTA, Faculty of Pharmacy, University of Barcelona, Spain.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Biogenic Amines</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:110-60-1">
<cas:registryNumber>110-60-1</cas:registryNumber>
<cas:name>Putrescine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:462-94-2">
<cas:registryNumber>462-94-2</cas:registryNumber>
<cas:name>Cadaverine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:51-67-2">
<cas:registryNumber>51-67-2</cas:registryNumber>
<cas:name>Tyramine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Biogenic Amines</document:subject>
<document:subject>Cadaverine</document:subject>
<document:subject>Chromatography, High Pressure Liquid</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Fermentation</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Hygiene</document:subject>
<document:subject>Lactobacillus</document:subject>
<document:subject>Meat Products</document:subject>
<document:subject>Putrescine</document:subject>
<document:subject>Staphylococcus</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Tyramine</document:subject>
<document:subject>Water</document:subject>
<document:subject>Biogenic Amines; analysis</document:subject>
<document:subject>Biogenic Amines; biosynthesis</document:subject>
<document:subject>Cadaverine; analysis</document:subject>
<document:subject>Cadaverine; biosynthesis</document:subject>
<document:subject>Lactobacillus; chemistry</document:subject>
<document:subject>Lactobacillus; growth &amp; development</document:subject>
<document:subject>Meat Products; analysis</document:subject>
<document:subject>Meat Products; microbiology</document:subject>
<document:subject>Putrescine; analysis</document:subject>
<document:subject>Putrescine; biosynthesis</document:subject>
<document:subject>Staphylococcus; chemistry</document:subject>
<document:subject>Staphylococcus; growth &amp; development</document:subject>
<document:subject>Tyramine; analysis</document:subject>
<document:subject>Tyramine; biosynthesis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079701">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Detection of radiation-induced hydrocarbons and 2-alkylcyclobutanones in irradiated perilla seeds.</document:title>
<document:abstractSection>The method consists of the extraction of fat from perilla seeds, separation of hydrocarbons and 2-alkylcyclobutanones with florisil column chromatography, and identification of hydrocarbons and 2-alkylcyclobutanones by gas chromatography-mass spectroscopy (GC-MS). Concentrations of hydrocarbons and 2-alkylcyclobutanones increased with the irradiation dose. The major hydrocarbons in the irradiated perilla seeds were 8-heptadecene and 1,7-hexadecadiene from oleic acid and 6,9-heptadecadiene and 1,7,10-hexadecatriene from linoleic acid. One of the 2-alkylcyclobutanones, 2-(5'-tetradecenyl)cyclobutanone, was found in the highest concentration in the irradiated perilla seeds. Radiation-induced hydrocarbons in the perilla seeds were detected at doses of 0.5 kGy and higher, and radiation-induced 2-alkylcyclobutanones were detected at doses of 1 kGy and higher. These compounds were not detected in nonirradiated perilla seeds.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>H J Lee</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M W Byun</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K S Kim</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food and Nutrition, Chosun University, Kwangju, Korea.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Butanones</document:subject>
<document:subject>Fatty Acids</document:subject>
<document:subject>Hydrocarbons</document:subject>
<document:subject>Butanones</document:subject>
<document:subject>Chromatography</document:subject>
<document:subject>Fatty Acids</document:subject>
<document:subject>Food Irradiation</document:subject>
<document:subject>Hydrocarbons</document:subject>
<document:subject>Lamiaceae</document:subject>
<document:subject>Mass Fragmentography</document:subject>
<document:subject>Radiation Dosage</document:subject>
<document:subject>Seeds</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Butanones; analysis</document:subject>
<document:subject>Butanones; chemistry</document:subject>
<document:subject>Chromatography; methods</document:subject>
<document:subject>Fatty Acids; metabolism</document:subject>
<document:subject>Fatty Acids; radiation effects</document:subject>
<document:subject>Hydrocarbons; analysis</document:subject>
<document:subject>Lamiaceae; chemistry</document:subject>
<document:subject>Lamiaceae; radiation effects</document:subject>
<document:subject>Mass Fragmentography; methods</document:subject>
<document:subject>Seeds; chemistry</document:subject>
<document:subject>Seeds; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079702">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>A differential medium for the enumeration of the spoilage yeast Zygosaccharomyces bailii in wine.</document:title>
<document:abstractSection>A collection of yeasts, isolated mostly from spoiled wines, was used in order to develop a differential medium for Zygosaccharomyces bailii. The 118 selected strains of 21 species differed in their origin and resistance to preservatives and belonged to the genera Pichia, Torulaspora, Dekkera, Debaryomyces, Saccharomycodes, Issatchenkia, Kluyveromyces, Kloeckera, Lodderomyces, Schizosaccharomyces, Rhodotorula, Saccharomyces, and Zygosaccharomyces. The design of the culture medium was based on the different ability of the various yeast species to grow in a mineral medium with glucose and formic acid (mixed-substrate medium) as the only carbon and energy sources and supplemented with an acid-base indicator. By manipulating the concentration of the acid and the sugar it was possible to select conditions where only Z. bailii strains gave rise to alkalinization, associated with a color change of the medium (positive response). The final composition of the mixed medium was adjusted as a compromise between the percentage of recovery and selectivity for Z. bailii. This was accomplished by the use of pure or mixed cultures of the yeast strains and applying the membrane filtration methodology. The microbiological analysis of two samples of contaminated Vinho Verde showed that the new medium can be considered as a differential medium to distinguish Z. bailii from other contaminating yeasts, having potential application in the microbiological control of wines and probably other beverages and foods.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D Schuller</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M C√¥rte-Real</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Le√£o</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Departamento de Biologia, Universidade do Minho, Braga, Portugal.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Culture Media</document:subject>
<document:subject>Formic Acids</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:50-99-7">
<cas:registryNumber>50-99-7</cas:registryNumber>
<cas:name>Glucose</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Culture Media</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Formic Acids</document:subject>
<document:subject>Glucose</document:subject>
<document:subject>Mycological Typing Techniques</document:subject>
<document:subject>Species Specificity</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Wine</document:subject>
<document:subject>Yeasts</document:subject>
<document:subject>Zygosaccharomyces</document:subject>
<document:subject>Culture Media; chemistry</document:subject>
<document:subject>Formic Acids; metabolism</document:subject>
<document:subject>Glucose; metabolism</document:subject>
<document:subject>Wine; microbiology</document:subject>
<document:subject>Yeasts; classification</document:subject>
<document:subject>Yeasts; growth &amp; development</document:subject>
<document:subject>Yeasts; isolation &amp; purification</document:subject>
<document:subject>Zygosaccharomyces; classification</document:subject>
<document:subject>Zygosaccharomyces; growth &amp; development</document:subject>
<document:subject>Zygosaccharomyces; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079703">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Norwalk-like virus sequences detected by reverse transcription-polymerase chain reaction in mineral waters imported into or bottled in Switzerland.</document:title>
<document:abstractSection>Norwalk-like viruses (NLVs) is a genus belonging to the Caliciviridae. NLVs are transmitted by the fecal-oral and the aerosol route and are the most common cause of outbreaks of nonbacterial gastroenteritis. NLVs are responsible for an estimated 67% of all illnesses caused by known foodborne pathogens and for 96% of nonbacterial gastroenteritis in the United States. Many outbreaks could be associated with the consumption of primarily or secondarily contaminated foods. To our knowledge, no epidemic arising from contaminated mineral water has been reported. We investigated the presence of NLV sequences in 63 mineral waters of 29 different brands that were imported into or bottled in Switzerland. NLV sequences were detected in 21 mineral waters by reverse transcription-seminested polymerase chain reaction. Specimens of two NLV genogroups (gg), gg I and gg II, were randomly present in the contaminated samples. The presence of NLV sequences could not be correlated either with bottle characteristics or with chemical properties like mineralization, pH, or the presence of carbonic acid. Nucleotide sequence analysis of 12 NLV-positive samples revealed several point mutations. All isolated NLV gg I strains have a similarity of 70 to 87% with the common Desert Shield virus (UO4469), and all isolated NLV gg II strains have a similarity of 89 to 93% with the Camberwell virus (U46500). Possible reasons for the presence of NLV sequences in mineral waters are discussed.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C Beuret</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Kohler</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T L√ºthi</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Cantonal Food Laboratory of Solothurn, Switzerland. beuret@hotmail.com</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>DNA, Viral</document:subject>
<document:subject>DNA, Viral</document:subject>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Mineral Waters</document:subject>
<document:subject>Molecular Sequence Data</document:subject>
<document:subject>Norwalk Virus</document:subject>
<document:subject>Point Mutation</document:subject>
<document:subject>Polymerase Chain Reaction</document:subject>
<document:subject>Reverse Transcriptase Polymerase Chain Reaction</document:subject>
<document:subject>Sequence Analysis, DNA</document:subject>
<document:subject>Switzerland</document:subject>
<document:subject>Water Microbiology</document:subject>
<document:subject>DNA, Viral; analysis</document:subject>
<document:subject>DNA, Viral; chemistry</document:subject>
<document:subject>Mineral Waters; virology</document:subject>
<document:subject>Norwalk Virus; classification</document:subject>
<document:subject>Norwalk Virus; genetics</document:subject>
<document:subject>Norwalk Virus; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079704">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Prevalence and characteristics of shiga toxin-producing Escherichia coli in beef cattle slaughtered on Prince Edward Island.</document:title>
<document:abstractSection>Fecal swabs obtained from a random sample of 1,000 beef slaughter steers and heifers from 123 Prince Edward Island (P.E.I.) farms were examined for the presence of Shiga toxin-producing Escherichia coli (STEC) using a Vero cell assay (VCA). Multiple isolates from each positive sample were tested similarly. VCA-positive isolates were confirmed as E. coli biochemically, tested for drug resistance, serotyped, and tested by polymerase chain reaction (PCR). Animals were classified as positive when an isolate was positive on VCA and the presence of the gene responsible for toxin production was confirmed by PCR. The prevalence of STEC in beef slaughter steers and heifers on P.E.I. was 4% (40 of 1,000). The total number of isolates was 43, and these comprised 26 serotypes, including 13 isolates belonging to 6 serotypes known to be associated with human illness. The most frequently isolated STEC serotype was E. coli O157 (5 isolates out of 43). Of the five E. coli O157 isolates, four were E. coli O157:H7, a serious human pathogen. The majority of STEC isolates, including all O157:H7, isolates, were susceptible to 16 commonly used antimicrobial drugs. According to PCR, 65% of the STEC isolates had the gene for Stx1. Four of these isolates, including two O157:H7, had genes for Shiga toxin (Stx)1 and Stx2.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R D Schurman</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H Hariharan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S B Heaney</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K Rahn</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Canada.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:75757-64-1">
<cas:registryNumber>75757-64-1</cas:registryNumber>
<cas:name>Shiga Toxin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Cattle Diseases</document:subject>
<document:subject>Cercopithecus aethiops</document:subject>
<document:subject>Drug Resistance</document:subject>
<document:subject>Escherichia coli Infections</document:subject>
<document:subject>Escherichia coli O157</document:subject>
<document:subject>Feces</document:subject>
<document:subject>Female</document:subject>
<document:subject>Male</document:subject>
<document:subject>Polymerase Chain Reaction</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Prince Edward Island</document:subject>
<document:subject>Serotyping</document:subject>
<document:subject>Shiga Toxin</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Vero Cells</document:subject>
<document:subject>Cattle Diseases; epidemiology</document:subject>
<document:subject>Escherichia coli Infections; epidemiology</document:subject>
<document:subject>Escherichia coli Infections; veterinary</document:subject>
<document:subject>Escherichia coli O157; classification</document:subject>
<document:subject>Escherichia coli O157; isolation &amp; purification</document:subject>
<document:subject>Feces; microbiology</document:subject>
<document:subject>Prince Edward Island; epidemiology</document:subject>
<document:subject>Shiga Toxin; biosynthesis</document:subject>
<document:subject>Shiga Toxin; classification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079705">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Analysis and modeling of the variability associated with UV inactivation of Escherichia coli in apple cider.</document:title>
<document:abstractSection>Raw data from validation studies of UV tubes used for nonthermal pathogen reduction in apple cider underwent comprehensive statistical analysis. Data from each tube that demonstrated at least a 5-log reduction of Escherichia coli ATCC 25922, a surrogate for E. coli O157:H7, in each of three trials were used in the analysis. The within- and between-tube variability was calculated for 70 tubes. The mean log reductions of the tubes fit a Beta distribution (Kolmogorov-Smirnov test, 0.0246), and the between-replicate variability followed a logistic distribution (Kolmogorov-Smirnov test, 0.0305). These two distributions can be used together to model UV cider treatment as part of an overall E. coli O157:H7 in cider risk assessment. Examples of codes from @RISK and Analyticato describe these distributions, such as one would find in a quantitative risk assessment, are included.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S Duffy</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Churey</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R W Worobo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D W Schaffner</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Food Risk Analysis Initiative, Rutgers University, New Brunswick, New Jersey 08901, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Beverages</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Escherichia coli</document:subject>
<document:subject>Food Irradiation</document:subject>
<document:subject>Models, Biological</document:subject>
<document:subject>Reproducibility of Results</document:subject>
<document:subject>Risk Assessment</document:subject>
<document:subject>Rosales</document:subject>
<document:subject>Statistics</document:subject>
<document:subject>Ultraviolet Rays</document:subject>
<document:subject>Beverages; microbiology</document:subject>
<document:subject>Escherichia coli; growth &amp; development</document:subject>
<document:subject>Escherichia coli; radiation effects</document:subject>
<document:subject>Food Irradiation; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079706">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Yersinia enterocolitica biogroup 1A, serotype O:5 in chicken carcasses.</document:title>
<document:abstractSection>To evaluate the presence of Yersinia enterocolitica in raw chicken, 70 samples of chicken carcasses were obtained from a Buenos Aires, Argentina, processing plant. The detection of this psychotropic microorganism was carried out using the whole carcass rinse method and enrichment in phosphate-buffered saline, 0.067 M, pH 7.6, at 4 degrees C, followed by alkaline treatment and isolation on cefsulodin-irgasan-novobiocin nutrient agar. Y. enterocolitica or related species were detected in 7 of 70 samples. From them, 4.3% were identified as Y. enterocolitica, 1.4% as Yersinia intermedia, and 4.3% as Yersinia frederiksenii. The serotype and phagotype of Y. intermedia isolates were O:5(2), 5(3), and Xz and those of Y. frederiksenii were O:4.16 and Xo. All Y. enterocolitica isolates belong to the biogroup 1A, serotype O:5, phagotype Xz, which presents uncertain pathogenic potential. These findings reinforce the worldwide concern on the microbiological quality of food products. Quality assurance programs on the whole poultry process are increasingly being adopted in Argentina.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M E Floccari</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M M Carranza</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J L Parada</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Departamento de Qu√≠mica Biol√≥gica, Facultad de Ciencas Exactas y Naturales, Universidad de Buenos Aires, Argentina.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Argentina</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Serotyping</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Virulence</document:subject>
<document:subject>Yersinia enterocolitica</document:subject>
<document:subject>Chickens; microbiology</document:subject>
<document:subject>Yersinia enterocolitica; classification</document:subject>
<document:subject>Yersinia enterocolitica; isolation &amp; purification</document:subject>
<document:subject>Yersinia enterocolitica; pathogenicity</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079707">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Reduction of Campylobacter jejuni in a simulated chicken digestive tract by Lactobacilli cultures.</document:title>
<document:abstractSection>Studies were conducted to investigate the impact of a selected lactobacilli mixed culture on Campylobacter jejuni in simulated chicken digestive tract models. Veronal buffer solutions corresponding to the pH of successive segments of the chicken digestive tract were prepared. The lactobacilli mixtures were prepared by mixing four fresh lactobacilli cultures, including Lactobacillus acidophilus, Lactobacillus fermenentum, Lactobacillus crispatus, and Lactobacillus brevis. The C. jejuni and lactobacilli mixture were mixed with sterile poultry feed, and the previously prepared veronal buffer solutions were then added separately. The mixture was incubated at 41.1 degrees C for various lengths of time with periodic agitation. The feed passage time for five segments of the digestive tract were adopted: crop (pH 4.5), 30 min; proventriculus (pH 4.4), 15 min; gizzard (pH 2.6), 90 min; small intestine (pH 6.2), 90 min; and large intestine (pH 6.3), 15 min. The Campylobacter and lactobacilli were enumerated. An antagonistic effect on C. jejuni by the tested lactobacilli spp. was found in individual sections and the complete simulated digestive tract models. In the simulated complete chicken digestion system, no C. jejuni were found during the final incubation period when a lactobacilli mixture was present. The results of this in vitro study indicate the potential value of future in vivo studies.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M H Chang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T C Chen</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Poultry Science Department, Mississippi State University, Mississippi 39762, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Antibiosis</document:subject>
<document:subject>Campylobacter jejuni</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Digestive System</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>In Vitro</document:subject>
<document:subject>Lactobacillus</document:subject>
<document:subject>Models, Biological</document:subject>
<document:subject>Random Allocation</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Campylobacter jejuni; growth &amp; development</document:subject>
<document:subject>Chickens; microbiology</document:subject>
<document:subject>Digestive System; microbiology</document:subject>
<document:subject>Lactobacillus; physiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079708">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Thermal stability of moniliformin at varying temperature, pH, and time in an aqueous environment.</document:title>
<document:abstractSection>Moniliformin (MON) is a widely occurring mycotoxin, produced mainly by Fusarium proliferatum and Fusarium subglutinans in corn, that has been shown to be acutely toxic for various animal species and is a suspected cause of Keshan disease in China. The effects of temperature (100, 125, and 150 degrees C) and pH (4, 7, and 9) on the stability of MON were determined in aqueous buffer solutions at processing times ranging from 10 to 60 min. The percentage of MON reduction was positively related to increasing temperature and pH. MON was most stable at pH 4. After 60 min at pH 4 and 150 degrees C, MON was reduced by only 5%. Heating at pH 10 caused major reduction of MON. After 60 min at pH 10 and 100, 125, and 150 degrees C, MON was reduced by 56, 72, and 83%, respectively. One trial done at 175 degrees C and pH 10 showed that less than 1% MON remained after 60 min of processing.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>G Pineda-Valdes</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L B Bullerman</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science and Technology, University of Nebraska, Lincoln 68583-0919, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Cyclobutanes</document:subject>
<document:subject>Mycotoxins</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:31876-38-7">
<cas:registryNumber>31876-38-7</cas:registryNumber>
<cas:name>moniliformin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Corn</document:subject>
<document:subject>Cyclobutanes</document:subject>
<document:subject>Drug Stability</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Fusarium</document:subject>
<document:subject>Heat</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Mycotoxins</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Water</document:subject>
<document:subject>Corn; microbiology</document:subject>
<document:subject>Cyclobutanes; chemistry</document:subject>
<document:subject>Fusarium; metabolism</document:subject>
<document:subject>Mycotoxins; chemistry</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:11">
<med:volume>63</med:volume>
<med:issue>11</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11079709">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>15</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Detection and analysis of animal materials in food and feed.</document:title>
<document:abstractSection>Bovine spongiform encephalopathy (BSE) belongs to a group of progressively degenerative neurological diseases known as transmissible spongiform encephalopathies (TSEs) associated with a variant form of Creutzfeldt-Jakob disease in humans. TSEs are fatal diseases caused by prions (proteinaceous infectious particle) and are characterized by an incubation period that may range from several months to several years, depending on the host. Because BSE is spread through animal feed, the main strategy for preventing the establishment and spread of BSE is to prohibit the use of proteins derived from mammalian tissue in feed for ruminant animals. Enforcement of these regulations relies on the ability to identify the presence of prohibited proteins in ruminant feed. The methods to detect bovine products in rendered and cooked materials are based on analyses of DNA, bone, or protein. In this article, we discuss the current methodology as well as other potentially useful methods of analysis of animal material in food. While methods are generally useful, none specifically distinguish between prohibited bovine material and allowable bovine products, such as milk or blood. Furthermore, all these methods are hampered by the fact that the rendering process involves heat treatment that denatures and degrades proteins and DNA. There is a need for improving existing methods and developing new methods to overcome these two limitations.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D Momcilovic</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A Rasooly</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Center of Veterinary Medicine, U.S. Food and Drug Administration, Rockville, Maryland, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Prions</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9007-49-2">
<cas:registryNumber>9007-49-2</cas:registryNumber>
<cas:name>DNA</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animal Feed</document:subject>
<document:subject>Biosensing Techniques</document:subject>
<document:subject>Blotting, Western</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>DNA</document:subject>
<document:subject>Electrophoresis, Polyacrylamide Gel</document:subject>
<document:subject>Encephalopathy, Bovine Spongiform</document:subject>
<document:subject>Enzyme-Linked Immunosorbent Assay</document:subject>
<document:subject>Great Britain</document:subject>
<document:subject>Meat Products</document:subject>
<document:subject>Polymerase Chain Reaction</document:subject>
<document:subject>Prions</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Animal Feed; analysis</document:subject>
<document:subject>DNA; analysis</document:subject>
<document:subject>Encephalopathy, Bovine Spongiform; prevention &amp; control</document:subject>
<document:subject>Encephalopathy, Bovine Spongiform; transmission</document:subject>
<document:subject>Meat Products; analysis</document:subject>
<document:subject>Prions; chemistry</document:subject>
<document:subject>Prions; pathogenicity</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041128">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>A summary of reported foodborne disease incidents in Sweden, 1992 to 1997.</document:title>
<document:abstractSection>Reports of foodborne disease incidents in Sweden from 1992 to 1997 are summarized. The results are based on reports from the municipal environmental and public health authorities to the National Food Administration and from medical authorities to the Swedish Institute for Infectious Diseases Control. A total of 555 incidents, of which 84% were outbreaks, were reported, involving 11,076 ill people. In 66% of the incidents, no disease agent was determined. Bacterial agents were implicated in 25% and viruses in 8% of the incidents. Calicivirus was the most reported agent both in terms of incidents and cases. Mixed dishes was the food category most often implicated in outbreaks, and smorgasbord and casserole or stews were the subcategories that caused the most cases. The place of consumption was unknown in 8% of the incidents. In about 60% of the incidents, the implicated food was consumed in commercial food establishments; in approximately 20% of incidents, it was consumed at home. The average annual incidence of reported foodborne disease in Sweden was estimated to be 21 cases per 100,000. The average annual incidence of reported foodborne salmonellosis and campylobacteriosis was estimated to be 2.0 and 0.6 cases per 100,000, respectively. The awareness and motivation to report foodborne diseases need to be improved, but additional sources of information are needed to counteract some of the limitations of reporting discussed in this work.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R Lindqvist</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Y Andersson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B de Jong</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Norberg</feature:name>
</feature:Person>
</document:author>
<dc:contributor>National Food Administration, Uppsala, Sweden. roli@slv.se</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Caliciviridae Infections</document:subject>
<document:subject>Calicivirus</document:subject>
<document:subject>Campylobacter Infections</document:subject>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Food Contamination</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Poisoning</document:subject>
<document:subject>Human</document:subject>
<document:subject>Incidence</document:subject>
<document:subject>Salmonella Food Poisoning</document:subject>
<document:subject>Sweden</document:subject>
<document:subject>Caliciviridae Infections; epidemiology</document:subject>
<document:subject>Calicivirus; isolation &amp; purification</document:subject>
<document:subject>Campylobacter Infections; epidemiology</document:subject>
<document:subject>Disease Outbreaks; prevention &amp; control</document:subject>
<document:subject>Disease Outbreaks; statistics &amp; numerical data</document:subject>
<document:subject>Food Contamination; statistics &amp; numerical data</document:subject>
<document:subject>Food Poisoning; epidemiology</document:subject>
<document:subject>Food Poisoning; microbiology</document:subject>
<document:subject>Salmonella Food Poisoning; epidemiology</document:subject>
<document:subject>Sweden; epidemiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041129">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Evaluation of safe food-handling instructions on raw meat and poultry products.</document:title>
<document:abstractSection>Every year in the United States, millions of people become ill, thousands of people die, and substantial economic costs are incurred from foodborne diseases. As a measure to prevent foodborne diseases, since July 1994, the U.S. Department of Agriculture has required that safe food-handling labels be placed on retail packages of raw or partially cooked meat and poultry products. Through selected states' Behavioral Risk Factor Surveillance System (BRFSS) interviews, survey data were collected to determine the proportion of adults aware of the label and adults who reported changing their raw meat-handling practices because of the label. Fifty-one percent of the 14,262 respondents reported that they had seen the label. Of these, 79% remembered reading the label, and 37% of persons who reported that they had seen and read the label reported changing their raw meat preparation methods because of the label. Women were more likely than men to have read the label, as were persons who are at least 30 years of age compared to younger adults (P &lt; 0.05). Both label awareness and risky food-handling behaviors increased with education and income, suggesting that safe food-handling labels have limited influence on consumer practices. Our results also suggest that the labels might be more effective in discouraging cross-contamination than in promoting thorough cooking practices. We suggest that the label is only one component among many food safety education programs that are needed to inform consumers about proper food-handling and preparation practices and to motivate persons who have risky food-handling and preparation behaviors to change these behaviors.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S Yang</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F J Angulo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S F Altekruse</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Foodborne and Diarrheal Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Adolescence</document:subject>
<document:subject>Adult</document:subject>
<document:subject>Age Factors</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Consumer Product Safety</document:subject>
<document:subject>Cookery</document:subject>
<document:subject>Educational Status</document:subject>
<document:subject>Female</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Labeling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Poisoning</document:subject>
<document:subject>Human</document:subject>
<document:subject>Knowledge, Attitudes, Practice</document:subject>
<document:subject>Male</document:subject>
<document:subject>Meat</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Motivation</document:subject>
<document:subject>Poultry Products</document:subject>
<document:subject>United States</document:subject>
<document:subject>Chickens; microbiology</document:subject>
<document:subject>Food Handling; methods</document:subject>
<document:subject>Food Handling; statistics &amp; numerical data</document:subject>
<document:subject>Food Poisoning; prevention &amp; control</document:subject>
<document:subject>Meat; microbiology</document:subject>
<document:subject>Poultry Products; microbiology</document:subject>
<document:subject>United States; epidemiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041130">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Interventions for the reduction of Salmonella Typhimurium DT 104 and non-O157:H7 enterohemorrhagic Escherichia coli on beef surfaces.</document:title>
<document:abstractSection>A study was conducted to determine if slaughter interventions currently used by the meat industry are effective against Salmonella Typhimurium definitive type 104 (DT 104) and two non-O157:H7 enterohemorrhagic Escherichia coli (EHEC). Three separate experiments were conducted by inoculating prerigor beef surfaces with a bovine fecal slurry containing Salmonella Typhimurium and Salmonella Typhimurium DT 104 (experiment 1), E. coli O157:H7 and E. coli O111:H8 (experiment 2), or E. coli O157:H7 and E. coli O26:H11 (experiment 3) and spray washing with water, hot water (72 degrees C), 2% acetic acid, 2% lactic acid, or 10% trisodium phosphate (15 s, 125 +/- 5 psi, 35 +/- 2 degrees C). Remaining bacterial populations were determined immediately after treatments (day 0), after 2 days of aerobic storage at 4 degrees C, and after 7, 21, and 35 days of vacuum-packaged storage at 4 degrees C. In addition to enumeration, confirmation of pathogen serotypes was performed for all treatments on all days. Of the interventions investigated, spray treatments with trisodium phosphate were the most effective, resulting in pathogen reductions of &gt;3 log10 CFU/cm2, followed by 2% lactic acid and 2% acetic acid (&gt;2 log10 CFU/cm2). Results also indicated that interventions used to reduce Salmonella Typhimurium on beef surfaces were equally effective against Salmonella Typhimurium DT 104 immediately after treatment and again after long-term, refrigerated, vacuum-packaged storage. Similarly, E. coli O111:H8 and E. coli O26:H11 associated with beef surfaces were reduced by the interventions to approximately the same extent as E. coli O157:H7 immediately after treatment and again after long-term, refrigerated, vacuum-packaged storage. It was also demonstrated that phenotypic characterization may not be sufficient to identify EHECs and that the organisms should be further confirmed with antibody- or genetic-based techniques. Based on these findings, interventions used by the meat industry to reduce Salmonella spp. and E. coli O157:H7 appear to be effective against DT 104 and other EHEC.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C N Cutter</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Rivera-Betancourt</feature:name>
</feature:Person>
</document:author>
<dc:contributor>U.S. Department of Agriculture, Agricultural Research Service, Roman L. Hruska U.S. Meat Animal Research Center, Clay Center, Nebraska 68933, USA. cnc3@psu.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Phosphates</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:50-21-5">
<cas:registryNumber>50-21-5</cas:registryNumber>
<cas:name>Lactic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:64-19-7">
<cas:registryNumber>64-19-7</cas:registryNumber>
<cas:name>Acetic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7632-05-5">
<cas:registryNumber>7632-05-5</cas:registryNumber>
<cas:name>sodium phosphate</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Acetic Acid</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Escherichia coli</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Lactic Acid</document:subject>
<document:subject>Meat</document:subject>
<document:subject>Phosphates</document:subject>
<document:subject>Salmonella typhimurium</document:subject>
<document:subject>Serotyping</document:subject>
<document:subject>Acetic Acid; pharmacology</document:subject>
<document:subject>Escherichia coli; classification</document:subject>
<document:subject>Escherichia coli; drug effects</document:subject>
<document:subject>Escherichia coli; growth &amp; development</document:subject>
<document:subject>Food Handling; methods</document:subject>
<document:subject>Lactic Acid; pharmacology</document:subject>
<document:subject>Meat; microbiology</document:subject>
<document:subject>Phosphates; pharmacology</document:subject>
<document:subject>Salmonella typhimurium; classification</document:subject>
<document:subject>Salmonella typhimurium; drug effects</document:subject>
<document:subject>Salmonella typhimurium; growth &amp; development</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041131">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Protective effect of Enterococcus faecium J96, a potential probiotic strain, on chicks infected with Salmonella Pullorum.</document:title>
<document:abstractSection>Enterococcus faecium J96 was isolated from a healthy free-range chicken and it inhibited Salmonella Pullorum, in vitro, due to its lactic acid and bacteriocin production. In vivo assays were carried out with 30-h-old broiler chicks. The lactic acid bacteria (approximately 1 x 10(9) cells per chick) were orally administered as preventive and as therapeutic treatments. In the first case they were given to the chicks twice a day for 3 consecutive days. In the second case the lactic bacteria were administered in the same way after a 24-h challenge by Salmonella Pullorum (in both instances the salmonella dose was 1 x 10(5) cells per chick). Cecal contents, liver, and spleens were analyzed and liver and spleen fragments were also fixed in formaldehyde (pH 7.00) in order to determine salmonella translocation. The chickens that were preventively treated with E. faecium J96 survived the Salmonella Pullorum challenge. Those that were infected on the first day and then inoculated with lactic bacteria died 4 days later. Salmonellae were isolated from their livers and spleens. From these results we may conclude that E. faecium J96 can protect newly hatched chicks from Salmonella Pullorum infection but cannot act as a good therapeutic agent.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M Carina Audisio</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G Oliver</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M C Apella</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Centro de Referencia para Lactobacilos (CERELA), San Miguel de Tucum√°n, Argentina.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Bacteriocins</document:subject>
<document:subject>Probiotics</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:50-21-5">
<cas:registryNumber>50-21-5</cas:registryNumber>
<cas:name>Lactic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Bacterial Translocation</document:subject>
<document:subject>Bacteriocins</document:subject>
<document:subject>Cecum</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Enterococcus faecium</document:subject>
<document:subject>Lactic Acid</document:subject>
<document:subject>Liver</document:subject>
<document:subject>Poultry Diseases</document:subject>
<document:subject>Probiotics</document:subject>
<document:subject>Salmonella</document:subject>
<document:subject>Salmonella Infections, Animal</document:subject>
<document:subject>Spleen</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Bacteriocins; biosynthesis</document:subject>
<document:subject>Cecum; microbiology</document:subject>
<document:subject>Chickens; microbiology</document:subject>
<document:subject>Enterococcus faecium; physiology</document:subject>
<document:subject>Lactic Acid; metabolism</document:subject>
<document:subject>Liver; microbiology</document:subject>
<document:subject>Liver; pathology</document:subject>
<document:subject>Poultry Diseases; microbiology</document:subject>
<document:subject>Poultry Diseases; prevention &amp; control</document:subject>
<document:subject>Probiotics; administration &amp; dosage</document:subject>
<document:subject>Probiotics; pharmacology</document:subject>
<document:subject>Salmonella; drug effects</document:subject>
<document:subject>Salmonella; growth &amp; development</document:subject>
<document:subject>Salmonella Infections, Animal; prevention &amp; control</document:subject>
<document:subject>Salmonella Infections, Animal; therapy</document:subject>
<document:subject>Spleen; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041132">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Surface application of lysozyme, nisin, and EDTA to inhibit spoilage and pathogenic bacteria on ham and bologna.</document:title>
<document:abstractSection>A study was conducted to determine if the effectiveness of an antimicrobial treatment for cooked ham and bologna would be increased or maintained when applied in a surface coating. Cooked 10-g disks of ham and bologna sausage received one of three treatments: no coating (control), coating with 0.2 g of 7% (wt/vol) gelatin gel (gel-control), or coating with 0.2 g of 7% gelatin gel containing 25.5 g/liter of lysozyme-nisin (1:3) plus 25.5 g/liter of EDTA (gel-treated). The samples were then inoculated with one of six test organisms: Brochothrix thermosphacta, Escherichia coli O157:H7, Lactobacillus sakei, Leuconostoc mesenteroides, Listeria monocytogenes, or Salmonella Typhimurium. Inoculated samples were vacuum packed and stored at 8 degrees C for 4 weeks. The antimicrobial gel treatment had an immediate bactericidal effect up to 4 log CFU/cm2 on the four gram-positive organisms tested (B. thermosphacta, Lactobacillus sakei, Leuconostoc mesenteroides, and Listeria monocytogenes) and inhibited the growth of these organisms during the 4 weeks of storage. The antimicrobial gel treatment also had a bactericidal effect on the growth of Salmonella Typhimurium during storage. The numbers of E. coli O157:H7 on ham were reduced by 2 log CFU/cm2 following treatment with both antimicrobial-containing and non-antimicrobial-containing gels during the 4-week storage period. No effect was observed on the growth of E. coli O157:H7 on bologna.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A O Gill</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R A Holley</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science, University of Manitoba, Winnipeg, Canada.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anti-Infective Agents</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:1414-45-5">
<cas:registryNumber>1414-45-5</cas:registryNumber>
<cas:name>Nisin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:60-00-4">
<cas:registryNumber>60-00-4</cas:registryNumber>
<cas:name>Edetic Acid</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:EC%203.2.1.17">
<cas:registryNumber>EC 3.2.1.17</cas:registryNumber>
<cas:name>Muramidase</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Anti-Infective Agents</document:subject>
<document:subject>Bacteria</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Edetic Acid</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Meat Products</document:subject>
<document:subject>Muramidase</document:subject>
<document:subject>Nisin</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Turkeys</document:subject>
<document:subject>Vacuum</document:subject>
<document:subject>Anti-Infective Agents; pharmacology</document:subject>
<document:subject>Bacteria; drug effects</document:subject>
<document:subject>Bacteria; growth &amp; development</document:subject>
<document:subject>Edetic Acid; pharmacology</document:subject>
<document:subject>Food Preservation; methods</document:subject>
<document:subject>Meat Products; microbiology</document:subject>
<document:subject>Muramidase; pharmacology</document:subject>
<document:subject>Nisin; pharmacology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041133">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Differentiation between types and strains of Clostridium botulinum by riboprinting.</document:title>
<document:abstractSection>The ability of automated ribotyping to differentiate between major types and individual strains of Clostridium botulinum was tested using the Qualicon Riboprinter Microbial Characterization System. Pure spores of C. botulinum type A, proteolytic type B, nonproteolytic type B, and type E strains were inoculated onto modified anaerobic egg yolk agar and incubated 24 h at 35 degrees C. Plates were rinsed with buffer (2 mM Tris + 20 mM EDTA) to remove vegetative cells that were heated for 10 min at 80 degrees C, treated with a lysing agent, and ribotyped in the Qualicon Riboprinter utilizing the enzyme EcoRI. Riboprint patterns were obtained for 30 strains of the four major types of C. botulinum most commonly involved in human foodborne botulism. Proteolytic strains yielded the best and most consistent results. Fifteen ribogroups were identified among the 31 strains tested. Interestingly, in two cases, a single ribogroup contained patterns from isolates belonging to evolutionarily distinct Clostridium lineages. This degree of differentiation between strains of C. botulinum may be useful in hazard analysis and identification, hazard analysis and critical control point monitoring and validation, environmental monitoring, and in inoculation studies.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>G E Skinner</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S M Gendel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G A Fingerhut</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H A Solomon</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Ulaszek</feature:name>
</feature:Person>
</document:author>
<dc:contributor>U.S. Food and Drug Administration, National Center for Food Safety and Technology, Summit-Argo, Illinois 60501, USA. gskinner@cfsan.fda.gov</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Botulism</document:subject>
<document:subject>Clostridium botulinum</document:subject>
<document:subject>DNA, Bacterial</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Human</document:subject>
<document:subject>Nucleic Acid Hybridization</document:subject>
<document:subject>Polymorphism, Restriction Fragment Length</document:subject>
<document:subject>Ribotyping</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Support, U.S. Gov't, Non-P.H.S.</document:subject>
<document:subject>Botulism; microbiology</document:subject>
<document:subject>Botulism; prevention &amp; control</document:subject>
<document:subject>Clostridium botulinum; classification</document:subject>
<document:subject>Clostridium botulinum; genetics</document:subject>
<document:subject>DNA, Bacterial; analysis</document:subject>
<document:subject>Nucleic Acid Hybridization; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041134">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Influence of traditional brine washing of smear Taleggio cheese on the surface spreading of Listeria innocua.</document:title>
<document:abstractSection>The influence of a traditional procedure of washing of smear Taleggio cheese on surface spreading of Listeria innocua was studied. This practice is carried out during ripening to remove molds, to select the surface microflora, and to control the ripening process. One cheese, both of 2 (i) and 4 (ii) weeks of ripening, was surface-inoculated with approximately 3 log CFU of L. innocua per entire cheese surface. The inoculated cheeses and others of the same age were weekly washed with brine solution. Listeria was spread both on the surface of the inoculated cheese and on the other cheeses, and it was also found in the brines and on the wooden boxes where the cheeses were ripened. The time of ripening when contamination occurs influenced the behavior of Listeria. At the moment of contamination, the smear surface microflora of (i) cheese was approximately 2 log CFU/g higher than of (ii) cheese. Listeria inoculated on 2-week-ripened cheese was able to colonize the entire surface of the cheese and to cross-contaminate the other cheeses. On the contrary, Listeria inoculated on a 4-week-ripened cheese was partially spread on the surface of the originally inoculated cheese, and the transfer of contamination by the washing procedure was restrained. Because a random distribution of Listeria on cheese surface was observed, the importance of the mode of sampling was discussed. Because of the lack of critical control points during ripening of Taleggio cheese, the Listeria hazard needs to be controlled by taking appropriate control measures to break off the contamination cycle (cheese --&gt; brine --&gt; wooden boxes --&gt; cheese).</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D Carminati</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A Perrone</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E Neviani</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G Mucchetti</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Istituto Sperimentale Lattiero Caseario, Lodi, Italy. carminati.ilc@pop.telware.it</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Salts</document:subject>
<document:subject>brine</document:subject>
<document:subject>Cheese</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Food Contamination</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Packaging</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Listeria</document:subject>
<document:subject>Salts</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Cheese; microbiology</document:subject>
<document:subject>Listeria; drug effects</document:subject>
<document:subject>Listeria; growth &amp; development</document:subject>
<document:subject>Listeria; isolation &amp; purification</document:subject>
<document:subject>Salts; pharmacology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041135">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Antimicrobial effect of rosemary extracts.</document:title>
<document:abstractSection>A rosemary extract commercially exploited (Oxy'less) as an antioxidant of lipids in foods was dissolved in ethanol (100 mg/ml), and the solution was tested against foodborne microorganisms. For gram-positive bacteria, the MIC of the ethanolic solution was 1% for Leuconostoc mesenteroides, 0.5% for Listeria monocytogenes, 0.5% for Staphylococcus aureus, 0.13% for Streptococcus mutans, and 0.06% for Bacillus cereus. It slowed the growth of Penicillium roquefortii and Botrytis cinerea. Up to 1% of the ethanolic solution had no activity on the gram-negative bacteria Escherichia coli, Salmonella Enteritidis, and Erwinia carotovora and on the yeasts Rhodotorula glutinis and Cryptococcus laurentii. Antibacterial activity of the rosemary extract was strongly influenced by the composition of the media. The MIC was reduced by low pH, high NaCl contents, and low temperatures. Low pH and high NaCl concentration had a synergistic effect on the MIC of the rosemary extract for S. aureus. Lipids, surface-active agents, and some proteins decreased its antibacterial activity, whereas pectin had no effect. The inhibitory effect was little modified by heat treatment (100 degrees C). The natural microflora of pasteurized zucchini broth was inhibited by 0.5% of the rosemary extract. The antibacterial activity was linked to the compounds extracted with hexane, which are presumably phenolic diterpenoids.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J Del Campo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M J Amiot</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Nguyen-The</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institut National de la Recherche Agronomique, Station de Technologie des Produits V√©g√©taux, Domaine Saint-Paul, Avignon, France.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anti-Infective Agents</document:subject>
<document:subject>Plant Extracts</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7647-14-5">
<cas:registryNumber>7647-14-5</cas:registryNumber>
<cas:name>Sodium Chloride</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Anti-Infective Agents</document:subject>
<document:subject>Chromatography, High Pressure Liquid</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Drug Synergism</document:subject>
<document:subject>Food Contamination</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Gram-Negative Bacteria</document:subject>
<document:subject>Gram-Positive Bacteria</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Lamiaceae</document:subject>
<document:subject>Microbial Sensitivity Tests</document:subject>
<document:subject>Plant Extracts</document:subject>
<document:subject>Sodium Chloride</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Temperature</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Water</document:subject>
<document:subject>Yeasts</document:subject>
<document:subject>Anti-Infective Agents; pharmacology</document:subject>
<document:subject>Gram-Negative Bacteria; drug effects</document:subject>
<document:subject>Gram-Negative Bacteria; growth &amp; development</document:subject>
<document:subject>Gram-Positive Bacteria; drug effects</document:subject>
<document:subject>Gram-Positive Bacteria; growth &amp; development</document:subject>
<document:subject>Plant Extracts; antagonists &amp; inhibitors</document:subject>
<document:subject>Plant Extracts; pharmacology</document:subject>
<document:subject>Sodium Chloride; pharmacology</document:subject>
<document:subject>Yeasts; drug effects</document:subject>
<document:subject>Yeasts; growth &amp; development</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041136">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Effect of conjugated bile salts on antibiotic susceptibility of bile salt-tolerant Lactobacillus and Bifidobacterium isolates.</document:title>
<document:abstractSection>Virtually every antibiotic may cause in vivo alterations in the number, level, and composition of the indigenous microbiotae. The degree to which the microbiotae are disturbed depends on many factors. Although bile may augment antibiotic activity, studies on the effect of bile on the antibiotic susceptibility of indigenous and exogenous probiotic microorganisms are lacking. It was against this background that the antibiotic susceptibility of 37 bile salt-tolerant Lactobacillus and 11 Bifidobacterium isolates from human and other sources was determined in the presence of 0.5% wt/wt oxgall (conjugated bile salts). Oxgall did not affect the intrinsic resistance of lactobacilli to metronidazole (5 microg), vancomycin (30 microg), and cotrimoxazole (25 microg), whereas it resulted in a complete loss of resistance to polymyxin B (300 microg) and the aminoglycosides gentamicin (10 microg), kanamycin (30 microg), and streptomycin (10 microg) for most strains studied (P &lt; 0.001). Oxgall did not affect the intrinsic resistance of bifidobacteria to metronidazole and vancomycin, whereas polymyxin B and co-trimoxazole resistance was diminished (P &lt; 0.05) and aminoglycoside resistance was lost (P &lt; 0.001). Seven lactobacilli, but no bifidobacteria strain, showed unaltered intrinsic antibiotic resistance profiles in the presence of oxgall. Oxgall affected the extrinsic susceptibility of lactobacilli and bifidobacteria to penicillin G (10 microg), ampicillin (10 microg), tetracycline (30 microg), chloramphenicol (30 microg), erythromycin (15 microg), and rifampicin (5 microg) in a source- and strain-dependent manner. Human strain-drug combinations of lactobacilli (P &lt; 0.05) and bifidobacteria (P &lt; 0.01) were more likely to show no change or decreased susceptibility compared with other strain-drug combinations. The antimicrobial activity spectra of polymyxin B and the aminoglycosides should not be considered limited to gram-negative bacteria but extended to include gram-positive genera of the indigenous and transiting microbiotae in the presence of conjugated bile salts. Those lactobacilli (7 of 37) that show unaltered intrinsic and diminished extrinsic antibiotic susceptibility in the presence of oxgall may possess greater upper gastrointestinal tract transit tolerance in the presence of antibiotics.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>W P Charteris</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P M Kelly</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Morelli</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J K Collins</feature:name>
</feature:Person>
</document:author>
<dc:contributor>SET Consultants Ltd., Douglas, Cork, Ireland. bcharteris@glanbia.ie</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Antibiotics</document:subject>
<document:subject>Bile Acids and Salts</document:subject>
<document:subject>Probiotics</document:subject>
<document:subject>Antibiotics</document:subject>
<document:subject>Bifidobacterium</document:subject>
<document:subject>Bile Acids and Salts</document:subject>
<document:subject>Drug Resistance, Microbial</document:subject>
<document:subject>Female</document:subject>
<document:subject>Gastrointestinal System</document:subject>
<document:subject>Human</document:subject>
<document:subject>Lactobacillus</document:subject>
<document:subject>Male</document:subject>
<document:subject>Microbial Sensitivity Tests</document:subject>
<document:subject>Probiotics</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Urogenital System</document:subject>
<document:subject>Antibiotics; pharmacology</document:subject>
<document:subject>Bifidobacterium; drug effects</document:subject>
<document:subject>Bifidobacterium; growth &amp; development</document:subject>
<document:subject>Bifidobacterium; isolation &amp; purification</document:subject>
<document:subject>Bile Acids and Salts; pharmacology</document:subject>
<document:subject>Gastrointestinal System; microbiology</document:subject>
<document:subject>Lactobacillus; drug effects</document:subject>
<document:subject>Lactobacillus; growth &amp; development</document:subject>
<document:subject>Lactobacillus; isolation &amp; purification</document:subject>
<document:subject>Urogenital System; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041137">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Heat resistance of Alicyclobacillus acidocaldarius in water, various buffers, and orange juice.</document:title>
<document:abstractSection>The effect of the pH or the composition of the heating medium and of the sporulation temperature on the heat resistance of spores of a thermoacidophilic spore-forming microorganism isolated from a dairy beverage containing orange fruit concentrate was investigated. The species was identified as Alicyclobacillus acidocaldarius. The spores showed the same heat resistance in citrate-phosphate buffers of pH 4 and 7, in distilled water, and in orange juice at any of the temperatures tested (D120 degrees C = 0.1 min and z = 7 degrees C). A raise in 20 degrees C in the sporulation temperature (from 45 to 65 degrees C) increased the heat resistance eightfold (from D110 degrees C = 0.48 min when sporulated at 45 degrees C to 3.9 min when sporulated at 65 degrees C). The z-values remained constant for all sporulation temperatures. The spores of this strain of A. acidocaldarius were very heat resistant and could easily survive any heat treatment currently applied to pasteurize fruit juices.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A Palop</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I Alvarez</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Raso</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Cond√≥n</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Tecnolog√≠a de Alimentos, Universidad de Zaragoza, Spain. alfredo.palop@upct.es</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Buffers</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Bacillaceae</document:subject>
<document:subject>Beverages</document:subject>
<document:subject>Buffers</document:subject>
<document:subject>Citrus</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Heat</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Spores, Bacterial</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Water</document:subject>
<document:subject>Bacillaceae; isolation &amp; purification</document:subject>
<document:subject>Bacillaceae; physiology</document:subject>
<document:subject>Beverages; microbiology</document:subject>
<document:subject>Citrus; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041138">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Extension of the shelf life of prawns (Penaeus japonicus) by vacuum packaging and high-pressure treatment.</document:title>
<document:abstractSection>The present study has investigated the application of high pressures (200 and 400 MPa) in chilled prawn tails, both conventionally stored (air) and vacuum packaged. Vacuum packaging and high-pressure treatment did extend the shelf life of the prawn samples, although it did affect muscle color very slightly, giving it a whiter appearance. The viable shelf life of 1 week for the air-stored samples was extended to 21 days in the vacuum-packed samples, 28 days in the samples treated at 200 MPa, and 35 days in the samples pressurized at 400 MPa. Vacuum packaging checked the onset of blackening, whereas high-pressure treatment aggravated the problem. From a microbiological point of view, batches conventionally stored reached about 6 log CFU/g or even higher at 14 days. Similar figures were reached in total number of bacteria in vacuum-packed samples and in pressurized at 200-MPa samples at 21 days. When samples were pressurized at 400 MPa, total numbers of bacteria were below 5.5 log CFU/g at 35 days of storage. Consequently, a combination of vacuum packaging and high-pressure treatment would appear to be beneficial in prolonging freshness and preventing spotting.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M E L√≥pez-Caballero</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M P√©rez-Mateos</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J A Border√≠as</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Montero</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Departamento de Ciencia y Tecnolog√≠a de Carnes y Pescados, Instituto del Fr√≠o (CSIC), Ciudad Universitaria, Madrid, Spain.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Bacteria</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Melanosis</document:subject>
<document:subject>Pressure</document:subject>
<document:subject>Shellfish</document:subject>
<document:subject>Shrimp</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Vacuum</document:subject>
<document:subject>Bacteria; growth &amp; development</document:subject>
<document:subject>Bacteria; isolation &amp; purification</document:subject>
<document:subject>Food Handling; methods</document:subject>
<document:subject>Food Preservation; methods</document:subject>
<document:subject>Shellfish; microbiology</document:subject>
<document:subject>Shrimp; microbiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041139">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Visual color and doneness indicators and the incidence of premature brown color in beef patties cooked to four end point temperatures.</document:title>
<document:abstractSection>An interlaboratory study was undertaken to assess the frequency that cooked color of ground beef patties appeared brown at internal temperatures of 52.7 degrees C (135 degrees F), 65.6 degrees C (150 degrees F), 71.1 degrees C (160 degrees F), and 79.4 degrees C (175 degrees F). In general, as internal cooked temperature of the patties increased, the following results were observed in the patties: (i) more brown meat color, (ii) less pink or red juice color, and (iii) more cooked texture. However, brown meat color occurred prematurely at the two lower internal temperatures (57.2 degrees C/135 degrees F and 65.6 degrees C/150 degrees F) that are insufficient to eliminate foodborne pathogens without holding times. The common consumer practice of freezing bulk ground beef, followed by overnight thawing in a refrigerator, led to substantial premature brown color in patties cooked from this product. In addition, at 71.1 degrees C (160 degrees F), recognized to be the lowest temperature for cooking ground beef safely in the home, meat color, juice color, and texture appearance were not fully apparent as doneness indicators. In fact, at no temperature studied did 100% of the patties appear done when evaluated by the criteria of no red or pink in the meat, no red or pink in the juices, or by texture appearance. Patties in this study were evaluated under a set protocol for forming the products, cooking, and viewing under the same lighting conditions. Other preparation conditions are possible and may produce different results. Thus, temperature to which patties have been cooked cannot be judged by color and appearance. This study provided the evidence to support the message to consumers regarding cooking of beef patties of "use an accurate food thermometer and cook beef patties to 160 degrees F (71.1 degrees C)" in place of messages based on consumer judgment of cooked color.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>B G Lyon</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B W Berry</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Soderberg</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N Clinch</feature:name>
</feature:Person>
</document:author>
<dc:contributor>U.S. Department of Agriculture, Agricultural Research Service, Russell Research Center, Athens, Georgia 30604-5677, U.S. bglyon@saa.ars.usda.gov</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Myoglobin</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Color</document:subject>
<document:subject>Consumer Product Safety</document:subject>
<document:subject>Cookery</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Heat</document:subject>
<document:subject>Meat</document:subject>
<document:subject>Myoglobin</document:subject>
<document:subject>Oxidation-Reduction</document:subject>
<document:subject>Consumer Product Safety; standards</document:subject>
<document:subject>Cookery; methods</document:subject>
<document:subject>Food Handling; methods</document:subject>
<document:subject>Food Handling; standards</document:subject>
<document:subject>Meat; microbiology</document:subject>
<document:subject>Meat; standards</document:subject>
<document:subject>Myoglobin; adverse effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041140">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>The mycobiota of speck, a traditional Tyrolean smoked and cured ham.</document:title>
<document:abstractSection>Speck is a ham specialty product traditionally produced in South Tyrol (Italy) and North Tyrol (Austria) by farmers, butcheries, and meat industries. To date, nothing has been learned about fungi associated with this smoked and cured meat. Therefore, it was the main objective of this study to assess the typical mycobiota of Speck in relation to the different production types and the geographic provenance. A total of 121 Speck samples from North Tyrol and South Tyrol was analyzed. From 63 isolated fungal species, only a few can be regarded as typical colonizers: Eurotium rubrum and Penicillium solitum were the dominating species in all types and parts of Speck (crust, meat, and fat). Eight other Penicillium spp. were relatively frequent. The species diversity increased from industrially produced Speck to products from butcheries and farmers, and it was higher in all types of South Tyrolean products. Among the typical mycobiota, Penicillium verrucosum, Penicillium canescens, and Penicillium commune are known as potentially mycotoxigenic.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>U Peintner</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Geiger</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R P√∂der</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institute of Microbiology, Leopold-Franzens-University Innsbruck, Austria.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Mycotoxins</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Ascomycota</document:subject>
<document:subject>Austria</document:subject>
<document:subject>Cookery</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Fungi</document:subject>
<document:subject>Italy</document:subject>
<document:subject>Meat</document:subject>
<document:subject>Mycotoxins</document:subject>
<document:subject>Penicillium</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Water</document:subject>
<document:subject>Ascomycota; classification</document:subject>
<document:subject>Ascomycota; growth &amp; development</document:subject>
<document:subject>Ascomycota; isolation &amp; purification</document:subject>
<document:subject>Food Handling; methods</document:subject>
<document:subject>Food Handling; standards</document:subject>
<document:subject>Fungi; classification</document:subject>
<document:subject>Fungi; growth &amp; development</document:subject>
<document:subject>Fungi; isolation &amp; purification</document:subject>
<document:subject>Meat; microbiology</document:subject>
<document:subject>Mycotoxins; biosynthesis</document:subject>
<document:subject>Penicillium; classification</document:subject>
<document:subject>Penicillium; growth &amp; development</document:subject>
<document:subject>Penicillium; isolation &amp; purification</document:subject>
<document:subject>Water; analysis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041141">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Comparison of capillary and test tube procedures for analysis of thermal inactivation kinetics of mold spores.</document:title>
<document:abstractSection>Characteristics of capillary and test tube procedures for thermal inactivation kinetic analysis of microbial cells were studied for mold spores. During heating, capillaries were submerged in a water bath and test tubes were held with their caps positioned above the level of the heating medium. Thermal inactivation curves of Aspergillus niger spores in capillaries at around 60 degrees C consisted of a shoulder and a fast linear decline, whereas curves in test tubes consisted of a shoulder, a fast linear decline, and a horizontal tail. There were no significant differences in values of the rate and the delay of fast declines in curves between the procedures. Some experiments were done to clarify the cause for tailing with test tubes. There were no tails with test tubes whose inner walls were not contaminated by A. niger spores, suggesting that tails arise from A. niger spores contaminating the inner walls of test tubes. Temperature of the inner wall at the level of a heating medium was lower than that of the medium. Further, there were no tails for test tubes submerged in the heating medium. These results showed that the reason for survival of contaminants on the upper wall of test tubes was that cells were not subjected to sufficient inactivation temperature. Finally, thermal inactivation curves of A. niger spores in capillaries at various constant temperatures were studied. Curves consisted of a shoulder and a fast linear decline at 57 degrees C and above, whereas curves at below 57 degrees C consisted of a shoulder, a fast linear decline, and a sloping tail.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>H Fujikawa</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Morozumi</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G H Smerage</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A A Teixeira</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Microbiology, Tokyo Metropolitan Research Laboratory of Public Health, Shinjuku, Japan. fujik@tokyo-eiken.go.jp</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Aspergillus niger</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Heat</document:subject>
<document:subject>Kinetics</document:subject>
<document:subject>Spores, Fungal</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Aspergillus niger; growth &amp; development</document:subject>
<document:subject>Aspergillus niger; physiology</document:subject>
<document:subject>Spores, Fungal; growth &amp; development</document:subject>
<document:subject>Spores, Fungal; physiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041142">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Isolation of Cyclospora oocysts from fruits and vegetables using lectin-coated paramagnetic beads.</document:title>
<document:abstractSection>Published techniques for recovering parasites from fruit and vegetables are generally inadequate, with low and variable recovery efficiencies. Herein, we describe an improved method for analyzing fruit and vegetables for Cyclospora oocysts. The technique includes washing procedures, sonication, and separation using lectin-coated paramagnetic beads. Identification is by microscopy (differential interference contrast and fluorescence). Oocyst recovery efficiencies from mushrooms, lettuce, and raspberries were approximately 12%. Recovery efficiencies from bean sprouts were approximately 4%. Although no significant difference in recovery efficiency could be detected between samples processed using the lectin-coated beads and samples processed without this procedure, distinct advantages were apparent when the lectin-coated beads were used. A considerably smaller, cleaner final volume remained for microscopy, which increases the sensitivity of the technique and reduces operator time.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>L J Robertson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B Gjerde</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A T Campbell</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Pharmacology, Microbiology and Food Hygiene, The Norwegian School of Veterinary Science, Oslo. lucy.robertson@veths.no</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Lectins</document:subject>
<document:subject>Cyclospora</document:subject>
<document:subject>Food Parasitology</document:subject>
<document:subject>Fruit</document:subject>
<document:subject>Immunomagnetic Separation</document:subject>
<document:subject>Lectins</document:subject>
<document:subject>Microscopy, Fluorescence</document:subject>
<document:subject>Microscopy, Interference</document:subject>
<document:subject>Parasite Egg Count</document:subject>
<document:subject>Sensitivity and Specificity</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Vegetables</document:subject>
<document:subject>Cyclospora; isolation &amp; purification</document:subject>
<document:subject>Fruit; parasitology</document:subject>
<document:subject>Immunomagnetic Separation; methods</document:subject>
<document:subject>Vegetables; parasitology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041143">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Formation of heterocyclic amines in fried fish fiber during processing and storage.</document:title>
<document:abstractSection>The formation of heterocyclic amines (HAs) in fried fish fiber during processing and storage was studied. Fried fish fiber was prepared by boiling of raw fish, followed by eviscerating, pressing, chopping, and then the fish meat was subjected to frying, during which the various additives such as sugar, soybean sauce, and edible oil were added. The various HAs in fried fish fiber were analyzed by high-performance liquid chromatography with photodiode-array detection. Only four HAs, Norharman, Harman, 2-amino-9H-pyrido[2,3-b]indole, and 2-amino-3-methyl-9H-pyrido[2,3-b]indole were detected in fried fish fiber. The amount of HAs increased with increasing frying temperature. Amino acids might play a more important role for HA formation than reducing sugar during processing of fried fish fiber. During storage, the HAs increased with increasing storage temperature when the fried fish fiber was packed in an aluminum foil bag. However, the relationship between storage temperature and HAs formation was not consistent when the fried fish fiber was packed in a plastic bag.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>B H Chen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K H Lee</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Y Tai</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Nutrition and Food Science, Fu Jen University, Taipei, Taiwan. nutr1007@mails.fju.edu.tw</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Amines</document:subject>
<document:subject>Heterocyclic Compounds</document:subject>
<document:subject>Mutagens</document:subject>
<document:subject>Amines</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Chromatography, High Pressure Liquid</document:subject>
<document:subject>Cookery</document:subject>
<document:subject>Fish Products</document:subject>
<document:subject>Fishes</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Packaging</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Heat</document:subject>
<document:subject>Heterocyclic Compounds</document:subject>
<document:subject>Mutagens</document:subject>
<document:subject>Oxidation-Reduction</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Amines; analysis</document:subject>
<document:subject>Amines; chemistry</document:subject>
<document:subject>Fish Products; adverse effects</document:subject>
<document:subject>Heterocyclic Compounds; analysis</document:subject>
<document:subject>Heterocyclic Compounds; chemistry</document:subject>
<document:subject>Mutagens; analysis</document:subject>
<document:subject>Mutagens; chemistry</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041144">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Detection, quantitation, and identification of residual aminopenicillins by high-performance liquid chromatography after fluorescamine derivation.</document:title>
<document:abstractSection>A high-performance liquid chromatographic (HPLC) method with fluorescence detection after precolumn fluorescamine derivation was developed to detect residues of two aminopenicillins, amoxicillin (AMPC) and ampicillin (ABPC), in bovine serum. Proteins in serum samples spiked with each of these penicillins were precipitated with sodium tungstate and sulfuric acid, centrifuged, and removed by passage through a C18 solid-phase extraction cartridge. After precolumn treatment of the extraction products of AMPC and ABPC with fluorescamine solution, HPLC analysis with fluorescence spectrophotometric detection at an excitation wavelength of 390 nm and an emission wavelength of 485 nm was performed to identify these products. Two mobile phases were used for residual analysis by the isocratic HPLC system. An ODP column (polyvinyl alcohol bonded with an octadecyl functional group) that can be used with strongly alkaline mobile phases (pH 2.0 to 13) was selected, and the column temperature was set at 40 degrees C. A mobile phase comprising 100-mM K2HPO4 solution and acetonitrile (72:28, vol/vol), which yielded AMPC and ABPC retention times of 4.1 and 7.9 min, respectively, was suitable for detection of residual ABPC but not for residual AMPC because interference was caused by peaks of other extracted substances. When a mobile phase comprising a different ratio of 100-mM K2HPO4 solution and acetonitrile (78:22, vol/vol) was used, the retention times of AMPC and ABPC were 7.3 and 26.3 min, respectively, and both penicillins could be analyzed using this system. The calculated standard curves of the reaction products with both mobile phases were linear, and the correlation coefficients were greater than 0.999. The lower limit of detection was 10 ng/ml for both penicillins. Analysis of extracts from bovine serum spiked with AMPC and ABPC at a concentration of 1 microg/ml yielded recovery rates of 102.2 +/- 5.5% and 79.0 +/- 5.2%, respectively. This detection method may be useful for routine laboratory testing of AMPC and ABPC.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C Hong</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Kondo</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Veterinary Public Health, Faculty of Agriculture, Miyazaki University, Gakuen, Japan.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Indicators and Reagents</document:subject>
<document:subject>Penicillins</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:26787-78-0">
<cas:registryNumber>26787-78-0</cas:registryNumber>
<cas:name>Amoxicillin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:38183-12-9">
<cas:registryNumber>38183-12-9</cas:registryNumber>
<cas:name>Fluorescamine</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:69-53-4">
<cas:registryNumber>69-53-4</cas:registryNumber>
<cas:name>Ampicillin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Amoxicillin</document:subject>
<document:subject>Ampicillin</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Chromatography, High Pressure Liquid</document:subject>
<document:subject>Drug Residues</document:subject>
<document:subject>Fluorescamine</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Indicators and Reagents</document:subject>
<document:subject>Penicillins</document:subject>
<document:subject>Spectrometry, Fluorescence</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Amoxicillin; analysis</document:subject>
<document:subject>Amoxicillin; chemistry</document:subject>
<document:subject>Amoxicillin; isolation &amp; purification</document:subject>
<document:subject>Ampicillin; analysis</document:subject>
<document:subject>Ampicillin; chemistry</document:subject>
<document:subject>Ampicillin; isolation &amp; purification</document:subject>
<document:subject>Chromatography, High Pressure Liquid; methods</document:subject>
<document:subject>Drug Residues; analysis</document:subject>
<document:subject>Drug Residues; chemistry</document:subject>
<document:subject>Drug Residues; isolation &amp; purification</document:subject>
<document:subject>Fluorescamine; chemistry</document:subject>
<document:subject>Indicators and Reagents; chemistry</document:subject>
<document:subject>Penicillins; analysis</document:subject>
<document:subject>Penicillins; chemistry</document:subject>
<document:subject>Penicillins; isolation &amp; purification</document:subject>
<document:subject>Spectrometry, Fluorescence; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041145">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Milkborne campylobacter infection in Hungary.</document:title>
<document:abstractSection>In April 1998, an annual 2-day animal farm sale was held in H√≥dmez√≥v√°s√°rhely, where 500 to 600 visitors consumed unpasteurized milk. The first signs of disease began 2 days after the end of the sale. Fifty-two people from a wide age range fell ill, primarily with inflammatory enteritis. These cases included 34 with Campylobacter positivity: 30 with Campylobacter jejuni and 4 with Campylobacter coli. Environmental samples (raw milk, udder swabs, and rectal swabs from 12 cows in the suspected herd) were tested 2 weeks after the first signs of the disease, and two rectal swabs were found to be positive for C. jejuni. Initially, the epidemic seemed to be sporadic and, accordingly, only 26 human and 2 animal Campylobacter isolates were reserved for randomly amplified polymorphic DNA analysis. This comparative analysis verified that fecally contaminated milk was the source of the outbreak. The DNA-banding patterns of 20 C. jejuni isolates (19 human and 1 animal) were identical. The antibiotic susceptibilities of the Campylobacter isolates were determined, and only six C. jejuni (human) isolates, one C. coli (human) isolate, and one C. jejuni (animal) isolate were resistant to tetracycline, both by disk diffusion and by E test (antimicrobial gradient strip for the quantitative determination of susceptibility or resistance of microorganisms). No plasmid was detected in these tetracycline-resistant isolates. The endotoxin production of Campylobacter isolates was examined via the cytopathogenic effect on the Vero cell line. This effect exhibited various degrees of positivity in 19 cases. Only two human C. jejuni isolates displayed + + + + positivity. Both isolates were from patients who had required antibiotic therapy and hospital care.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M K√°lm√°n</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E Sz√∂ll√≥si</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B Czermann</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Zim√°nyi</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Szekeres</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M K√°lm√°n</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Csongr√°d County Public Health and Medical Officer Service, Szeged, Hungary. info@antsz.csm.hu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anti-Infective Agents</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Anti-Infective Agents</document:subject>
<document:subject>Bacterial Typing Techniques</document:subject>
<document:subject>Campylobacter Infections</document:subject>
<document:subject>Campylobacter coli</document:subject>
<document:subject>Campylobacter jejuni</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Cercopithecus aethiops</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Diarrhea</document:subject>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Dose-Response Relationship, Drug</document:subject>
<document:subject>Enteritis</document:subject>
<document:subject>Feces</document:subject>
<document:subject>Female</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Food Microbiology</document:subject>
<document:subject>Human</document:subject>
<document:subject>Hungary</document:subject>
<document:subject>Milk</document:subject>
<document:subject>Random Amplified Polymorphic DNA Technique</document:subject>
<document:subject>Tetracycline Resistance</document:subject>
<document:subject>Vero Cells</document:subject>
<document:subject>Anti-Infective Agents; pharmacology</document:subject>
<document:subject>Campylobacter Infections; drug therapy</document:subject>
<document:subject>Campylobacter Infections; epidemiology</document:subject>
<document:subject>Campylobacter Infections; microbiology</document:subject>
<document:subject>Campylobacter coli; classification</document:subject>
<document:subject>Campylobacter coli; drug effects</document:subject>
<document:subject>Campylobacter coli; isolation &amp; purification</document:subject>
<document:subject>Campylobacter jejuni; classification</document:subject>
<document:subject>Campylobacter jejuni; drug effects</document:subject>
<document:subject>Campylobacter jejuni; isolation &amp; purification</document:subject>
<document:subject>Diarrhea; epidemiology</document:subject>
<document:subject>Diarrhea; microbiology</document:subject>
<document:subject>Disease Outbreaks; prevention &amp; control</document:subject>
<document:subject>Enteritis; drug therapy</document:subject>
<document:subject>Enteritis; epidemiology</document:subject>
<document:subject>Enteritis; microbiology</document:subject>
<document:subject>Feces; microbiology</document:subject>
<document:subject>Hungary; epidemiology</document:subject>
<document:subject>Milk; microbiology</document:subject>
<document:subject>Random Amplified Polymorphic DNA Technique; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041146">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Diminution of Campylobacter colonization in neonatal pigs reared off-sow.</document:title>
<document:abstractSection>Pigs may be a natural reservoir of Campylobacter and can be colonized as early as 24 h after birth. The purpose of the present study was to evaluate what effect early removal of piglets from Campylobacter-positive sows has on Campylobacter prevalence in neonates. In two trials, piglets were removed from sows within 24 h of birth and were reared in nurseries isolated from sows for 21 days. From the neonates rectal swabs were cultured for Campylobacter, and Campylobacter status of the isolated piglets was compared to that of littermates reared on sows. The nurseries consisted of wire-floored farrowing crates that were equipped with heaters and self-feeders. In trial I, the Campylobacter prevalence in nursery-reared piglets was 13 of 14 on day 2 and 0 of 14 on day 20. Campylobacter prevalence in the sow-reared piglets was 8 of 9 from days 2 to 20. In trial II, 12 of 29 on day 2, and 5 of 26 on day 20, of the nursery-reared piglets were culture positive for Campylobacter. For the sow-reared piglets, Campylobacter prevalence was 7 of 15 on day 1 and 15 of 15 (100%) on day 20. These data suggest that successful permanent colonization of the gut by Campylobacter is probably related to constant exposure of piglets to Campylobacter-positive feces. Campylobacter prevalence may be diminished in neonates that are reared off-sow in isolated nurseries.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R B Harvey</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C R Young</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R C Anderson</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R E Droleskey</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K J Genovese</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L F Egan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D J Nisbet</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Southern Plains Agricultural Research Center, Agricultural Research Service, U.S. Department of Agriculture, College Station, Texas 77845, USA. harvey@ffsru.tamu.edu</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Animal Husbandry</document:subject>
<document:subject>Animals, Newborn</document:subject>
<document:subject>Campylobacter</document:subject>
<document:subject>Campylobacter Infections</document:subject>
<document:subject>Disease Transmission, Vertical</document:subject>
<document:subject>Female</document:subject>
<document:subject>Male</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Random Allocation</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Swine Diseases</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Animal Husbandry; methods</document:subject>
<document:subject>Campylobacter; growth &amp; development</document:subject>
<document:subject>Campylobacter; isolation &amp; purification</document:subject>
<document:subject>Campylobacter Infections; epidemiology</document:subject>
<document:subject>Campylobacter Infections; microbiology</document:subject>
<document:subject>Campylobacter Infections; veterinary</document:subject>
<document:subject>Disease Transmission, Vertical; prevention &amp; control</document:subject>
<document:subject>Disease Transmission, Vertical; veterinary</document:subject>
<document:subject>Swine Diseases; epidemiology</document:subject>
<document:subject>Swine Diseases; microbiology</document:subject>
<document:subject>Swine Diseases; transmission</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041147">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Comparison of the attachment of Escherichia coli O157:H7, Listeria monocytogenes, Salmonella typhimurium, and Pseudomonas fluorescens to lettuce leaves.</document:title>
<document:abstractSection>Attachment of Escherichia coli O157:H7, Listeria monocytogenes, Salmonella Typhimurium, and Pseudomonas fluorescens on iceberg lettuce was evaluated by plate count and confocal scanning laser microscopy (CSLM). Attachment of each microorganism (approximately 10(8) CFU/ml) on the surface and the cut edge of lettuce leaves was determined. E. coli O157:H7 and L. monocytogenes attached preferentially to cut edges, while P. fluorescens attached preferentially to the intact surfaces. Differences in attachment at the two sites were greatest with L. monocytogenes. Salmonella Typhimurium attached equally to the two sites. At the surface, P. fluorescens attached in greatest number, followed by E. coli O157:H7, L. monocytogenes, and Salmonella Typhimurium. Attached microorganisms on lettuce were stained with fluorescein isothiocyanate and visualized by CSLM. Images at the surface and the cut edge of lettuce confirmed the plate count data. In addition, microcolony formation by P. fluorescens was observed on the lettuce surface. Some cells of each microorganism at the cut edge were located within the lettuce tissues, indicating that penetration occurred from the cut edge surface. The results of this study indicate that different species of microorganisms attach differently to lettuce structures, and CSLM can be successfully used to detect these differences.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>K Takeuchi</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C M Matute</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A N Hassan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J F Frank</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science and Technology, University of Georgia, Athens 30602-2106, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Bacterial Adhesion</document:subject>
<document:subject>Bacteriological Techniques</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Escherichia coli O157</document:subject>
<document:subject>Lettuce</document:subject>
<document:subject>Listeria monocytogenes</document:subject>
<document:subject>Microscopy, Confocal</document:subject>
<document:subject>Pseudomonas fluorescens</document:subject>
<document:subject>Salmonella typhimurium</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Bacterial Adhesion; physiology</document:subject>
<document:subject>Escherichia coli O157; physiology</document:subject>
<document:subject>Lettuce; microbiology</document:subject>
<document:subject>Listeria monocytogenes; physiology</document:subject>
<document:subject>Microscopy, Confocal; methods</document:subject>
<document:subject>Pseudomonas fluorescens; physiology</document:subject>
<document:subject>Salmonella typhimurium; physiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041148">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Listeria monocytogenes contamination pattern in pig slaughterhouses.</document:title>
<document:abstractSection>Ten low-capacity slaughterhouses were examined for Listeria by collecting a total of 373 samples, of which 50, 250, and 73 were taken from carcasses, pluck sets, and the slaughterhouse environment, respectively. Six slaughterhouses and 9% of all samples were positive for Listeria monocytogenes. Of the samples taken from pluck sets, 9% were positive for L. monocytogenes, the highest prevalence occurring in tongue and tonsil samples, at 14% and 12%, respectively. Six of 50 (12%) carcasses were contaminated with L. monocytogenes. In the slaughterhouse environment, L. monocytogenes was detected in two, one, one, and one sample originating from the saws, drain, door, and table, respectively. Carcasses were contaminated with L. monocytogenes in those two slaughterhouses, where the mechanical saws, used for both brisket and back splitting, were also positive for L. monocytogenes. A total of 58 L. monocytogenes isolates were characterized by pulsed-field gel electrophoresis typing. The isolates were divided into 18 pulsotypes, 15 of which were detected in pluck sets. In two slaughterhouses, where the carcasses were contaminated with L. monocytogenes, the same pulsotypes were also recovered from splitting saws. In addition, identical pulsotypes were recovered from pluck sets. Our findings indicate that L. monocytogenes of tongue and tonsil origin may contaminate the slaughtering equipment that may in turn spread the pathogen to carcasses. Thus, it is of the utmost importance to follow good manufacturing practices and to have efficient cleaning and disinfection procedures to prevent equipment being contaminated with L. monocytogenes.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>T Autio</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T S√§teri</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Fredriksson-Ahomaa</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Rahkio</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Lund√©n</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H Korkeala</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food and Environmental Hygiene, Faculty of Veterinary Medicine, University of Helsinki, Finland. Tiina.Jo.Autio@Helsinki.fi</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Abattoirs</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Disinfection</document:subject>
<document:subject>Electrophoresis, Gel, Pulsed-Field</document:subject>
<document:subject>Food Contamination</document:subject>
<document:subject>Food Handling</document:subject>
<document:subject>Listeria Infections</document:subject>
<document:subject>Listeria monocytogenes</document:subject>
<document:subject>Prevalence</document:subject>
<document:subject>Restriction Mapping</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Swine Diseases</document:subject>
<document:subject>Electrophoresis, Gel, Pulsed-Field; veterinary</document:subject>
<document:subject>Food Contamination; prevention &amp; control</document:subject>
<document:subject>Food Handling; methods</document:subject>
<document:subject>Food Handling; standards</document:subject>
<document:subject>Listeria Infections; epidemiology</document:subject>
<document:subject>Listeria Infections; microbiology</document:subject>
<document:subject>Listeria Infections; prevention &amp; control</document:subject>
<document:subject>Listeria Infections; veterinary</document:subject>
<document:subject>Listeria monocytogenes; classification</document:subject>
<document:subject>Listeria monocytogenes; genetics</document:subject>
<document:subject>Listeria monocytogenes; isolation &amp; purification</document:subject>
<document:subject>Restriction Mapping; veterinary</document:subject>
<document:subject>Swine Diseases; epidemiology</document:subject>
<document:subject>Swine Diseases; microbiology</document:subject>
<document:subject>Swine Diseases; prevention &amp; control</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041149">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Improved detection of nontyphoid and typhoid Salmonellae with balanced agar formulations.</document:title>
<document:abstractSection>A strategically balanced medium was developed for the improved detection of nontyphoid and typhoid salmonellae. Its balanced sugar (cellobiose, lactose, mannitol, and trehalose) and protein (beef extract and polypeptone peptone) formulation provided Salmonella with a selective growth advantage over non-Salmonella enteric organisms. The formulations promoted the production and detection of H2S production levels that otherwise might be missed with traditional agar formulations. In combination, these advantages contributed to increased sensitivity without the loss of specificity. In comparative studies using 86 samples of meat products (beef, pork, and chicken), the new media, Miller-Mallinson (MM) agar and xylose lysine tergitol (Niaproof) 4 agar, possessed significantly higher sensitivity (P &lt; 0.001) and an improved specificity over bismuth sulfite, hektoen enteric, and xylose lysine desoxycholate agars. However, these samples did not contain nontyphoid salmonellae with weak to ultraweak H2S production characteristics. Modified formulations of MM agar were generally similar to bismuth sulfite and hektoen enteric agars in the identification of four of seven globally diverse strains of Salmonella serotype Typhi. Two of these seven strains were found to produce more readily identifiable black (H2S-positive) colonies on MM agar, whereas one of the seven was not readily detected by any of the media. The improved detection of nontyphoid and typhoid salmonellae attests to the sensitivity of MM agar and to its potentially broad utility in both clinical and food quality laboratories.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>R G Miller</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E T Mallinson</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland Campus, College Park 20742-3711, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Culture Media</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7783-06-4">
<cas:registryNumber>7783-06-4</cas:registryNumber>
<cas:name>Hydrogen Sulfide</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9002-18-0">
<cas:registryNumber>9002-18-0</cas:registryNumber>
<cas:name>Agar</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Agar</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Chickens</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Culture Media</document:subject>
<document:subject>Hydrogen Sulfide</document:subject>
<document:subject>Salmonella</document:subject>
<document:subject>Sensitivity and Specificity</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Agar; chemistry</document:subject>
<document:subject>Culture Media; chemistry</document:subject>
<document:subject>Hydrogen Sulfide; metabolism</document:subject>
<document:subject>Salmonella; growth &amp; development</document:subject>
<document:subject>Salmonella; isolation &amp; purification</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:7703944">
<dc:coverage>UNITED STATES</dc:coverage>
<dc:title>J Food Prot</dc:title>
<med:code>C48</med:code>
<med:nlmUniqueID>7703944</med:nlmUniqueID>

<med:issn>0362-028X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:7703944:63:10">
<med:volume>63</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11041150">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>11</date:month>
<date:day>08</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Comparison of different peptidase substrates for evaluation of microbial quality of aerobically stored meats.</document:title>
<document:abstractSection>Different aminopeptidase and endopeptidase substrates were assessed for the detection of enzymatic activity of microorganisms collected from the surface of aerobically cold-stored pork and beef. The most sensitive substrates were fluorogenic Ala-7-amino-4-methylcoumarin (Ala-AMC) or Leu-AMC and colorogenic Ala-p-nitroanilide (Ala-pNA). Activity on natural oligopeptides, e.g., bradykinin or alpha(s1) casein fragment 1 to 23, was very low. The correlation coefficient (r) between log surface counts of 66 meat samples and log fluorescence or absorbance after incubation of surface microbial cells for 2 h with Ala-AMC, Leu-AMC, and Ala-pNA was 0.89, 0.83, and 0.82, respectively. A distinct yellow color was obtained with Ala-pNA when the surface count was approximately 10(6) CFU/cm2. Although correlation and sensitivity was better, no clear advantage is obtained with the use of the fluorogenic Ala-AMC or Leu-AMC instead of Ala-pNA, a substrate proposed by Alvarado et al. (J. Food Sci. 57:1330, 1992) for rapidly assessing the microbial quality of refrigerated meat. The correlation coefficient (r) between time of cold storage and surface count was 0.69.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>L Stepaniak</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Food Science, Agricultural University of Norway. leszek.stepaniak@inf.nlh.no</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Fluorescent Dyes</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:EC%203.4">
<cas:registryNumber>EC 3.4</cas:registryNumber>
<cas:name>Peptide Hydrolases</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Aerobiosis</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Cold</document:subject>
<document:subject>Colony Count, Microbial</document:subject>
<document:subject>Color</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Fluorescent Dyes</document:subject>
<document:subject>Food Preservation</document:subject>
<document:subject>Meat</document:subject>
<document:subject>Peptide Hydrolases</document:subject>
<document:subject>Statistics</document:subject>
<document:subject>Substrate Specificity</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Fluorescent Dyes; metabolism</document:subject>
<document:subject>Meat; microbiology</document:subject>
<document:subject>Peptide Hydrolases; metabolism</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252224">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Nikolaƒ≠ Vladimirovich Timofeev-Resovskiƒ≠ (1900-1981). (Essay on his life and works)]</document:title>
<document:abstractSection>The article contains a brief review of the basic works (1925-1981) written by Nikolay V. Timofeeff-Ressovsky--one of the famous geneticist of the elapsing century, the founder of radiobiology and radiation genetics, biocenology and radioecology, a prominent evolutionary biologist. In genetics, his name is associated with the development of fundamental problems of population genetics, phenogenetics, gene interaction and investigations of the role of environmental and genetic factors in expression of different characters. Timofeeff-Ressovsky classical works on mutagenesis process and especially, radiation mutagenesis, promoted penetration of methods and approaches applied in molecular physics and chemistry, into genetic analysis, and accelerated forming of the modern molecular genetics. A special place in the development of population genetics is occupied by the hypothesis of microevolutionary process developed by Nikolay V. Timofeeff-Ressovsky along with other famous biologists in the end of the 30-ies. This hypothesis connected Darwin's evolutionary theory with rapidly developing concepts of genetics. In the last years of his life, Timofeeff-Ressovsky was especially interested in a global problem which was called by him "The Biosphere and Humanity". Here was especially strikingly shown the broadness of his approach to the analysis of the biosphere phenomena in the best traditions of the Russian natural science. In the course of time, the wealth of Nikolay V. Timofeeff-Ressovsky's scientific heritage not only remains valuable, but also takes on more profundity and value.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V I Ivanov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I A Liapunova</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Research Center for Medical Genetics, Russian Academy of Medical Sciences, Moscow, 115478, Russia. viimgnc@corbina.ru</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>English Abstract</document:subject>
<document:subject>History of Medicine, 20th Cent.</document:subject>
<document:subject>Portraits</document:subject>
<document:subject>Radiobiology</document:subject>
<document:subject>Russia</document:subject>
<document:subject>Radiobiology; history</document:subject>
<document:subject>
<feature:Person>
<feature:name>N V Timofeev-Resovskiƒ≠</feature:name>
</feature:Person>
</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130944">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Theoretical foundation and experimental proof of the accumulating transfer of tritium from water into DNA and other biomolecules in vitro and in vivo.</document:title>
<document:abstractSection>Heisenberg's uncertainty principle, which describes a fundamental property of matter, predicts the light hydrogen isotope to prefer the strong hydrogen bridge positions (with large local uncertainty). In contrast, the heavy hydrogen isotope tritium originally localized in water, should finally be found in the exchangeable hydrogen bridge positions of proteins, carbohydrates and nucleotides which are definitely less strong than those of water. The fractionation factor of tritium and protium measured between water and DNA as well as the mixture of biomolecules of liver confirm this conclusion and show in addition, a tritum accumulation also in the hydration sheets of the biomolecules. Furthermore, the larger intrinsic rate of natural increase of tritium than of hydrogen in tissue solids of growing maize and barley confirm the accumulating tritium transfer from water to biomolecules taking place in vivo.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>F Baumg√§rtner</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institut f√ºr Radiochemie, Technische Universit√§t M√ºnchen, Germany. bgt@rad.chemie.tu-muenchen.de</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:10028-17-8">
<cas:registryNumber>10028-17-8</cas:registryNumber>
<cas:name>Tritium</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7732-18-5">
<cas:registryNumber>7732-18-5</cas:registryNumber>
<cas:name>Water</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9007-49-2">
<cas:registryNumber>9007-49-2</cas:registryNumber>
<cas:name>DNA</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>DNA</document:subject>
<document:subject>Fishes</document:subject>
<document:subject>Hydrogen Bonding</document:subject>
<document:subject>In Vitro</document:subject>
<document:subject>Liver</document:subject>
<document:subject>Plants</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Tritium</document:subject>
<document:subject>Water</document:subject>
<document:subject>DNA; radiation effects</document:subject>
<document:subject>Liver; chemistry</document:subject>
<document:subject>Liver; radiation effects</document:subject>
<document:subject>Tritium; chemistry</document:subject>
<document:subject>Water; chemistry</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252225">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>The A beta 6w302 gene and molecular mechanisms of resistance to the spread of radiation-induced lymphoma in a mouse mutant, survivor-27.</document:title>
<document:abstractSection>Metastatic tumors escape from immune response and spread in the body; survivors are very rare. Novel single exon genes A beta 4-7 and a pseudogene A beta 8 psi have been cloned from survivors. Their protein coding sequences are similar to MHC class II beta H2-Ab cDNA while their promoter is different from MHC promoters. The A beta 4 protein was demonstrated on macrophages (antigen presenting cells). The A beta gene family is genetically unstable in germ line and somatic cells of survivors. Mutants S-27 and S-87/1 lost the A beta 5s5 and acquired the A beta 6w302 gene; the Ab gene mutated in S-27. The proposed mechanism of resistance is molecular instability of the A beta gene family resulting in somatic mutations and wandering immune responses that destroy the tumor in the survivor.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>Y Liu</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A Y Savinov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D L McMinimy</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S G Kremlev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A I Chapoval</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I K Egorov</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Jackson Laboratory, Bar Harbor, Maine 04609-1500, USA.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>H-2 Antigens</document:subject>
<document:subject>Animal</document:subject>
<document:subject>H-2 Antigens</document:subject>
<document:subject>Immunity, Natural</document:subject>
<document:subject>Lymphoma</document:subject>
<document:subject>Mice</document:subject>
<document:subject>Mice, Mutant Strains</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Neoplasm Metastasis</document:subject>
<document:subject>Neoplasms, Radiation-Induced</document:subject>
<document:subject>Support, U.S. Gov't, P.H.S.</document:subject>
<document:subject>H-2 Antigens; genetics</document:subject>
<document:subject>Lymphoma; etiology</document:subject>
<document:subject>Lymphoma; genetics</document:subject>
<document:subject>Neoplasms, Radiation-Induced; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252226">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Study of genome instability using DNA fingerprinting of the offspring of male mice subjected to chronic low dose gamma irradiation]</document:title>
<document:abstractSection>By a polymerase chain reaction with an arbitrary primer (AP-PCR), the possibility of transmission of genome instability to somatic cells of the offspring (F1 generation) from male parents of mice exposed to chronic low-level gamma-radiation was studied. Male BALB/c mice 15 days after exposure to 10-50 cGy were mated with unirradiated females. Biopsies were taken from tale tips of two month-old offspring mice and DNA was isolated. The primer in the AP-PCR was a 20-mer oligonucleotide flanking the microsatellite locus Atp1b2 on chromosome 11 of the mouse. A comparative analysis of individual fingerprints of AP-PCR products on DNA-templates from the offspring of irradiated and unirradiated male mice revealed an increased variability of microsatellite-associated sequences in the genome of the offspring of the males exposed to 25 and 50 cGy. The DNA-fingerprints of the offspring of male mice exposed to chronic irradiation with the doses 10 and 25 cGy 15 days before fertilization (at the post-meiotic stage of spermatogenesis) showed an increased frequency of "non-parent bands". The results of the study point to the possibility of transmission to the offspring somatic cells of changes increasing genome instability from male parents exposed to chronic low-level radiation prior to fertilization.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V G Bezlepkin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G V Vasil'eva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M G Lomaeva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N P Sirota</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A I Gaziev</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, 142290, Moscow oblast. bezlepkin@venus.iteb.serpukhov.su</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Animal</document:subject>
<document:subject>DNA Damage</document:subject>
<document:subject>DNA Fingerprinting</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Gamma Rays</document:subject>
<document:subject>Genome</document:subject>
<document:subject>Male</document:subject>
<document:subject>Mice</document:subject>
<document:subject>Mice, Inbred BALB C</document:subject>
<document:subject>Microsatellite Repeats</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Radiation Dosage</document:subject>
<document:subject>Radiation Injuries, Experimental</document:subject>
<document:subject>Random Amplified Polymorphic DNA Technique</document:subject>
<document:subject>Radiation Injuries, Experimental; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252227">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Independence of DNA repair after gamma irradiation and radioadaptive response in lymphocytes of patients with Bloom syndrome]</document:title>
<document:abstractSection>The evidence for independency of DNA repair and radioadaptive response (RAR) was obtained in cells of patients with Bloom syndrome. The cells of patients with Bloom syndrome (human autosomal recessive disorder) are characterized by chromosomal instability and increased risk of malignancy at an early age. Resynthesis of gamma-induced DNA breaks wasn't find in lymphocytes of 3 patients with Bloom syndrome while the level of RAR was the same as in the cells of healthy donors.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>G D Zasukhina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I M Vasil'eva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A N Semiachkina</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Vavilov Institute of General Genetic, Russian Academy of Science, Moscow, 117809 Russia.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Bloom Syndrome</document:subject>
<document:subject>Cells, Cultured</document:subject>
<document:subject>Child</document:subject>
<document:subject>DNA Damage</document:subject>
<document:subject>DNA Repair</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gamma Rays</document:subject>
<document:subject>Human</document:subject>
<document:subject>Lymphocytes</document:subject>
<document:subject>Radiation Tolerance</document:subject>
<document:subject>Bloom Syndrome; genetics</document:subject>
<document:subject>Lymphocytes; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252228">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Changes in the number of DNA-protein cross links in spleen lymphocytes of mice exposed to low intensity low dose gamma irradiation]</document:title>
<document:abstractSection>Levels of DNA-protein cross-links (DPC) and DNA single-strand breaks (SSB) in spleen lymphocytes were studied in mice exposed to low-intensity gamma-radiation (1.7 mGy/day) for 1, 4, 10, 20, and 30 days. The spleen mass and count of lymphocytes isolated from this organ also has been investigated. The significant increase in the DPC level as compared to the control occurred on the 10-th and 30-th days of irradiation at doses of 1.7 and 5.1 cGy, accordingly. The number of spleen lymphocytes normalized to organ mass significantly decreased on the 4-th and 30-th days of the experiment. No increase was found in levels of alkali-labile sites and SSB. In contrast, the increase in the amount of duplex form DNA was recorded on the 4-th and 30-th days of the experiment. Our indicate that DPC formation after irradiation at low doses represents some form of cellular response to the damaging agent.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A N Osipov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V D Sypin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P V Puchkov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A S Razumova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E M Kuznetsova</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Moscow State Enterprise-United Ecology-Technology and Science-Industry Center for Decontamination of Radioactive Waste and Environmental Protection (Scientific and Industrial Association Radon), 119121 Russia. aosipov@radon.ru</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>DNA-Binding Proteins</document:subject>
<document:subject>Animal</document:subject>
<document:subject>DNA-Binding Proteins</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gamma Rays</document:subject>
<document:subject>Lymphocyte Count</document:subject>
<document:subject>Lymphocytes</document:subject>
<document:subject>Male</document:subject>
<document:subject>Mice</document:subject>
<document:subject>Mice, Inbred C57BL</document:subject>
<document:subject>Radiation Dosage</document:subject>
<document:subject>Spleen</document:subject>
<document:subject>DNA-Binding Proteins; metabolism</document:subject>
<document:subject>DNA-Binding Proteins; radiation effects</document:subject>
<document:subject>Lymphocytes; metabolism</document:subject>
<document:subject>Lymphocytes; radiation effects</document:subject>
<document:subject>Spleen; metabolism</document:subject>
<document:subject>Spleen; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252229">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Radiation mapping as one of main methods of creating high resolution maps of human and animal genomes]</document:title>
<document:abstractSection>Radiation hybrid mapping (RH mapping) is considered as one of the main methods of constructing physical maps of mammalian genomes. In introduction, theoretical prerequisites of developing of the RH mapping and statistical methods of data analysis are discussed. Comparative characteristics of universal commercial panels of the radiation hybrid somatic cells (RH panels) are shown. In experimental part of the work, RH mapping is used to localise nucleotide sequences adjacent to NotI sites of human chromosome 3 with the aim to integrate contig map of NotI clones to comprehensive maps of human genome. Five nucleotide sequences adjacent to the sites of integration of papilloma virus in human genome and expressed in the cells of cervical cancer were localised. It was demonstrated that the region 13q14.3-q21.1 was enriched with nucleotide sequences involved in the processes of oncogenesis. RH mapping can be considered as one of the most perspective applications of the modern radiation biology in the field of molecular genetics, that is, in constructing physical maps of mammalian genomes with high resolution level.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>G E Sulimova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A A Kompaniƒ≠tsev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E V Moƒ≠siak</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E R Rakhmanaliev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E A Klimov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I G Udina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I A Zakharov</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, 117809 Russia. sge@vigg.ru</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Genetic Markers</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Chromosome Mapping</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Genetic Markers</document:subject>
<document:subject>Genome</document:subject>
<document:subject>Genome, Human</document:subject>
<document:subject>Human</document:subject>
<document:subject>Chromosome Mapping; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130945">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Distinguishing potential sources of genotoxic exposure via HPRT mutations.</document:title>
<document:abstractSection>We utilize T-cell HPRT mutations to monitor exposure to environmental mutagens in siblings of children who have developed cancer at a persistently high rate in Toms River, New Jersey, U.S.A. A preliminary epidemiological study has found a statistically-significant association between drinking public water (by pregnant mother or infant) and subsequent risk for childhood cancer. Three potential sources of mutagenic exposures in Toms River may have increased the rate of carcinogenic initiation significantly in children: 1. Benzidine-based, other azo dye and anthraquinone dye wastes released by Ciba-Geigy, 2. Styrene-acrylonitrile (SAN) trimer and other plastic wastes of Union Carbide, and 3. Radium-224, present in unusually high concentrations in the Cohansey aquifer. Specific patterns of HPRT mutations are utilized to distinguish these various potential sources of carcinogenic exposures in the drinking water of families with childhood cancer and to differentiate chemically or radiologically induced cancers from those which occur spontaneously.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>B Molholt</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B A Finette</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institute for Environmental Studies, University for Pennsylvania, USA. bmolholt@aol.com</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Genetic Markers</document:subject>
<document:subject>Water Pollutants, Chemical</document:subject>
<document:subject>Water Pollutants, Radioactive</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7440-14-4">
<cas:registryNumber>7440-14-4</cas:registryNumber>
<cas:name>Radium</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:EC%202.4.2.8">
<cas:registryNumber>EC 2.4.2.8</cas:registryNumber>
<cas:name>Hypoxanthine Phosphoribosyltransferase</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Child</document:subject>
<document:subject>Environmental Monitoring</document:subject>
<document:subject>Female</document:subject>
<document:subject>Genetic Markers</document:subject>
<document:subject>Human</document:subject>
<document:subject>Hypoxanthine Phosphoribosyltransferase</document:subject>
<document:subject>Neoplasms</document:subject>
<document:subject>Neoplasms, Radiation-Induced</document:subject>
<document:subject>New Jersey</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Radium</document:subject>
<document:subject>Water Pollutants, Chemical</document:subject>
<document:subject>Water Pollutants, Radioactive</document:subject>
<document:subject>Water Supply</document:subject>
<document:subject>Hypoxanthine Phosphoribosyltransferase; genetics</document:subject>
<document:subject>Neoplasms; chemically induced</document:subject>
<document:subject>Neoplasms; epidemiology</document:subject>
<document:subject>Neoplasms; genetics</document:subject>
<document:subject>Neoplasms, Radiation-Induced; genetics</document:subject>
<document:subject>New Jersey; epidemiology</document:subject>
<document:subject>Radium; toxicity</document:subject>
<document:subject>Water Pollutants, Chemical; toxicity</document:subject>
<document:subject>Water Pollutants, Radioactive; toxicity</document:subject>
<document:subject>Water Supply; standards</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130946">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Some aspects of the plant radioresistance.</document:title>
<document:abstractSection>Mutant strains of unicellular green algae--Chlorella and Chlamydomonas which differ in their radioresistance have been investigated at different levels: cellular, molecular, biochemical and ultrastructural. It is obtained that several futures are typical for investigated strains. There are several features typical for radioresistant mutant strains investigated by us: in some cases a relationship was found between radioresistance and ssb-DNA repair efficiency; a high level of SH-groups; SOD; pigments content, especially carotenoids and chlorophyll a; a lower level of Pro content; a stability of the ultrastructural cell components or/and of the presence and structure of the cell envelope.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S G Chankova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V M Kapchina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D P Stoyanova</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Central Laboratory of General Ecology-Bulgarian Academy of Sciences, Sofia, Bulgaria. steph.ch@ecolab.bas.bg</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>DNA, Single-Stranded</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Chlamydomonas</document:subject>
<document:subject>Chlorella</document:subject>
<document:subject>DNA Repair</document:subject>
<document:subject>DNA, Single-Stranded</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Radiation Tolerance</document:subject>
<document:subject>Chlamydomonas; radiation effects</document:subject>
<document:subject>Chlorella; radiation effects</document:subject>
<document:subject>DNA, Single-Stranded; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252230">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Increased radiosensitivity after irradiation of lymphocytes low adaptive doses]</document:title>
<document:abstractSection>The variability of blood lymphocyte reaction on the adaptive irradiation (0.05 Gy at first, then 1.0 Gy 5 h later) was investigated by micronuclei assay. Blood samples were obtained from 700 children. It was shown that in all groups studied there were children with enhanced radiosensitivity ("radiosensitivity syndrome"-RS) after exposure to adaptive low dose of radiation. The radiosensitivity syndrome occurred more often in groups of ill children; part of them was characterized by the enhanced blood content of immunoglobulin E, enhanced level of T helpers and T suppressors. A high spontaneous level of lymphocytes with micronucleus is a factor of radiosensitivity formation. The possible factors resulted in radiosensitivity syndrome are discussed.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>I I Pelevina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A V Aleshchenko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V Ia Gotlib</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O V Kudriashova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L A Noskin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L P Semenova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E N Sotnikova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A M Serebrianyƒ≠</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Semenov Institute of Chemical Physics, Russion Academy of Sciences, Moscow, 117977 Russia.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:37341-29-0">
<cas:registryNumber>37341-29-0</cas:registryNumber>
<cas:name>IgE</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Adaptation, Biological</document:subject>
<document:subject>Cells, Cultured</document:subject>
<document:subject>Child</document:subject>
<document:subject>Child, Preschool</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>IgE</document:subject>
<document:subject>Infant</document:subject>
<document:subject>Lymphocytes</document:subject>
<document:subject>Radiation Dosage</document:subject>
<document:subject>Radiation Tolerance</document:subject>
<document:subject>T-Lymphocytes</document:subject>
<document:subject>IgE; immunology</document:subject>
<document:subject>Lymphocytes; radiation effects</document:subject>
<document:subject>T-Lymphocytes; immunology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252231">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Results of and prospects for methods of determination of the frequency of mutant cells for glycophorin A and T-cell receptor loci to estimate long-term genotoxic effect of ionizing radiation]</document:title>
<document:abstractSection>The usage of two methods for assessment of somatic gene mutations for the purpose of biological dosimetry and estimation of consequences of irradiation at long time after the exposure has been discussed. The determination of cells bearing mutated glycophorin A (GPA) locus is a reliable method for biodosimetry at both short and long time after the acute irradiation according to our results and the data of other authors. For prolonged exposure, the GPA-method is less informative than in cases of acute irradiation. The determination of mutant cell frequency at T-cell receptor (TCR) locus may be used only at short time after the irradiation. Meanwhile, the TCR-method is more sensitive and informative for biodosimetry of recent irradiation than the GPA test. The both methods may be used for individual assessment of long-term health consequences after the irradiation, because persons with elevated frequencies of mutant cells may represent a group at high risk in respect to oncological diseases.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A S Saenko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I A Zamulaeva</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Medical Radiological Research Centre, Russian Academy of Medical Sciences, Obninsk, 249020 Russia.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Glycophorin</document:subject>
<document:subject>Receptors, Antigen, T-Cell</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gene Frequency</document:subject>
<document:subject>Glycophorin</document:subject>
<document:subject>Human</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Radiometry</document:subject>
<document:subject>Receptors, Antigen, T-Cell</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Glycophorin; genetics</document:subject>
<document:subject>Receptors, Antigen, T-Cell; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252232">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Potential relationship between mutation process induced by low doses of ionizing radiation, and positional dynamics of chromosomes in nuclei of eukaryotic cells]</document:title>
<document:abstractSection>The mutation process has many stages. The information presented in this article suggest that a cell exposed to low LET radiation in the low-dose range (up to 1 cGy) must almost completely repair all spontaneous and radiation-induced DNA lesions. But reparation of DNA double-stranded breaks (DSB), which are the basis of genome instability has peculiarity. We have shown that the mechanisms of action of low doses (which initiate natural antimutagenic reactions of resting cells--an adaptive response) are associated with chromosome loci (centromere) movement in a cell nucleus. We suggest that the movement of chromosome loci in cell nucleus is the fundamental mechanism for repair of DSB and switching of the transcription of gene (it is known that in case of lymphoid cells Ikaros-complexes repressor is colocolizated with centromere loci); in particular, of nucleolar transcription activities because the latter is dependent on centromere arrangement. Because the movement of chromosome loci in both the mitotic cycle and under adapting dose on resting cells is much the same it could be assumed that in latter case the cells also lose their functional characteristic for differentiated resting cells. Under chronic exposure to low doses the functional changes can be the cause of organic changes if adapting dose affects the sufficient part of the cells. The role of cells of evolutional or ontogenetic reserve in mutation process is considered.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>D M Spitkovskiƒ≠</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I V Kuz'mina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N N Veƒ≠ko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A V Ermakov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F I Ingel'</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A A Makarenkov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N I Pospekhova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A G Salimov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T A Talyzina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A V Karpukhin</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Research Centre for Medical Genetics, Russian Academy of Medical Science, Moscow, 117478 Russia.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Cell Nucleus</document:subject>
<document:subject>Chromosomes</document:subject>
<document:subject>DNA Damage</document:subject>
<document:subject>DNA Repair</document:subject>
<document:subject>Dose-Response Relationship, Radiation</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Eukaryotic Cells</document:subject>
<document:subject>Human</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Cell Nucleus; radiation effects</document:subject>
<document:subject>Cell Nucleus; ultrastructure</document:subject>
<document:subject>Chromosomes; radiation effects</document:subject>
<document:subject>Eukaryotic Cells; radiation effects</document:subject>
<document:subject>Mutation; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252233">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Genetic effects in Drosophila melanogaster induced by chronic low-dose irradiation]</document:title>
<document:abstractSection>It was investigated the influence of the chronic gamma-irradiation in the dose rate of 0.17 sGy/h on the rate of genetic variability in the laboratory strains of Drosophila melanogaster with genotypic distinguishes in mobile genetic elements and defects in the DNA repair processes. It was shown that the rates of induction of recessive lethal mutations depended on genotype of investigated strains. In the different strains we have observed an increase as well as a decrease of the mutation rate. Also in was established that irradiation leads to the frequencies of the GD-sterility and mutability of the snw and h(w+) in the P-M and H-E dysgenic crosses. The obtained results suggest that mobile genetic elements play an important role in the forming of genetic effects in response to low dose irradiation.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V G Zaƒ≠nullin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M V Shaposhnikov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I N Iuraneva</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institute of Biology, Komi Scientific Center, Ural Division of the Russian Academy of Sciences, Syktyvkar, Russia, 167982. zainullin@komisc.ru</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Genetic Markers</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Dose-Response Relationship, Radiation</document:subject>
<document:subject>Drosophila melanogaster</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gamma Rays</document:subject>
<document:subject>Genes, Lethal</document:subject>
<document:subject>Genetic Markers</document:subject>
<document:subject>Interspersed Repetitive Sequences</document:subject>
<document:subject>Drosophila melanogaster; genetics</document:subject>
<document:subject>Genes, Lethal; radiation effects</document:subject>
<document:subject>Interspersed Repetitive Sequences; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130947">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Biology versus engineering: the TMI accident as a case study in problems of dosimetry.</document:title>
<document:abstractSection>Official investigations concluded that no environmental damage was caused by the 1979 accident at the Three Mile Island nuclear generation plant, Unit 2 (TMI). Years later, highly-exposed populations were discovered through investigation of anecdotal information. Absorbed doses in the order of 1 Gy were confirmed by cytogenic and immune status tests.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>N O Aamodt</feature:name>
</feature:Person>
</document:author>
<dc:contributor>MMA@CAPITAL.NET</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Accidents, Radiation</document:subject>
<document:subject>Epidemiologic Studies</document:subject>
<document:subject>Human</document:subject>
<document:subject>Mortality</document:subject>
<document:subject>Nuclear Reactors</document:subject>
<document:subject>Pennsylvania</document:subject>
<document:subject>Public Health</document:subject>
<document:subject>Radiometry</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130948">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Assessment of external dose to inhabitants evacuated from the 30-km zone soon after the Chernobyl accident.</document:title>
<document:abstractSection>According to reports by the former USSR government, IAEA and WHO, no case of acute radiation effects was recognized among inhabitants who were evacuated from the 30-km zone around the Chernobyl site soon after the accident on April 26, 1986. Along with the collapse of the USSR, however, several documents appeared that report the occurrence of acute radiation effects among inhabitants. In order to check the possibility of acute radiation effects among evacuees, we evaluated the external dose of evacuees until their evacuation based on the data about the radiation situation soon after the accident. Our estimates indicate that a substantial number of inhabitants in some villages could have received more than 0.5 Sv that is recognized by ICRP and UNSCEAR as a threshold dose for a clinically significant depression of the blood-forming function of bone marrow. Some of them could have received more than 1 Sv.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>T Imanaka</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H Koide</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Research Reactor Institute, Kyoto University, Kumatori-cho, Osaka 590-0494, Japan. imanaka@rri.kyoto-u.ac.jp</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Accidents, Radiation</document:subject>
<document:subject>Disaster Planning</document:subject>
<document:subject>Gamma Rays</document:subject>
<document:subject>Human</document:subject>
<document:subject>Power Plants</document:subject>
<document:subject>Radiation Injuries</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Ukraine</document:subject>
<document:subject>Radiation Injuries; epidemiology</document:subject>
<document:subject>Ukraine; epidemiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252234">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Results of cytogenetic studies of the consequences of the Chernobyl accident]</document:title>
<document:abstractSection>The selected results of the cytogenetic studies of the Chernobyl accident consequences were summarised. The chromosomal aberrations were used as a method of biodosimetry for a dose assessment for victims during the initial period after the Chernobyl accident. A good correlation between doses calculated based on chromosomal aberrations (dicentrics) and severity of acute radiation syndrome observed in clinic was found. The biodosimetry based on conventional cytogenetic technique (dicentrics) has been unsuccessful for various groups (rehabilitation workers, evacuees, inhabitants of contaminated areas) sampled long time after the Chernobyl accident. The possible reasons of the failure are analysed. The original results of multiaberration cell yield observed in different cohorts of the Chernobyl victims are presented. The problems related to the phenomena are discussed.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A V Sevan'kaev</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Medical Radiological Research Centre Russian Academy of Medical Science, Obninsk, 249036 Russia. mrrc@obninsk.ru</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Accidents, Radiation</document:subject>
<document:subject>Chromosome Aberrations</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Power Plants</document:subject>
<document:subject>Radiation Injuries</document:subject>
<document:subject>Radiometry</document:subject>
<document:subject>Ukraine</document:subject>
<document:subject>Radiation Injuries; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252235">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Cytogenetic studies of blood lymphocytes of cosmonauts after long-ter, space flights]</document:title>
<document:abstractSection>An analysis was performed of unstable chromosomal aberrations in peripheral blood of 36 cosmonauts after long-term space missions on "Mir" orbital station. 25 cosmonauts were examined before their flights to score spontaneous yields of cytogenetical damage. In all cases the doses absorbed by crews during space flights did not exceed permissible levels of irradiation, adopted for cosmonauts. The frequencies of chromosomal-type aberrations after space missions were found to increase significantly compared to the pre-flight levels. The yields of dicentrics and centric rings on the average were as high as 0.12 +/- 0.02 and 0.47 +/- 0.06% before and after the 1st flight, 0.18 +/- 0.05 and 0.71 +/- 0.11% before and after the 2nd flight respectively. During the inter-flight periods, usually lasted 1.5-2 years, the yields of chromosome damage lowered, but did not reach their spontaneous values. After each next flight the yields of chromosome aberrations increased again. The cytogenetical damage detected in cosmonauts' peripheral blood lymphocytes after chronic action of low doses of space radiation points out a possible increase in risks of stochastic effects in distant future for crews after long-term space missions.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>B S Fedorenko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V A Shevchenko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G P Snigireva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S V Druzhinin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L A Repina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N N Novitskaia</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Iu A Akatov</feature:name>
</feature:Person>
</document:author>
<dc:contributor>State Research Centre of Russia-Institute for Biomedical Problems, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Astronauts</document:subject>
<document:subject>Chromosome Aberrations</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Lymphocytes</document:subject>
<document:subject>Male</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Radiation Dosage</document:subject>
<document:subject>Space Flight</document:subject>
<document:subject>Lymphocytes; ultrastructure</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252236">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Mutagenesis in Muridae from regions with increased radiation level]</document:title>
<document:abstractSection>Genetic monitoring of wild populations of mouse-like rodents has been carried out since 1992 in areas with the increased radioactivity in the south of the Bryansk region. The radioactive background ranged from 0.20 to 2.20 mkGy/h. Over 400 rodents of different species have been examined. Bank vole constituted more than a half of the examined animals. The genetic effect of radiation was estimated by the frequency of micronuclei in normochromatic erythrocytes of peripheral blood and by the frequency of abnormal sperm heads. In house mice the frequency of reciprocal translocations and the level of embryo mortality were studied in the progeny of the caught male mice mated with intact laboratory females. The data obtained demonstrate that the yield of induced genetic disorders by all tests was relatively low and only in a few cases the frequency of disturbances tended to increase with an increase in the level of radionuclide contamination in the examined areas.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A V Chekhovich</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M D Pomerantseva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L K Ramaƒ≠ia</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V A Shevchenko</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, 117809 Russia.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Accidents, Radiation</document:subject>
<document:subject>Animal</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Male</document:subject>
<document:subject>Micronucleus Tests</document:subject>
<document:subject>Muridae</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Power Plants</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Spermatozoa</document:subject>
<document:subject>Ukraine</document:subject>
<document:subject>Muridae; genetics</document:subject>
<document:subject>Spermatozoa; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252237">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Radiation-population monitoring of Pinus sylvestris L. in the zone of the Chernobyl power plant]</document:title>
<document:abstractSection>Cytogenetic and genetic effects in populations of Pinus sylvestris L. suffered wiak, average, strong and sublethal radiation damage after the Chernobyl accident in 1986 were studied. The absorbed dozes for trees in these plantings were from 0.1 up to 20 Gy. It was shown that the amount of cells with chromosome aberrations in sprouts of seeds of a crop of 1993, are comparable with effects marked at once after accident in 1986. In 1997 and in 1998 the amount of cells with chromosome aberrations in sprouts of seeds in majority inspected plantings decreased to control values. The effect of adaptation was detected, when seeds of Pinus sylvestris L., gathered in 1997 from inspected trees, were exposed to additional 4 Gy gamma-radiation.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V A Kal'chenko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I S Fedotov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E V Igonina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A V Rubanovich</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V A Shevchenko</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Vavilov Institute of General Genetics, Russian Academy of Science, Moscow, 117809 Russia.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Accidents, Radiation</document:subject>
<document:subject>Chromosome Aberrations</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gymnosperms</document:subject>
<document:subject>Power Plants</document:subject>
<document:subject>Radiation Monitoring</document:subject>
<document:subject>Ukraine</document:subject>
<document:subject>Gymnosperms; genetics</document:subject>
<document:subject>Gymnosperms; radiation effects</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130949">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Genomic instability, bystander effects and radiation risks: implications for development of protection strategies for man and the environment.</document:title>
<document:abstractSection>The last few years has seen what people are now referring to as a "shifting Paradigm" in our way of thinking about radiation effects on biological systems. The concept of the central role of DNA damage due to double strand breaks induced by a radiation "hit" has been itself hit by many studies showing persistent effects in the distant progeny of radiation exposed cells. This phenomenon is known as radiation induced genomic instability. More recently evidence has been accumulating that not even the parent cell need be exposed to radiation (the bystander effect). The new paradigm suggests that cellular stress responses or damage signalling through a range of signal transduction pathways are involved and that cell-cell contact or secretion of damage signalling molecules can induce responses in undamaged and unirradiated cells. Are these new effects relevant to risk assessment, or does it matter HOW radiation affects cells if we have good epidemiological evidence of which to base our risk estimates? The aim of this paper is to introduce the new concepts and to consider reasons why they might alter our methods of risk estimation. The paper also considers the impact of the new concepts on environmental protection and discusses the need for research in the field of comparative radiobiology if we are to develop policies which can adequately protect biodiversity.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C Mothersill</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Seymour</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Radiation and Environmental Science Centre, Dublin Institute of Technology, Ireland. cmothersill@rsc.iol.ie</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>DNA Damage</document:subject>
<document:subject>Human</document:subject>
<document:subject>Radiation Monitoring</document:subject>
<document:subject>Radiation Tolerance</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130950">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Estimation of genetic risks of exposure to ionizing radiation: status in the year 2000.</document:title>
<document:abstractSection>This paper provides an overview of the advances in the estimation of genetic risks of exposure of human populations to ionizing radiation with particular emphasis on the advances during the last decade. Among the latter are: (a) an upward revision of the estimates of the baseline frequencies of Mendelian diseases (from 1.25 to 2.4%); (b) the conceptual change to the use of a doubling dose based on human data on spontaneous mutation rates and mouse data on induced mutation rates (from the one based entirely on mouse data on spontaneous and induced mutation rates, which was the case thus far); (c) the fuller development of the concept of mutation component (MC) and its application to predict the responsiveness of Mendelian and chronic multifactorial diseases to induced mutations; (d) the concept that the major adverse effects of radiation exposure of human germ cells are likely to be manifest as multi-system developmental abnormalities and (e) the concept of potential recoverability correction factor (PRCF) to bridge the gap between induced mutations studied in mice and the risk of genetic disease in humans. For a population exposed to low LET, chronic/low dose-rate irradiation, the current estimates of risk for the first generation progeny are the following (all estimates per million live born progeny per Gy of parental irradiation): autosomal dominant and X-linked diseases, approximately 750 to 1,500 cases; autosomal recessive, nearly zero; chronic multifactorial diseases, approximately 250 to 1,200 cases and congenital abnormalities, approximately 2,000 cases. The total risk per Gy is of the order of approximately 3,000 to 4,700 cases which represent approximately 0.4 to 0.6% of the baseline frequency of these diseases. The main message is that at low doses of radiation of interest in risk estimation, the risk of adverse hereditary effects is small.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>K Sankaranarayanan</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Radiation Genetics and Chemical Mutagenesis Leiden University Medical Centre, The Netherlands. sankaran@rullf2.medfac.leidenuniv.nl</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Disease Susceptibility</document:subject>
<document:subject>Human</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Radiation Tolerance</document:subject>
<document:subject>Risk Assessment</document:subject>
<document:subject>Disease Susceptibility; genetics</document:subject>
<document:subject>Radiation Tolerance; genetics</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11130951">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Exposition of humans to low doses and low dose rate irradiation: an urgent need for new markers and new models.</document:title>
<document:abstractSection>In human radiation protection, the shape of the dose effects curve for low doses irradiation (LDI) is assumed to be linear, extrapolated from the clinical consequences of Hiroshima and Nagasaki nuclear explosions. This extrapolation probably overestimates the risk below 200 mSv. In many circumstances, the living species and cells can develop some mechanisms of adaptation. Classical epidemiological studies will not be able to answer the question and there is a need to assess more sensitive biological markers of the effects of LDI. The researches should be focused on DNA effects (strand breaks), radioinduced expression of new genes and proteins involved in the response to oxidative stress and DNA repair mechanisms. New experimental biomolecular techniques should be developed in parallel with more conventional ones. Such studies would permit to assess new biological markers of radiosensitivity, which could be of great interest in radiation protection and radio-oncology.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>C Chenal</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Legue</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K Nourgalieva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V Brouazin-Jousseaume</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Durel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N Guitton</feature:name>
</feature:Person>
</document:author>
<dc:contributor>University of Rennes 1, Radiobiology Unit/Regional Cancer Center, 35042 Rennes, France. christian.chenal@univ-rennes1.fr</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Dose-Response Relationship, Radiation</document:subject>
<document:subject>Human</document:subject>
<document:subject>Models, Biological</document:subject>
<document:subject>Neoplasms, Radiation-Induced</document:subject>
<document:subject>Risk Assessment</document:subject>
<document:subject>Neoplasms, Radiation-Induced; etiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:9317212">
<dc:coverage>Russia</dc:coverage>
<dc:title>Radiats Biol Radioecol</dc:title>
<med:code>BWZ</med:code>
<med:nlmUniqueID>9317212</med:nlmUniqueID>

<med:issn>0869-8031</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:9317212:40:5">
<med:volume>40</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11252238">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>21</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Current problems of estimation of genetic risk of human exposure to radiation]</document:title>
<document:abstractSection>The methodology of assessing the genetic risk of radiation exposure is based on the concept of "hitting the target" in development of which N.V. Timofeeff-Ressovsky has played and important role. To predict genetic risk posed by irradiation, the UN Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) has worked out direct and indirect methods of assessment, extrapolational, integral and populational criteria of risk analysis that together permit calculating the risk from human exposure on the basis of data obtained for mice. Laboratory mice are the main objects in studying radiation mutagenesis due to the fact that the data on the frequency of radiation-induced human mutations are rather scarce. The method of doubling dose based on the determination of a dose doubling the level of natural mutational process in humans is the main one used to predict the genetic risk. The evolution of views about the genetics risk of human exposure to radiation for last 40 years is considered. Till 1972 the main model for assessing the genetic risk was the "human/mouse" model (the use of data on the spontaneous human variability and data on the frequency of induced mutations in mice). In the period form 1972 till 1994 the "mouse/mouse" model was intensively elaborated in many laboratories. This model was also used in this period by UNSCEAR experts to analyze the genetic risk from human irradiation. Recent achievements associated with the study of the molecular nature of many hereditary human diseases as well as the criticism of number fundamental principles of the "mouse/mouse" model for estimating the genetic risk on a new basis. The estimates of risk for the different classes of genetic diseases have been obtained using the doubling-dose method. The estimate of doubling dose used in the calculations is 1 Gy for low dose/chronic low-LET radiation conditions.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V A Shevchenko</feature:name>
</feature:Person>
</document:author>
<dc:contributor>N.I. Vavilov Institute of General Genetics, Russian Academy of Science, Moscow, 117809 Russia. shevchenko@vigg.ru</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Animal</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Mice</document:subject>
<document:subject>Models, Animal</document:subject>
<document:subject>Mutation</document:subject>
<document:subject>Radiation Injuries</document:subject>
<document:subject>Risk Assessment</document:subject>
<document:subject>Radiation Injuries; etiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076293">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Small cell carcinoma and carcinoids of the lung: morphology of apoptosis and expression of biomolecular markers of tumor growth]</document:title>
<document:abstractSection>Neuroendocrine lung tumors (NELT) from 50 patients were studied immunohistochemically. Malignant carcinoid and small-cell lung carcinoma (SCC) have a higher level of apoptosis than ordinary carcinoid. An increase of apoptosis index in NELT coincides with an increase in NELT proliferative activity (Ki-67, Bcl-2, c-myc, p-53) as compared to a typical carcinoid. Phagocytosis of apoptotic bodies was absent in SCC. Classic SCC differs from combined SCC by a higher apoptosis index and lower expression of p-53 and Bcl-2. Metastatic SCC differs from SCC without metastases by lower apoptosis level and higher level of proliferative indices (Ki-67, Bcl-2) of tumor cells. Development of unbalance between apoptosis and proliferation may result from mitosis and apoptosis pathology.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M A Pal'tsev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S A Demura</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E A Kogan</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G Jack</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B Zende</feature:name>
</feature:Person>
</document:author>
<dc:contributor>I. M. Sechenov Moscow Medical Academy.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Protein p53</document:subject>
<document:subject>Proto-Oncogene Proteins c-bcl-2</document:subject>
<document:subject>Proto-Oncogene Proteins c-myc</document:subject>
<document:subject>Tumor Markers, Biological</document:subject>
<document:subject>Apoptosis</document:subject>
<document:subject>Carcinoid Tumor</document:subject>
<document:subject>Carcinoma, Small Cell</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Lung Neoplasms</document:subject>
<document:subject>Male</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Protein p53</document:subject>
<document:subject>Proto-Oncogene Proteins c-bcl-2</document:subject>
<document:subject>Proto-Oncogene Proteins c-myc</document:subject>
<document:subject>Tumor Markers, Biological</document:subject>
<document:subject>Carcinoid Tumor; metabolism</document:subject>
<document:subject>Carcinoid Tumor; pathology</document:subject>
<document:subject>Carcinoma, Small Cell; metabolism</document:subject>
<document:subject>Carcinoma, Small Cell; pathology</document:subject>
<document:subject>Lung Neoplasms; metabolism</document:subject>
<document:subject>Lung Neoplasms; pathology</document:subject>
<document:subject>Protein p53; biosynthesis</document:subject>
<document:subject>Proto-Oncogene Proteins c-bcl-2; biosynthesis</document:subject>
<document:subject>Proto-Oncogene Proteins c-myc; biosynthesis</document:subject>
<document:subject>Tumor Markers, Biological; biosynthesis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076294">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Ultrastructural phenotypes of tumor cells of endocrine-cellular neoplasms of hepatopancreatoduodenal organs and their role in determining the degree of malignancy and prognosis of these diseases]</document:title>
<document:abstractSection>78 tumors of the hepatopancreoduodenal system were studied clinically, cytologically and ultrastructurally. Hormonal disturbances were observed in 36% of the patients. The 5-year survival after radical surgery did not depend on the tumor size, tumor cell atypia or metastases to the regional lymph nodes. The prognosis was worse when the tumor was located in the liver. Ultrastructural features of the tumor cells were reliable criteria of the malignancy degree and tumor prognosis. The prognosis, recurrence-free interval and survival improve with an increase in the number of ultrastructurally differentiated cells and organoids in cytoplasm, and with a reduction in nuclear polymorphism and number of dark cells. The degree of histologic and ultrastructural differentiation of tumor cells may not coincide.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>N T Raƒ≠khlin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E A Smirnova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Kh V Badalian</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O V Chistiakova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Iu I Patiutko</feature:name>
</feature:Person>
</document:author>
<dc:contributor>N. N. Blokhin Russian Cancer Research Centre, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Aged</document:subject>
<document:subject>Apudoma</document:subject>
<document:subject>Duodenal Neoplasms</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Liver Neoplasms</document:subject>
<document:subject>Male</document:subject>
<document:subject>Microscopy, Electron</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Pancreatic Neoplasms</document:subject>
<document:subject>Prognosis</document:subject>
<document:subject>Apudoma; mortality</document:subject>
<document:subject>Apudoma; pathology</document:subject>
<document:subject>Apudoma; ultrastructure</document:subject>
<document:subject>Duodenal Neoplasms; mortality</document:subject>
<document:subject>Duodenal Neoplasms; pathology</document:subject>
<document:subject>Duodenal Neoplasms; ultrastructure</document:subject>
<document:subject>Liver Neoplasms; mortality</document:subject>
<document:subject>Liver Neoplasms; pathology</document:subject>
<document:subject>Liver Neoplasms; ultrastructure</document:subject>
<document:subject>Pancreatic Neoplasms; mortality</document:subject>
<document:subject>Pancreatic Neoplasms; pathology</document:subject>
<document:subject>Pancreatic Neoplasms; ultrastructure</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076295">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Morphofunctional characteristics of cellular and tissue components of the thyroid gland during its pathology]</document:title>
<document:abstractSection>Surgical material of thyroid with goitre from 79 females aged 25-55 years was investigated. Basing on histological, histochemical and histostereometric evidence as well as correlation analysis it was established that each morphological variant of the thyroid pathology has its own specific pattern of unbalance of the cellular and tissue components.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>E B Tupikina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S A Stepanov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N V Bogomolova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N M Amirova</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Saratov State Medical University.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Cell Count</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Thyroid Diseases</document:subject>
<document:subject>Thyroid Gland</document:subject>
<document:subject>Thyroid Diseases; pathology</document:subject>
<document:subject>Thyroid Gland; pathology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076292">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[The role of immunohistochemical methods for determining the type of treatment and prognosis of tumoral diseases]</document:title>
<document:abstractSection>In the last decade various immunohistochemical markers have been widely used as prognostic indices of tumors, for the most part carcinoma. These include oncogenes and oncoproteins (C-erb B-2, bcl-2), gene-suppressor p53, estrogen and progesterone receptors, proliferation markers (5-brom-2'-deoxyuridine, Ki-67, proliferation cell nuclear antigen-PCNA, cyclins, cyclin dependent kinase inhibitors), the degree of tumor angiogenesis and its modificators, adhesion molecules, factors of invasion and metastasizing. Many of these markers are independent prognostic indices and their immunohistochemical detection may be more informative than their biochemical and even molecular-biological identification. Wide use of immunohistochemistry in practical oncology makes clinical pathologist an active participant in diagnosis and treatment of tumors.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>K M Pozharisskiƒ≠</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E E Leenman</feature:name>
</feature:Person>
</document:author>
<dc:language>rus</dc:language>
<document:subject>Tumor Markers, Biological</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Immunohistochemistry</document:subject>
<document:subject>Neoplasms</document:subject>
<document:subject>Prognosis</document:subject>
<document:subject>Tumor Markers, Biological</document:subject>
<document:subject>Neoplasms; metabolism</document:subject>
<document:subject>Neoplasms; pathology</document:subject>
<document:subject>Neoplasms; therapy</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076296">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Cytomorphological differentiation diagnosis and evaluation of p53mut, bcl-2, CD95 in peripheral B-cell small cell lymphomas]</document:title>
<document:abstractSection>Basing on the analysis of the cytological evidence, the authors suggest criteria for differential diagnosis of peripheral small-cell B-cell lymphomas including position of the tumor cells in cytological preparations and cell composition of the tumor. A high level of p53mut and bcl-2 expression in centrofollicular lymphomas and lymphomas originating from small lymphocytes may serve an additional criterion in differential diagnosis with reactive changes in the lymph nodes.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A M Kovrigina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E Iu Lysiuk</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V M Bogatyrev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N A Probatova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E N Sholokhova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I V Poddubnaia</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Z V Takhaev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A Iu Baryshnikov</feature:name>
</feature:Person>
</document:author>
<dc:contributor>N. N. Blokhin Russian Cancer Research Centre, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Antigens, CD95</document:subject>
<document:subject>Protein p53</document:subject>
<document:subject>Proto-Oncogene Proteins c-bcl-2</document:subject>
<document:subject>Tumor Markers, Biological</document:subject>
<document:subject>Antigens, CD95</document:subject>
<document:subject>Diagnosis, Differential</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Lymphoma, B-Cell</document:subject>
<document:subject>Lymphoma, Small-Cell</document:subject>
<document:subject>Protein p53</document:subject>
<document:subject>Proto-Oncogene Proteins c-bcl-2</document:subject>
<document:subject>Tumor Markers, Biological</document:subject>
<document:subject>Antigens, CD95; analysis</document:subject>
<document:subject>Lymphoma, B-Cell; metabolism</document:subject>
<document:subject>Lymphoma, B-Cell; pathology</document:subject>
<document:subject>Lymphoma, Small-Cell; metabolism</document:subject>
<document:subject>Lymphoma, Small-Cell; pathology</document:subject>
<document:subject>Protein p53; analysis</document:subject>
<document:subject>Proto-Oncogene Proteins c-bcl-2; analysis</document:subject>
<document:subject>Tumor Markers, Biological; analysis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076297">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Morphological manifestations of large cell anaplastic Ki1(CD30)-positive lymphoma in children]</document:title>
<document:abstractSection>Classic morphological and lymphohistiocytic variant were found in 46 and 2 cases, respectively, of 49 LCAL cases studied pathohistologically. One patient had a variant with a predominance of small tumor cells. Ultrastructurally, cells with feature of histiocytic and lymphoid differentiation and undifferentiated cells in various proportions were observed.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A I Pavlovskaia</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N A Probatova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E A Smirnova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E N Sholokhova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N N Tupitsyn</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I A Bukaeva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A I Slugin</feature:name>
</feature:Person>
</document:author>
<dc:contributor>N. N. Blokhin Russian Cancer Research Centre, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Antigens, CD30</document:subject>
<document:subject>Adolescence</document:subject>
<document:subject>Antigens, CD30</document:subject>
<document:subject>Child</document:subject>
<document:subject>Child, Preschool</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Infant</document:subject>
<document:subject>Lymphoma, Large-Cell, Ki-1</document:subject>
<document:subject>Male</document:subject>
<document:subject>Microscopy, Electron</document:subject>
<document:subject>Antigens, CD30; analysis</document:subject>
<document:subject>Lymphoma, Large-Cell, Ki-1; pathology</document:subject>
<document:subject>Lymphoma, Large-Cell, Ki-1; ultrastructure</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076298">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Ultrastructure of the thymus after gamma irradiation during inhibition of steroidogenesis]</document:title>
<document:abstractSection>Experimental investigations on rats have shown that development of dyshormonal immunodepression after ionizing radiation in sublethal doses depends on indirect effect of corticosteroids. Inhibition of steroidogenesis corrects ultrastructural lesions of the thymus after gamma irradiation.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V V Popuchiev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N D Iakovleva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>K Kita</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L N Kotlova</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I M Kvetnoƒ≠</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Medical Radiological Research Center, Obninsk.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Glucocorticoids</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:54-36-4">
<cas:registryNumber>54-36-4</cas:registryNumber>
<cas:name>Metyrapone</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gamma Rays</document:subject>
<document:subject>Glucocorticoids</document:subject>
<document:subject>Male</document:subject>
<document:subject>Metyrapone</document:subject>
<document:subject>Microscopy, Electron</document:subject>
<document:subject>Rats</document:subject>
<document:subject>Rats, Wistar</document:subject>
<document:subject>Thymus Gland</document:subject>
<document:subject>Glucocorticoids; antagonists &amp; inhibitors</document:subject>
<document:subject>Metyrapone; pharmacology</document:subject>
<document:subject>Thymus Gland; metabolism</document:subject>
<document:subject>Thymus Gland; radiation effects</document:subject>
<document:subject>Thymus Gland; ultrastructure</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076299">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Algorithm of immunomorphological criteria of diagnosis of gastric mucosa dysplasias and early cancer in stomach biopsies]</document:title>
<document:abstractSection>Indices of systemic and local immunity of gastric mucosa were studied in patients with chronic gastritis (n = 27), epithelial dysplasia of gastric mucosa (n = 13), early gastric carcinoma (n = 9) and advanced gastric carcinoma (n = 6). Local immunity was estimated by calculation of lymphocytes and plasma cells expressing IgA and IgM in the epithelium of stomach mucosa. Systemic immunity was studied by radial diffusion according to Manchini's method. This approach provides objectivization of morphological results, particularly in endoscopic biopsies, and therefore to improvement of the patient examination and diagnosis of early cancer.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>O K Khmel'nitskiƒ≠</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B V Sarantsev</feature:name>
</feature:Person>
</document:author>
<dc:contributor>St-Petersburg Medical Academy of Postgraduate Education.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Algorithms</document:subject>
<document:subject>Antibody Formation</document:subject>
<document:subject>Biopsy</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Gastric Mucosa</document:subject>
<document:subject>Human</document:subject>
<document:subject>Immunity, Cellular</document:subject>
<document:subject>Precancerous Conditions</document:subject>
<document:subject>Prognosis</document:subject>
<document:subject>Stomach Neoplasms</document:subject>
<document:subject>Gastric Mucosa; immunology</document:subject>
<document:subject>Gastric Mucosa; pathology</document:subject>
<document:subject>Precancerous Conditions; immunology</document:subject>
<document:subject>Precancerous Conditions; pathology</document:subject>
<document:subject>Stomach Neoplasms; immunology</document:subject>
<document:subject>Stomach Neoplasms; mortality</document:subject>
<document:subject>Stomach Neoplasms; pathology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076300">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Eccrine mucinous adenocarcinoma]</document:title>
<document:abstractSection>A case of a rare malignant tumour of the sweat glands is reported. Such tumors are often taken for visceral adenocarcinoma metastasis. The tumor was diagnosed by means of immunohistochemistry.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>Iu V Sergeev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V A Molochkov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G A Galil-Ogly</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A M Bershchanskaia</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O V Paklina</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Medical Center of the President Administration, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Adenocarcinoma, Mucinous</document:subject>
<document:subject>Aged</document:subject>
<document:subject>Case Report</document:subject>
<document:subject>Eccrine Glands</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Male</document:subject>
<document:subject>Sweat Gland Neoplasms</document:subject>
<document:subject>Adenocarcinoma, Mucinous; pathology</document:subject>
<document:subject>Eccrine Glands; pathology</document:subject>
<document:subject>Sweat Gland Neoplasms; pathology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076301">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Malignant cylindroma]</document:title>
<document:abstractSection>A case of malignant eccrine cylindroma of the skin studied immunohistochemically is reported.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>Iu V Sergeev</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V A Molochkov</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O V Paklina</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A M Bershchanskaia</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Medical Centre of President Administration, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Carcinoma, Adenoid Cystic</document:subject>
<document:subject>Case Report</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Male</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Neoplasm Invasiveness</document:subject>
<document:subject>Skin Neoplasms</document:subject>
<document:subject>Carcinoma, Adenoid Cystic; pathology</document:subject>
<document:subject>Carcinoma, Adenoid Cystic; surgery</document:subject>
<document:subject>Skin Neoplasms; pathology</document:subject>
<document:subject>Skin Neoplasms; surgery</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076302">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Spitz's nevus: differential diagnosis with malignant skin melanoma]</document:title>
<document:abstractSection>Spitz's nevus is one of the most frequent simulators of malignant melanoma of the skin. Histological features of this nevus and differential diagnosis with so-called melanoma with minimum deviation are discussed.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V V Mordovtseva</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A M Vavilov</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Central Research Dermatovenerological Institute, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Diagnosis, Differential</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Melanoma</document:subject>
<document:subject>Nevus, Epithelioid and Spindle Cell</document:subject>
<document:subject>Skin Neoplasms</document:subject>
<document:subject>Melanoma; pathology</document:subject>
<document:subject>Nevus, Epithelioid and Spindle Cell; pathology</document:subject>
<document:subject>Skin Neoplasms; pathology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076303">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Microphotography: some peculiarities of microphotography using black-and-white and color reversible films]</document:title>
<document:abstractSection>Three aspects of microphotography are considered: 1) taking pictures on black and white film with maximum contrast; 2) taking pictures of thick slides; 3) taking pictures of weakly coloured objects on black and white and colored reversible films.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M K Magomedov</feature:name>
</feature:Person>
</document:author>
<dc:contributor>War Veterans Hospital, Moscow.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>English Abstract</document:subject>
<document:subject>Photography</document:subject>
<document:subject>Photography; instrumentation</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0370604">
<dc:coverage>RUSSIA</dc:coverage>
<dc:title>Arkh Patol</dc:title>
<med:code>8OE</med:code>
<med:nlmUniqueID>0370604</med:nlmUniqueID>

<med:issn>0004-1955</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0370604:62:5">
<med:volume>62</med:volume>
<med:issue>5</med:issue>
<med:publicationDate>2000 Sep-Oct</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11076304">
<med:creationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>12</date:month>
<date:day>06</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Autopsy: problems and approaches to their solving]</document:title>
<document:abstractSection>Further upgrading of pathology expertise should be based on scientific legitimate grounds with creation of national and regional consulting and controlling centres, cost-effect standards of pathology diagnosis and expertise.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>V L Kovalenko</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L S Khodasevich</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Chelyabinsk Regional Bureau of Pathology.</dc:contributor>
<dc:language>rus</dc:language>
<document:subject>Autopsy</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Autopsy; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244631">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Emergency hormonal contraception in France in 2000]</document:title>
<document:author>
<feature:Person>
<feature:name>E Aub√©ny</feature:name>
</feature:Person>
</document:author>
<dc:language>fre</dc:language>
<document:subject>Contraceptives, Postcoital</document:subject>
<document:subject>Estrogens, Synthetic</document:subject>
<document:subject>Progestational Hormones, Synthetic</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:57-63-6">
<cas:registryNumber>57-63-6</cas:registryNumber>
<cas:name>Ethinyl Estradiol</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:797-63-7">
<cas:registryNumber>797-63-7</cas:registryNumber>
<cas:name>Levonorgestrel</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Contraceptives, Postcoital</document:subject>
<document:subject>Estrogens, Synthetic</document:subject>
<document:subject>Ethinyl Estradiol</document:subject>
<document:subject>Female</document:subject>
<document:subject>France</document:subject>
<document:subject>Human</document:subject>
<document:subject>Levonorgestrel</document:subject>
<document:subject>Progestational Hormones, Synthetic</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244632">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Postpartum hemorrhage: treatment by embolization]</document:title>
<document:author>
<feature:Person>
<feature:name>J F Deux</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Bazot</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N Berkane</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Maillet</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Boudgh√®ne</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Uzan</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de radiologie, h√¥pital Tenon, 4, rue de la Chine, 75970 Paris, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Embolization, Therapeutic</document:subject>
<document:subject>Emergency Treatment</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Postpartum Hemorrhage</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Embolization, Therapeutic; adverse effects</document:subject>
<document:subject>Postpartum Hemorrhage; epidemiology</document:subject>
<document:subject>Postpartum Hemorrhage; etiology</document:subject>
<document:subject>Postpartum Hemorrhage; therapy</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244633">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Umbilical cutaneous metastasis (or Sister Mary Joseph's nodule) disclosing an ovarian adenocarcinoma]</document:title>
<document:abstractSection>In this study, the case is described of an umbilical metastasis as the presenting symptom of an ovarian adenosarcoma. The overall frequency of cutaneous metastases has been estimated at between 5 and 9%. Umbilical metastases are a rare occurrence: it is estimated that between 1 and 3% of patients with abdomino-pelvic disease present with an umbilical nodule. Epidemiological studies have shown the female predominance of this disease. The clinical characteristics of umbilical metastases cannot be visually distinguished from those of primary lesions. The clinical appearance is often that of a nodule of varying size, more or less painful, and sometimes ulcerated or suppurating as in the present case. The nodule may be indicative of cancer, or of cancer recurrence. The most frequently encountered histological type is adenocarcinoma (about 75% of cases), and is more rarely epidermoid, undifferentiated, or carcinoid. Etiological findings have indicated a digestive origin in over 55% of cases (stomach, colon, rectum, pancreas, in decreasing order of frequency), with a clear male predominance; cancers of gynecological origin are the second most frequent etiology, with ovarian cancers being the most common (34% of cases). Sister Mary Joseph nodule accounts for 60% of all malignant umbilical tumors (primary or secondary), and is usually associated with a poor prognosis (mean survival: 10-12 months). However, patient survival time could be lengthened by aggressive therapy, i.e., surgery combined with chemotherapy.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J P Touraud</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>N Lentz</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>Y Dutronc</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E Mercier</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Sagot</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Lambert</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de dermatologie, h√¥pital du Bocage, centre hospitalier universitaire, 2, boulevard Mar√©chal-de-Lattre-de-Tassigny, 21034 Dijon, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Adenocarcinoma</document:subject>
<document:subject>Aged</document:subject>
<document:subject>Case Report</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Ovarian Neoplasms</document:subject>
<document:subject>Skin Neoplasms</document:subject>
<document:subject>Umbilicus</document:subject>
<document:subject>Adenocarcinoma; diagnosis</document:subject>
<document:subject>Adenocarcinoma; secondary</document:subject>
<document:subject>Adenocarcinoma; therapy</document:subject>
<document:subject>Ovarian Neoplasms; diagnosis</document:subject>
<document:subject>Ovarian Neoplasms; therapy</document:subject>
<document:subject>Skin Neoplasms; secondary</document:subject>
<document:subject>Skin Neoplasms; therapy</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244634">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Human papillomavirus typing in routine cervical smears. Results from a series of 3778 patients]</document:title>
<document:abstractSection>AIM: As human papillomavirus (HPV) infection is a significant risk factor for cervical cancer, the aim of this study was to assess the efficacy of HPV detection techniques in predicting the presence or the development of a high-grade squamous intra epithelial lesion. Additional reasons for carrying out this investigation were as follows. It was considered that the clinical value of HPV typing may have been underestimated in certain previous reports, which based their findings on first-generation assays. Moreover, until the present investigation most studies only investigated the cases with abnormal smear findings and did not include long-term follow-up, nor detailed follow-up of women with a normal smear but positive HPV typing, although this patient subgroup is of particular interest. The patient population included 3778 women who underwent routine cytological cervical screening and who gave their informed consent to participate in this study, consisting of a cervical smear, HPV testing via a second-generation Hybrid Capture II assay (which is more sensitive than first-generation tests, and can detect 18 different HPV types, i.e., 13 oncogenic and five non-oncogenic types); and in the case of abnormal smear findings, colposcopic examination and directed biopsies of the sites of suspected lesions. The women with cytomorphologically normal cervical smears but which who HPV-positive were reexamined six months later. RESULTS: HPV findings were positive in 66 cases where the initial smear indicated the presence of a high-grade lesion with the diagnosis confirmed by biopsy in 65 cases; in 155 cases (76.1%) where the initial smear indicated the presence of a low-grade lesion; in 44 (57.1%) out of 77 smears indicating the presence of ASCUS-type (atypical squamous cells of undetermined significance) lesions; and in 366 cases (10.5%) of apparently normal initial smears. After colposcopy and follow-up, a final diagnosis of high-grade lesion was made for 85 patients. All these patients were found to have high-risk (oncogene-positive) HPV at the first examination, but in only 65 cases (76.5%) was the initial smear indicative of a high-grade lesion. Finally, in the patient groups with low-grade or ASCUS-type smear findings or with an apparently normal smear, a high-grade lesion was only found in those patients with persistent high-risk HPV infection. In all, the sensitivity of the Hybrid Capture II assay in detecting high-grade lesions was 100% versus 85.9% for standard cytology. However, its specificity (86.3%) and positive predictive value were not as high as the latter. CONCLUSION: The results of this study indicate that HPV typing via this second-generation assay displays good sensitivity for the detection of at-risk cases, i.e., those involving the presence or development of high-grade cervical lesions. However, a number of issues have to be addressed before HPV typing is adopted in clinical practice, such as the fairly high HPV prevalence in women aged over 60 years, and whether the implications of this are the same as for younger age groups. Also, the present cost of complete typing remains too high for it to be used on a widespread scale. Nevertheless, HPV typing may have a useful role to play in the detection of cervical cancer.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M Levert</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Clavel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O Graesslin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M Masure</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Birembaut</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Quereux</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R Gabriel</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de gyn√©cologie obst√©trique, CHU de Reims, 51092 Reims, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>DNA, Viral</document:subject>
<document:subject>Adult</document:subject>
<document:subject>Cervix Diseases</document:subject>
<document:subject>Cervix Neoplasms</document:subject>
<document:subject>Colposcopy</document:subject>
<document:subject>DNA, Viral</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Papillomavirus, Human</document:subject>
<document:subject>Papovaviridae Infections</document:subject>
<document:subject>Risk Factors</document:subject>
<document:subject>Sensitivity and Specificity</document:subject>
<document:subject>Tumor Virus Infections</document:subject>
<document:subject>Vaginal Smears</document:subject>
<document:subject>Cervix Diseases; pathology</document:subject>
<document:subject>Cervix Diseases; virology</document:subject>
<document:subject>Cervix Neoplasms; pathology</document:subject>
<document:subject>Cervix Neoplasms; virology</document:subject>
<document:subject>DNA, Viral; analysis</document:subject>
<document:subject>Papillomavirus, Human; classification</document:subject>
<document:subject>Papillomavirus, Human; genetics</document:subject>
<document:subject>Papillomavirus, Human; isolation &amp; purification</document:subject>
<document:subject>Papovaviridae Infections; diagnosis</document:subject>
<document:subject>Papovaviridae Infections; epidemiology</document:subject>
<document:subject>Tumor Virus Infections; diagnosis</document:subject>
<document:subject>Tumor Virus Infections; epidemiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244635">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Fetal arrhythmias: diagnosis, prognosis, treatment; apropos of 33 cases]</document:title>
<document:abstractSection>From October 1993 to February 1998, 33 cases of fetal cardiac arrhythmia were investigated by doppler-echocardiography at the Lille infantile and congenital cardiology department. Extrasystolic arrhythmias were the most frequently encountered disorder (25 fetuses, i.e., 76% of cases: 24 instances of extrasystolic auricular arrhythmia and one case of extrasystolic ventricular arrhythmia). They were invariably benign, and apart from one case only required standard monitoring. Tachycardia was observed in 15% of cases (three cases of supraventricular tachycardia [SVT] and two cases of auricular flutter [AF]). In no instance was a cardiopathic syndrome noted. A number of efficient treatments have been described, but the prognosis is often poor in the presence of hydrops fetalis. Direct fetal treatments (cordocentesis) are currently under evaluation, and at present can only be used as a last resort. In our series, one fetus died 15 minutes after transplacental Flecaine (flecainide) administration. Two of the three SVT and the two AF cases were successfully treated. Bradycardia, which was unassociated with extrasystolic arrhythmia, was found in 9% of cases. It is concluded that Flecaine is probably the treatment of choice for supraventricular and ventricular fetal tachycardia, as it has no teratogenic effect and crosses the placenta at a fetal concentration that is 80% of the maternal level. However, the administration of this drug is not without risk. It is known to possess certain negative side effects, and its pharmacological profile and maternal and fetal health risks have not yet been fully investigated. At present, no entirely safe and efficient treatment for fetal cardiac arrhythmia has been found.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S Vautier-Rit</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Dufour</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G Vaksmann</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Subtil</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Vaast</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A S Valat</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J P Dubos</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Puech</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Clinique de gyn√©cologie-obst√©trique-n√©onatologie, h√¥pital Jeanne-de-Flandre, 59037 Lille, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Anti-Arrhythmia Agents</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:54143-55-4">
<cas:registryNumber>54143-55-4</cas:registryNumber>
<cas:name>Flecainide</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Anti-Arrhythmia Agents</document:subject>
<document:subject>Arrhythmia</document:subject>
<document:subject>Bradycardia</document:subject>
<document:subject>Cardiac Complexes, Premature</document:subject>
<document:subject>Echocardiography, Doppler</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Fetal Diseases</document:subject>
<document:subject>Flecainide</document:subject>
<document:subject>Human</document:subject>
<document:subject>Hydrops Fetalis</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Prognosis</document:subject>
<document:subject>Retrospective Studies</document:subject>
<document:subject>Tachycardia</document:subject>
<document:subject>Anti-Arrhythmia Agents; administration &amp; dosage</document:subject>
<document:subject>Anti-Arrhythmia Agents; adverse effects</document:subject>
<document:subject>Anti-Arrhythmia Agents; therapeutic use</document:subject>
<document:subject>Arrhythmia; diagnosis</document:subject>
<document:subject>Arrhythmia; therapy</document:subject>
<document:subject>Bradycardia; diagnosis</document:subject>
<document:subject>Bradycardia; therapy</document:subject>
<document:subject>Cardiac Complexes, Premature; diagnosis</document:subject>
<document:subject>Cardiac Complexes, Premature; therapy</document:subject>
<document:subject>Fetal Diseases; diagnosis</document:subject>
<document:subject>Fetal Diseases; therapy</document:subject>
<document:subject>Flecainide; administration &amp; dosage</document:subject>
<document:subject>Flecainide; adverse effects</document:subject>
<document:subject>Flecainide; therapeutic use</document:subject>
<document:subject>Hydrops Fetalis; complications</document:subject>
<document:subject>Tachycardia; diagnosis</document:subject>
<document:subject>Tachycardia; therapy</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244636">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Role of luteinizing hormone in follicular and corpus luteum physiology]</document:title>
<document:abstractSection>Luteinizing hormone (LH) is an hypophyseal glycoprotein involved in both follicular maturation and corpus luteum function. During the follicular phase, effects of LH must be considered according to the stages of follicular development: in the early follicular phase, LH acts through specific receptors, constitutively present on thecal cells, for stimulating androgen production. Androgens seem to be positively involved in the folliculogenesis in primates. Indeed, a positive correlation has been recently established between androgen receptor expression and follicular cell proliferation. Furthermore, androgens are active through a conversion to estrogens in granulosa cells. Estrogens are needed for achieving pregnancy. Thus, a question remains: what in the minimal amount of endogenous LH required for an optimal production of oestradiol? Several models have been investigated in clinical situations with hypogonadotrophic hypogonadism: WHO type I anovulation or GnRH analog-induced hypogonadisms. A large majority of these studies conclude that the minimal amount of LH needed during the follicular phase is probably low (&lt; 1.5 IU/L of plasma LH level). Recent availability of GnRH antagonist will give a new opportunity for evaluating this minimal LH threshold. During the late follicular phase, LH plays a biphasic role, with a positive effect on steroidogenesis but a negative effect on cell proliferation. As suggested by S. Hillier, this negative effect on cell proliferation may be relevant to control the rate of follicular growth. One study, performed in WHO type I anovulatory patients, seems to confirm this assumption but further evaluation is needed to give support to this concept. Finally, LH is also involved in corpus luteum function. Due to the short half-life of LH as compared to hCG, the role of LH must be evaluated according to the adjunct therapies. For example, following a long-term GnRH aganist administration that constantly induces a profound hypophyseal desensitization, LH administration must be repeated to adequately sustain the corpus luteum function. This conclusion must be reconsidered with the recent introduction of GnRH antagonists. Indeed, according to their short-term effects on LH secretion, it may be presumed that a single injection of LH may be effective to maintain an adequate corpus luteum function.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J N Hugues</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I Cedrin-Durnerin</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de m√©decine de la reproduction, h√¥pital Jean-Verdier, 93143 Bondy, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9002-67-9">
<cas:registryNumber>9002-67-9</cas:registryNumber>
<cas:name>LH</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Corpus Luteum</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Follicular Phase</document:subject>
<document:subject>Human</document:subject>
<document:subject>LH</document:subject>
<document:subject>Luteal Phase</document:subject>
<document:subject>Macaca mulatta</document:subject>
<document:subject>Ovarian Follicle</document:subject>
<document:subject>Corpus Luteum; physiology</document:subject>
<document:subject>LH; physiology</document:subject>
<document:subject>Ovarian Follicle; physiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244637">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Effects of hormone replacement therapy for menopause on prognostic factors of breast cancer]</document:title>
<document:abstractSection>AIM: Hormone replacement therapy (HRT) is widely used by post-menopausal women. Although this treatment may slightly increase the incidence of breast cancer, more and more cases are diagnosed while women are taking HRT. The purpose of this study was to ascertain the influence of HRT on prognostic factors and outcome of breast cancer. Data on all breast cancer patients, including precise information on HRT, was prospectively and systematically recorded in a data base. PATIENTS AND METHODS: From 1990 to 1998, 1223 post-menopausal women fulfilled the eligibility criteria for this study. The clinical features, laboratory findings and survival rates in 245 HRT users who developed breast cancer while being treated were compared with those of 245 matched breast cancer patients who had never received HRT. RESULTS: Patients who developed breast cancer during HRT had fewer locally advanced cancers and smaller and better-differentiated cancers. Estradiol receptivity was quantitatively lower in users. Metastasis-free survival were better for the users. CONCLUSION: We conclude that HRT does not affect the prognosis of breast cancer. Regular surveillance during HRT allows early detection of smaller lesions. The higher number of well-differentiated cancers and the distribution of hormone receptivity may reflect interaction between neoplastic tissue and exogenous hormones.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>P Bonnier</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R Sakr</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F Bessenay</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Lejeune</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Charpin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P M Martin</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Piana</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de gyn√©cologie obst√©trique A, h√¥pital de la Conception, 147, boulevard Braille, 13385 Marseille, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Receptors, Estradiol</document:subject>
<document:subject>Adult</document:subject>
<document:subject>Aged</document:subject>
<document:subject>Breast Neoplasms</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hormone Replacement Therapy</document:subject>
<document:subject>Human</document:subject>
<document:subject>Menopause</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Neoplasm Metastasis</document:subject>
<document:subject>Prognosis</document:subject>
<document:subject>Receptors, Estradiol</document:subject>
<document:subject>Survival Rate</document:subject>
<document:subject>Breast Neoplasms; chemistry</document:subject>
<document:subject>Breast Neoplasms; epidemiology</document:subject>
<document:subject>Breast Neoplasms; pathology</document:subject>
<document:subject>Hormone Replacement Therapy; adverse effects</document:subject>
<document:subject>Receptors, Estradiol; analysis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244638">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[The First World War and venereal disease morbidity. I. The amplitude of the plague]</document:title>
<document:author>
<feature:Person>
<feature:name>P Darmon</feature:name>
</feature:Person>
</document:author>
<dc:language>fre</dc:language>
<document:subject>Disease Outbreaks</document:subject>
<document:subject>Female</document:subject>
<document:subject>France</document:subject>
<document:subject>History of Medicine, 20th Cent.</document:subject>
<document:subject>Human</document:subject>
<document:subject>Male</document:subject>
<document:subject>Prostitution</document:subject>
<document:subject>Sexually Transmitted Diseases</document:subject>
<document:subject>War</document:subject>
<document:subject>Disease Outbreaks; history</document:subject>
<document:subject>France; epidemiology</document:subject>
<document:subject>Prostitution; history</document:subject>
<document:subject>Sexually Transmitted Diseases; epidemiology</document:subject>
<document:subject>Sexually Transmitted Diseases; history</document:subject>
<document:subject>Sexually Transmitted Diseases; transmission</document:subject>
<document:subject>War; history</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244639">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Analogues agonists and antagonists: what is their role outside of fertilization in vitro?]</document:title>
<document:author>
<feature:Person>
<feature:name>J M Antoine</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Merviel</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Alvarez</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Mandelbaum</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Salat-Baroux</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Uzan</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de gyn√©cologie-obst√©trique et m√©decine de la reproduction, h√¥pital Tenon, 4, rue de la Chine, 75020 Paris, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:33515-09-2">
<cas:registryNumber>33515-09-2</cas:registryNumber>
<cas:name>Gonadorelin</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:9002-67-9">
<cas:registryNumber>9002-67-9</cas:registryNumber>
<cas:name>LH</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Abortion, Spontaneous</document:subject>
<document:subject>Female</document:subject>
<document:subject>Fertilization in Vitro</document:subject>
<document:subject>Gonadorelin</document:subject>
<document:subject>Human</document:subject>
<document:subject>LH</document:subject>
<document:subject>Ovarian Hyperstimulation Syndrome</document:subject>
<document:subject>Ovulation Induction</document:subject>
<document:subject>Abortion, Spontaneous; prevention &amp; control</document:subject>
<document:subject>Gonadorelin; agonists</document:subject>
<document:subject>Gonadorelin; analogs &amp; derivatives</document:subject>
<document:subject>Gonadorelin; antagonists &amp; inhibitors</document:subject>
<document:subject>LH; blood</document:subject>
<document:subject>Ovarian Hyperstimulation Syndrome; prevention &amp; control</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244640">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Thin layer cytology of the cervix uteri]</document:title>
<document:author>
<feature:Person>
<feature:name>C Bergeron</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Laboratoire Pasteur-Cerba, 95066 Cergy-Pontoise, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Cervix Neoplasms</document:subject>
<document:subject>Cervix Uteri</document:subject>
<document:subject>Comparative Study</document:subject>
<document:subject>Cytodiagnosis</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Vaginal Smears</document:subject>
<document:subject>Cervix Neoplasms; diagnosis</document:subject>
<document:subject>Cervix Neoplasms; pathology</document:subject>
<document:subject>Cervix Uteri; pathology</document:subject>
<document:subject>Cytodiagnosis; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244641">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Controversy: systemic amniocentesis for women 38 years and more? Is it still lawful to recommend amniocentesis with the sole criterion being maternal age of 38 years or more?]</document:title>
<document:author>
<feature:Person>
<feature:name>J P Bernard</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Centre hospitalier intercommunal de Poissy, St-Germain-en-Laye, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Amniocentesis</document:subject>
<document:subject>Chromosome Aberrations</document:subject>
<document:subject>Down Syndrome</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Labor, Premature</document:subject>
<document:subject>Maternal Age 35 and over</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Neck</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Risk Factors</document:subject>
<document:subject>Amniocentesis; adverse effects</document:subject>
<document:subject>Down Syndrome; diagnosis</document:subject>
<document:subject>Labor, Premature; etiology</document:subject>
<document:subject>Neck; embryology</document:subject>
<document:subject>Neck; ultrasonography</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100936305">
<dc:coverage>France</dc:coverage>
<dc:title>Gynecol Obstet Fertil</dc:title>
<med:code>DLB</med:code>
<med:nlmUniqueID>100936305</med:nlmUniqueID>

<med:issn>1297-9589</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100936305:28:10">
<med:volume>28</med:volume>
<med:issue>10</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Oct</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11270348">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>27</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Controversy: systemic amniocentesis for women 38 years and more? Is it not premature to no longer accept performing amniocentesis on a patient age 38 years or more?]</document:title>
<document:author>
<feature:Person>
<feature:name>P Sagot</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de gyn√©cologie-obst√©trique, m√©decine foetale et de la reproduction, Dijon, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Amniocentesis</document:subject>
<document:subject>Chromosome Aberrations</document:subject>
<document:subject>Down Syndrome</document:subject>
<document:subject>Female</document:subject>
<document:subject>Human</document:subject>
<document:subject>Maternal Age 35 and over</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Risk Factors</document:subject>
<document:subject>Amniocentesis; adverse effects</document:subject>
<document:subject>Down Syndrome; diagnosis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100955112">
<dc:coverage>Germany</dc:coverage>
<dc:title>J Vet Med A Physiol Pathol Clin Med</dc:title>
<med:code>DO7</med:code>
<med:nlmUniqueID>100955112</med:nlmUniqueID>

<med:issn>0931-184X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100955112:47:9">
<med:volume>47</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11246480">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Acceptance and digestibility of some selected browse feeds with varying tannin content as supplements in sheep nutrition in west Africa.</document:title>
<document:abstractSection>In 1994 and 1995 leaves from 10 selected West African trees and shrubs with varying tannin content were tested to determine their suitability as an alternative and supplementary browse feed for West African dwarf sheep to improve productivity in small-scale holdings in Benin. Dry matter intake per kg metabolic body weight (DM g/kg W0.75) varied between the different browse feeds and between the different trials and ranged from zero (Leucaena leucocephala) up to 26.7 DM g/kg W0.75 (Margaritaria discoidea). The digestibility of the organic matter varied between 58.9% (L. leucocephala) and 68.2% (Mallotus oppositifolius). Agelaea obliqua showed the highest levels of total phenols (10.2%), tannin phenols (8.8%) and extractable condensed tannins (8.0%). Leaves from various browse feeds are a good and protein-rich supplementary fodder in addition to the grass Panicum maximum. However, feeding of A. obliqua and Cnestis ferruginea should be avoided due to toxic components.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>A Aschfalk</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H Steingass</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>W M√ºller</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>W Drochner</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institute of Animal Nutrition Hohenheim University, Stuttgart and Institute of Animal Hygiene and Environmental Protection, The Free University of Berlin, Berlin, Germany. Ansgar.Aschfalk@veths.no</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Tannic Acid</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Animal Feed</document:subject>
<document:subject>Animal Nutrition</document:subject>
<document:subject>Benin</document:subject>
<document:subject>Digestion</document:subject>
<document:subject>Grasses</document:subject>
<document:subject>Plant Leaves</document:subject>
<document:subject>Sheep</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Tannic Acid</document:subject>
<document:subject>Weight Gain</document:subject>
<document:subject>Grasses; chemistry</document:subject>
<document:subject>Plant Leaves; chemistry</document:subject>
<document:subject>Sheep; metabolism</document:subject>
<document:subject>Tannic Acid; analysis</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100955112">
<dc:coverage>Germany</dc:coverage>
<dc:title>J Vet Med A Physiol Pathol Clin Med</dc:title>
<med:code>DO7</med:code>
<med:nlmUniqueID>100955112</med:nlmUniqueID>

<med:issn>0931-184X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100955112:47:9">
<med:volume>47</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244860">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Haematology and plasma biochemistry of Stamboek pre-pubertal gilts in Italy: reference values.</document:title>
<document:abstractSection>Blood samples were taken between February and April from 105 healthy Stamboek pre-pubertal gilts, aged 1-3 months, which were housed at a modern pig farm in northern Italy. The blood was analysed for nine haematological and nine selected haematochemical variables by means of automated and semiautomated blood analysis apparatus. After detection and rejection of outliers, the data were submitted to reference limits evaluation, also taking into account the limits for the red blood cell volume histogram as the anisocytosis index. Some haematological reference values deal with previously published data; in the haematochemical parameters, several discrepancies between evaluated limits and existing reference limits were noted, mainly for aspartate aminotransferase, alanine aminotransferase and lactate dehydrogenase levels and total protein concentration. The results confirm the relevance of age in determining blood reference intervals and that 'normal' values should be determined by each laboratory, taking into account the age of subjects, the sample size and methods of analysis.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M Faustini</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E Munari</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Colombani</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>V Russo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>G Maffeo</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>D Vigo</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Istituto di Fisiologia Veterinaria e Biochimica, Facolt√† di Medicina Veterinaria, Universit√† degli Studi di Milano, Italia. faustima@mailserver.unimi.it</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Age Factors</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Blood Chemical Analysis</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hematologic Tests</document:subject>
<document:subject>Italy</document:subject>
<document:subject>Reference Values</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Blood Chemical Analysis; veterinary</document:subject>
<document:subject>Hematologic Tests; veterinary</document:subject>
<document:subject>Swine; blood</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100955112">
<dc:coverage>Germany</dc:coverage>
<dc:title>J Vet Med A Physiol Pathol Clin Med</dc:title>
<med:code>DO7</med:code>
<med:nlmUniqueID>100955112</med:nlmUniqueID>

<med:issn>0931-184X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100955112:47:9">
<med:volume>47</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244861">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Course of epidermal growth factor (EGF) and insulin-like growth factor I (IGF-I) in mammary secretions of the goat during end-pregnancy and early lactation.</document:title>
<document:abstractSection>The epidermal growth factor (EGF) plays a crucial role in mammogenesis in many species. In ruminants, studies are limited, as EGF does not occur in peripheral plasma and specific analytical systems do not exist. Therefore a heterologous radioimmunoassay based on rhEGF was set up to monitor EGF in mammary gland secretions from goats during end-pregnancy and early lactation. IGF-I was measured with an established radioimmunoassay. Samples were collected from 13 goats for 25 days ante-partum and 25 days post-partum. Mammary gland secretions were obtained ante-partum by removing a small amount of the udder secretions (control half) or milking (stimulated half). Post-partum normal milk samples were collected. Blood samples were drawn by jugular venipuncture for the same period. EGF was found to occur in different molecular weight forms in the mammary glands. For routine measurements these proteins were extracted with acetone and not further separated. IGF-I and EGF concentrations in mammary secretions and similarly IGF-I in blood were high ante-partum and decreased slightly towards birth. IGF-I but not EGF is found in the peripheral plasma. Whereas IGF-I concentrations in blood were quite constant post-partum, IGF-I and EGF dropped in mammary secretions close to the detection limits. The decrease was more pronounced in the stimulated half than in the control half. The data support a synergistic role for EGF and IGF-I for mammogenesis. Both factors are further influenced by the milking stimulus and thus the functional state of the udder.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M Dehnhard</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R Claus</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>O Munz</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>U Weiler</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Institut f√ºr Tierhaltung und Tierz√ºchtung, Universit√§t  Hohenheim, Stuttgart, Germany. thsekret@uni-hohenheim.de</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>
<cas:Chemical rdf:about="urn:cas:62229-50-9">
<cas:registryNumber>62229-50-9</cas:registryNumber>
<cas:name>Epidermal Growth Factor</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:67763-96-6">
<cas:registryNumber>67763-96-6</cas:registryNumber>
<cas:name>Insulin-Like Growth Factor I</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Epidermal Growth Factor</document:subject>
<document:subject>Female</document:subject>
<document:subject>Goats</document:subject>
<document:subject>Insulin-Like Growth Factor I</document:subject>
<document:subject>Lactation</document:subject>
<document:subject>Mammae</document:subject>
<document:subject>Milk</document:subject>
<document:subject>Pregnancy</document:subject>
<document:subject>Puerperium</document:subject>
<document:subject>Radioimmunoassay</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Epidermal Growth Factor; analysis</document:subject>
<document:subject>Epidermal Growth Factor; metabolism</document:subject>
<document:subject>Goats; physiology</document:subject>
<document:subject>Insulin-Like Growth Factor I; analysis</document:subject>
<document:subject>Insulin-Like Growth Factor I; metabolism</document:subject>
<document:subject>Lactation; physiology</document:subject>
<document:subject>Mammae; secretion</document:subject>
<document:subject>Milk; metabolism</document:subject>
<document:subject>Radioimmunoassay; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100955112">
<dc:coverage>Germany</dc:coverage>
<dc:title>J Vet Med A Physiol Pathol Clin Med</dc:title>
<med:code>DO7</med:code>
<med:nlmUniqueID>100955112</med:nlmUniqueID>

<med:issn>0931-184X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100955112:47:9">
<med:volume>47</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244863">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Evaluation of a transportable [Ca++] and pH analyser and of the impact of different anticoagulants and sampling sites in cattle.</document:title>
<document:abstractSection>A mobile, hand-held ionized calcium and pH analyser, the IRMA (Immediate Response Mobile Analyser) SL (Diametrics Medical Inc. St. Paul, MN, USA), was evaluated and results interpreted with help from data derived on biological variation in five dry cows. The maximum allowable analytical imprecision (CMAX) was estimated as 1.33% for [Ca++] and 0.12% for pH; the maximal allowable analytical inaccuracy (BMAX) was estimated to be 1.82% ([Ca++]) and 0.09% (pH), and the maximum allowable difference between two methods (MAXDIFF) was calculated as 0.89% ([Ca++]) and 0.08% (pH). These values were compared with the coefficient of variation obtained by calculation from analysis results in blood samples obtained from 51 cows, heifers and calves. The between-cow coefficient of variation (CV), within-cow CV, critical difference (two-sided) and index of individuality were estimated as 4.77, 2.66 and 14.29%, and 1.08 for [Ca++] analysis. For pH measurements, values of 0.12, 0.24 and 0.96% and 2.95 were estimated. The number of samples required to determine the true value of either [Ca++] or pH in an individual cow was 5 and 1, respectively. Further, it was observed that, in investigations of blood Ca++ and blood pH in cattle, neither the use of electrolyte-balanced syringes interchangeable with sodium-heparin vacutainer nor the use of different blood sampling sites was to be recommended. IRMA SL did not correlate significantly with the chosen reference analyser (Stat Profile 5 Analyser; Nova Biomedical, Waltham, MA) with regard to plasma [Ca++] analyses (correlation coefficient r = -0.24, P = 0.22). However, a significant correlation coefficient (r = 0.63, P &lt; 0.01) was found between analyses of pH performed on IRMA SL and Stat Profile 5 Analyser. Analysis on IRMA SL was very easy to perform. It could be a very useful aid in veterinary clinical practice, when determination of plasma pH in cattle is needed. The analyser should not yet be applied uncritically with respect to [Ca++] analyses in cattle.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>S S Hansen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A L Jensen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R J J√∏rgensen</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Clinical Studies, Royal Veterinary and Agricultural University, Copenhagen, Denmark.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Anticoagulants</document:subject>
<document:subject>
<cas:Chemical rdf:about="urn:cas:7440-70-2">
<cas:registryNumber>7440-70-2</cas:registryNumber>
<cas:name>Calcium</cas:name>
</cas:Chemical>
</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Anticoagulants</document:subject>
<document:subject>Blood Chemical Analysis</document:subject>
<document:subject>Calcium</document:subject>
<document:subject>Cattle</document:subject>
<document:subject>Cattle Diseases</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hydrogen-Ion Concentration</document:subject>
<document:subject>Hypocalcemia</document:subject>
<document:subject>Male</document:subject>
<document:subject>Sensitivity and Specificity</document:subject>
<document:subject>Anticoagulants; chemistry</document:subject>
<document:subject>Blood Chemical Analysis; instrumentation</document:subject>
<document:subject>Blood Chemical Analysis; methods</document:subject>
<document:subject>Blood Chemical Analysis; veterinary</document:subject>
<document:subject>Calcium; analysis</document:subject>
<document:subject>Cattle Diseases; blood</document:subject>
<document:subject>Cattle Diseases; diagnosis</document:subject>
<document:subject>Hypocalcemia; blood</document:subject>
<document:subject>Hypocalcemia; diagnosis</document:subject>
<document:subject>Hypocalcemia; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100955112">
<dc:coverage>Germany</dc:coverage>
<dc:title>J Vet Med A Physiol Pathol Clin Med</dc:title>
<med:code>DO7</med:code>
<med:nlmUniqueID>100955112</med:nlmUniqueID>

<med:issn>0931-184X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100955112:47:9">
<med:volume>47</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244862">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Differential electrocardiographic study on Iberica and Duroc breeds of pig during physical maturation.</document:title>
<document:abstractSection>Sequential electrocardiograms were taken of 50 pigs (25 Iberica and 25 Duroc), from the ages of 5 days to 205 days. The records were analysed to establish the normal values of the different electrocardiographic intervals (RR, QRS, QT, TQ and ST intervals), the diastole/systole quotient and heart score in the first 7 months of life, as well as age-related electrocardiographic variations. In addition, it was intended to determine which of these two breeds showed the greater heart recovery capacity. Finally, positive or negative correlations between the RR interval and the electrocardiographic incidents studied were analysed. The mean values obtained for the electrocardiographic parameters were similar in the two breeds and increased with their physical maturity. Analysis of the correlation between the duration of the heart cycle and the different electrocardiographic incidents showed a positive and significant correlation, the r-values being higher for the RR interval-TQ interval correlation. There was very little correlation between RR interval and heart score in Duroc pigs and practically no correlation between the RR interval and the QRS interval in either breed.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>P Fern√°ndez</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>F M Castej√≥n</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E I Ag√ºera</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B Escribano</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>M D Rubio</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Animal Biology, Section of Physiology, Faculty of Veterinary Medicine, University of Cordoba, Spain. ba1rulum@lucano.uco.es</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Animal</document:subject>
<document:subject>Body Weight</document:subject>
<document:subject>Electrocardiography</document:subject>
<document:subject>Female</document:subject>
<document:subject>Heart</document:subject>
<document:subject>Male</document:subject>
<document:subject>Reference Values</document:subject>
<document:subject>Swine</document:subject>
<document:subject>Electrocardiography; veterinary</document:subject>
<document:subject>Heart; physiology</document:subject>
<document:subject>Swine; classification</document:subject>
<document:subject>Swine; growth &amp; development</document:subject>
<document:subject>Swine; physiology</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:100955112">
<dc:coverage>Germany</dc:coverage>
<dc:title>J Vet Med A Physiol Pathol Clin Med</dc:title>
<med:code>DO7</med:code>
<med:nlmUniqueID>100955112</med:nlmUniqueID>

<med:issn>0931-184X</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:100955112:47:9">
<med:volume>47</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244864">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>Production of reactive oxygen species in neutrophils after repeated bouts of exercise in standardbred trotters.</document:title>
<document:abstractSection>Six trained Standardbred trotters exercised on a  racetrack on 2 days with a 3-day interval. On both exercise days the horses trotted three different exercise bouts with increasing intensity with 60-min intervals. Exercise-induced stress was manifested as leucocytosis, an increase in the neutrophil:lymphocyte (N:L) ratio, and increased capacity to produce reactive oxygen species in the peripheral blood as indicated by an increase in whole blood chemiluminescence. The leucocytosis was mainly due to neutrophilia, which lasted for 6 h. Production of reactive oxygen species per single neutrophil showed no significant change during a day of exercise, but was lower on the second exercise day. The cortisol concentrations and N:L ratio, used as indicators of stress, behaved differently: Cortisol did not change significantly after exercise, whereas the N:L ratio increased. These results suggest that in trained horses, the N:L ratio is a sensitive indicator of stress of short duration, and an attenuated N:L response can be taken as an indicator of adaptation to exercise stress.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>P A Korhonen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>E M Lilius</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>S Hyypp√§</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L A R√§s√§nen</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A R P√∂s√∂</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Department of Basic Veterinary Sciences, University of Helsinki, Helsinki, Finland.</dc:contributor>
<dc:language>eng</dc:language>
<document:subject>Reactive Oxygen Species</document:subject>
<document:subject>Animal</document:subject>
<document:subject>Chemiluminescence</document:subject>
<document:subject>Female</document:subject>
<document:subject>Horses</document:subject>
<document:subject>Leukocytosis</document:subject>
<document:subject>Male</document:subject>
<document:subject>Neutrophils</document:subject>
<document:subject>Physical Conditioning, Animal</document:subject>
<document:subject>Reactive Oxygen Species</document:subject>
<document:subject>Stress</document:subject>
<document:subject>Support, Non-U.S. Gov't</document:subject>
<document:subject>Horses; metabolism</document:subject>
<document:subject>Leukocytosis; veterinary</document:subject>
<document:subject>Neutrophils; metabolism</document:subject>
<document:subject>Physical Conditioning, Animal; physiology</document:subject>
<document:subject>Reactive Oxygen Species; metabolism</document:subject>
<document:subject>Stress; veterinary</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0140722">
<dc:coverage>France</dc:coverage>
<dc:title>Ann Chir</dc:title>
<med:code>50E</med:code>
<med:nlmUniqueID>0140722</med:nlmUniqueID>

<med:issn>0003-3944</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0140722:125:9">
<med:volume>125</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244586">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Radiofrequency: storm looming over hepatic surgery]</document:title>
<document:author>
<feature:Person>
<feature:name>D Elias</feature:name>
</feature:Person>
</document:author>
<dc:language>fre</dc:language>
<document:subject>Catheter Ablation</document:subject>
<document:subject>Diffusion of Innovation</document:subject>
<document:subject>Evidence-Based Medicine</document:subject>
<document:subject>Hepatectomy</document:subject>
<document:subject>Human</document:subject>
<document:subject>Laparoscopy</document:subject>
<document:subject>Liver Neoplasms</document:subject>
<document:subject>Treatment Outcome</document:subject>
<document:subject>Ultrasonography, Interventional</document:subject>
<document:subject>Catheter Ablation; methods</document:subject>
<document:subject>Catheter Ablation; trends</document:subject>
<document:subject>Hepatectomy; methods</document:subject>
<document:subject>Hepatectomy; trends</document:subject>
<document:subject>Laparoscopy; methods</document:subject>
<document:subject>Laparoscopy; trends</document:subject>
<document:subject>Liver Neoplasms; surgery</document:subject>
<document:subject>Ultrasonography, Interventional; methods</document:subject>
<document:subject>Ultrasonography, Interventional; trends</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0140722">
<dc:coverage>France</dc:coverage>
<dc:title>Ann Chir</dc:title>
<med:code>50E</med:code>
<med:nlmUniqueID>0140722</med:nlmUniqueID>

<med:issn>0003-3944</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0140722:125:9">
<med:volume>125</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244587">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Curative treatment of local and regional rectal cancer recurrences]</document:title>
<document:abstractSection>How to select patients likely to benefit from reoperation? When a neoadjuvant treatment is still feasible, is it useful to perform preoperative radiation or chemoradiation? What can be expected after resection of local recurrences in terms of survival and quality of life? Does surveillance of patients operated for rectal carcinoma influence resectability of local recurrences and results? These are the main questions concerning the management of local recurrences after resection of a rectal carcinoma.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>J R Delpero</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Lasser</feature:name>
</feature:Person>
</document:author>
<dc:contributor>D√©partement de chirurgie, institut Paoli-Calmettes, 232, boulevard de Sainte-Marguerite, 13273 Marseille, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Aftercare</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Human</document:subject>
<document:subject>Neoplasm Recurrence, Local</document:subject>
<document:subject>Patient Selection</document:subject>
<document:subject>Postoperative Care</document:subject>
<document:subject>Preoperative Care</document:subject>
<document:subject>Prognosis</document:subject>
<document:subject>Radiotherapy, Adjuvant</document:subject>
<document:subject>Rectal Neoplasms</document:subject>
<document:subject>Reoperation</document:subject>
<document:subject>Survival Analysis</document:subject>
<document:subject>Treatment Outcome</document:subject>
<document:subject>Neoplasm Recurrence, Local; diagnosis</document:subject>
<document:subject>Neoplasm Recurrence, Local; mortality</document:subject>
<document:subject>Neoplasm Recurrence, Local; surgery</document:subject>
<document:subject>Rectal Neoplasms; diagnosis</document:subject>
<document:subject>Rectal Neoplasms; mortality</document:subject>
<document:subject>Rectal Neoplasms; surgery</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0140722">
<dc:coverage>France</dc:coverage>
<dc:title>Ann Chir</dc:title>
<med:code>50E</med:code>
<med:nlmUniqueID>0140722</med:nlmUniqueID>

<med:issn>0003-3944</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0140722:125:9">
<med:volume>125</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244588">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Proximal bile duct cholangiocarcinomas]</document:title>
<document:abstractSection>AIM: The aim of this retrospective study was to report a series of 12 patients with hilar cholangiocarcinoma treated by curative resection. PATIENTS AND METHODS: Between 1980 and 1998, curative resection was performed in 12 patients out of 33 patients with a Klatskin's tumor. Preoperative biliary drainage was performed in 6 cases. Resection was limited to the extrahepatic bile duct in one case only. Resection was extended to the liver in 11 cases including segmentectomy I (n = 9), left hepatectomy (n = 7), right hepatectomy (n = 3) and segmentectomy IV (n = 1). Postoperative brachytherapy was performed in 3 patients combined with conventional radiotherapy. Conventional radiotherapy irradiation was performed in 2 patients and was associated with chemotherapy in 1 patient. RESULTS: There was no postoperative mortality. Postoperative follow-up was uneventful in 5 patients. Actuarial survival rate at 1, 2, 3, and 5 years was 81, 57, 28 and 28%, respectively. Prolonged survivals (88 and 114 months) were observed. CONCLUSION: Hilar cholangiocarcinomas have a poor prognosis. Curative resections are usually performed with major liver resections. RM cholangiography is now the most efficient examination for selection of surgical indications and choice of the best strategy. Long-term survival can be obtained with curative surgery. Adjuvant treatment has to be assessed by controlled trials.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>M C Blanchet</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Ducerf</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>L Benoit</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J P G√©rard</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J Baulieux</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de chirurgie digestive et de la transplantation h√©patique, h√¥pital de la Croix-Rousse, 103, grande rue de la Croix-Rousse, 69317 Lyon, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Antineoplastic Agents</document:subject>
<document:subject>Actuarial Analysis</document:subject>
<document:subject>Aged</document:subject>
<document:subject>Aged, 80 and over</document:subject>
<document:subject>Antineoplastic Agents</document:subject>
<document:subject>Bile Duct Neoplasms</document:subject>
<document:subject>Brachytherapy</document:subject>
<document:subject>Cholangiocarcinoma</document:subject>
<document:subject>Cholangiography</document:subject>
<document:subject>Combined Modality Therapy</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Hepatectomy</document:subject>
<document:subject>Human</document:subject>
<document:subject>Male</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Patient Selection</document:subject>
<document:subject>Retrospective Studies</document:subject>
<document:subject>Survival Analysis</document:subject>
<document:subject>Treatment Outcome</document:subject>
<document:subject>Antineoplastic Agents; therapeutic use</document:subject>
<document:subject>Bile Duct Neoplasms; diagnosis</document:subject>
<document:subject>Bile Duct Neoplasms; mortality</document:subject>
<document:subject>Bile Duct Neoplasms; therapy</document:subject>
<document:subject>Cholangiocarcinoma; diagnosis</document:subject>
<document:subject>Cholangiocarcinoma; mortality</document:subject>
<document:subject>Cholangiocarcinoma; therapy</document:subject>
<document:subject>Hepatectomy; methods</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0140722">
<dc:coverage>France</dc:coverage>
<dc:title>Ann Chir</dc:title>
<med:code>50E</med:code>
<med:nlmUniqueID>0140722</med:nlmUniqueID>

<med:issn>0003-3944</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0140722:125:9">
<med:volume>125</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244589">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Cholelithiasis in heart transplant patients]</document:title>
<document:abstractSection>The incidence of cholelithiasis is increased in heart transplant recipients. STUDY AIM: The aim of this retrospective study was to report a series of 27 heart transplant recipients operated for cholelithiasis and to assess the indications and safety of cholecystectomy in this population. PATIENTS AND METHODS: Over a 9-year period, from January 1991 to December 1999, 27 heart transplant recipients (21 men and 6 women; mean age: 54.6 years, mainly transplanted for ischemic or dilated cardiomyopathy) underwent cholecystectomy. All patients received immunosuppressive therapy with a combination of corticosteroids and cyclosporin and 10 also received azathioprine. Five patients admitted urgently with calculous acute cholecystitis and one patient with previous gastrectomy underwent laparotomy, while the other 21 patients were operated by laparoscopy. RESULTS: There were no postoperative deaths. In patients operated by laparoscopy, there was no conversion to laparotomy and oral immunosuppressive drugs were continued without interruption. There was one postoperative hemoperitoneum related to liver biopsy performed concomitantly. In patients operated by laparotomy, intravenous cyclosporin was necessary until return to bowel function and the only complication was a wound abscess. Mean length of hospital stay was 3.1 days after laparoscopy and 8.8 days after laparotomy. CONCLUSION: Systematic ultrasound screening of cholelithiasis after heart transplantation is necessary because cholelithiasis carries a risk of septic complications in these patients. Laparoscopic cholecystectomy, associated with a low morbidity, is justified even in asymptomatic cases. In patients with acute cholecystitis, "open" cholecystectomy must be preferred in order to minimize the risk of biliary complications which would be very serious in these immunosuppressed patients.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>F Menegaux</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>C Huraux</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>P Jordi-Galais</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R Dorent</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J J Ghossoub</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>A Pavie</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>I Gandjbakhch</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>J P Chigot</feature:name>
</feature:Person>
</document:author>
<dc:contributor>Service de chirurgie g√©n√©rale et digestive, h√¥pital de la Piti√©, 47-83 boulevard de l'H√¥pital, 75651 Paris, France. fabrice.menegaux@psl.ap-hop-paris.fr</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Immunosuppressive Agents</document:subject>
<document:subject>Adult</document:subject>
<document:subject>Aged</document:subject>
<document:subject>Cholecystectomy</document:subject>
<document:subject>Cholelithiasis</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Female</document:subject>
<document:subject>Heart Transplantation</document:subject>
<document:subject>Human</document:subject>
<document:subject>Immunosuppressive Agents</document:subject>
<document:subject>Incidence</document:subject>
<document:subject>Laparoscopy</document:subject>
<document:subject>Male</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Myocardial Diseases</document:subject>
<document:subject>Retrospective Studies</document:subject>
<document:subject>Risk Factors</document:subject>
<document:subject>Safety</document:subject>
<document:subject>Treatment Outcome</document:subject>
<document:subject>Cholecystectomy; adverse effects</document:subject>
<document:subject>Cholecystectomy; methods</document:subject>
<document:subject>Cholelithiasis; diagnosis</document:subject>
<document:subject>Cholelithiasis; etiology</document:subject>
<document:subject>Cholelithiasis; surgery</document:subject>
<document:subject>Heart Transplantation; adverse effects</document:subject>
<document:subject>Heart Transplantation; immunology</document:subject>
<document:subject>Immunosuppressive Agents; therapeutic use</document:subject>
<document:subject>Laparoscopy; adverse effects</document:subject>
<document:subject>Laparoscopy; methods</document:subject>
<document:subject>Myocardial Diseases; surgery</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
<med:Journal rdf:about="urn:nlm:0140722">
<dc:coverage>France</dc:coverage>
<dc:title>Ann Chir</dc:title>
<med:code>50E</med:code>
<med:nlmUniqueID>0140722</med:nlmUniqueID>

<med:issn>0003-3944</med:issn>
<med:journalIssue>
<med:JournalIssue rdf:about="urn:nlm:0140722:125:9">
<med:volume>125</med:volume>
<med:issue>9</med:issue>
<med:publicationDate>
<date:Date>
<date:year>2000</date:year>
<date:month>Nov</date:month>
</date:Date>
</med:publicationDate>
<med:article>
<document:Document rdf:about="urn:pmid:11244590">
<med:creationDate>
<date:Date>
<date:year>2001</date:year>
<date:month>03</date:month>
<date:day>13</date:day>
</date:Date>
</med:creationDate>
<med:completionDate>
<date:Date>
<date:year>2001</date:year>
<date:month>04</date:month>
<date:day>05</date:day>
</date:Date>
</med:completionDate>
<document:title>[Immediate postoperative complications after a laparoscopic partial posterior fundoplication. Early laparoscopic reoperation]</document:title>
<document:abstractSection>AIM OF THE STUDY: The immediate postoperative course of laparoscopic partial posterior fundoplication can be complicated by severe dysphagia or paraesophageal hernia. The aim of this study was to describe the technical causes of these complications. PATIENTS AND METHOD: Four patients, operated for gastroesophageal reflux disease by laparoscopic partial posterior fundoplication, developed severe dysphagia (n = 2) or paraesophageal hernia (n = 2) during the immediate postoperative period. A barium swallow examination visualized the complication in both cases of dysphagia and in 1 case of paraesophageal hernia. The correct diagnosis was established by CT scan in the other case of paraesophageal hernia. Reoperations were performed by laparoscopy, 3 days (n = 2) or 6 days (n = 2) postoperatively. RESULTS: Dysphagia was due to compression of the esophagus against the hiatus by the fundoplication. A new and looser fundoplication was easily performed. Dysphagia was no longer present postoperatively. The two patients were symptom-free after 6 and 12 months of follow-up, respectively. In the cases of paraesophageal hernia, the bottoms of the crura were torn. In the patient reoperated 3 days postoperatively, the procedure was easily performed, the postoperative course was uneventful and the patient was symptom-free after a follow-up of 20 months. In the patient reoperated 6 days postoperatively, the upper part of the stomach had moved into the left pleural cavity, the procedure was difficult due to inflammation and thickening of the gastric wall, and the postoperative course was uneventful, but reflux recurred 18 months later. CONCLUSION: When severe dysphagia or paraesophageal hernia occurs during the immediate postoperative course of laparoscopic partial posterior fundoplication, reoperation, possibly by laparoscopy, identifies and cures the technical defects. Based on our experience, we suggest that surgical cure of paraesophageal hernia is easier when performed during the immediate postoperative period.</document:abstractSection>
<document:author>
<feature:Person>
<feature:name>G Sciaudone</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>T Perniceni</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>R Chiche</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>H Levard</feature:name>
</feature:Person>
</document:author>
<document:author>
<feature:Person>
<feature:name>B Gayet</feature:name>
</feature:Person>
</document:author>
<dc:contributor>D√©partement m√©dicochirurgical de pathologie digestive, institut mutualiste montsouris, universit√© Paris VI, 42, boulevard Jourdan, 75014 Paris, France.</dc:contributor>
<dc:language>fre</dc:language>
<document:subject>Adult</document:subject>
<document:subject>Case Report</document:subject>
<document:subject>Deglutition Disorders</document:subject>
<document:subject>English Abstract</document:subject>
<document:subject>Esophagoscopy</document:subject>
<document:subject>Female</document:subject>
<document:subject>Follow-Up Studies</document:subject>
<document:subject>Fundoplication</document:subject>
<document:subject>Gastroscopy</document:subject>
<document:subject>Hernia, Hiatal</document:subject>
<document:subject>Human</document:subject>
<document:subject>Male</document:subject>
<document:subject>Middle Age</document:subject>
<document:subject>Reoperation</document:subject>
<document:subject>Risk Factors</document:subject>
<document:subject>Time Factors</document:subject>
<document:subject>Tomography, X-Ray Computed</document:subject>
<document:subject>Treatment Outcome</document:subject>
<document:subject>Deglutition Disorders; etiology</document:subject>
<document:subject>Deglutition Disorders; radiography</document:subject>
<document:subject>Deglutition Disorders; surgery</document:subject>
<document:subject>Esophagoscopy; adverse effects</document:subject>
<document:subject>Esophagoscopy; methods</document:subject>
<document:subject>Fundoplication; adverse effects</document:subject>
<document:subject>Fundoplication; methods</document:subject>
<document:subject>Gastroscopy; adverse effects</document:subject>
<document:subject>Gastroscopy; methods</document:subject>
<document:subject>Hernia, Hiatal; etiology</document:subject>
<document:subject>Hernia, Hiatal; radiography</document:subject>
<document:subject>Hernia, Hiatal; surgery</document:subject>
</document:Document>
</med:article>
</med:JournalIssue>
</med:journalIssue>
</med:Journal>
</rdf:RDF>
